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1037-3 Statewide Risk Modeling for CABG Postoperative Length of 
Stay and the Importance of Patient Reported Health Status: 
Data From the Pilot Phase of the Washington State Cardiac 
Outcomes Assessment Program 
Gilbert Johnston, Judith Malmgren, Richard Goss, John Spertus. Franciscan Health 
System; Sf Joseph Hospital, Tacoma, WA, University of Washington, Se&f/e, WA 
Background: Assessing Surgical Length of Stay (SLOS) as a possible quality of care 
indicator for hospital programs within a state requires quantification of the relative contra- 
butions of factors influencing the outcomes. Preoperative health status is the major 
determinant of postoperative outcome assuming common methods of management and 
a standard quality of care. Standardized, patient reported, preoperative “health status” 
as a determinant of SLOS among multiple centers has not been quantified previously for 
CABG. 
Methods: In the pilot phase of the Washington State Outcomes Assessment Program, 
patient case Series cohorts at all hospitals with a cardiac surgery program were adminis- 
tered preoperative SF-36 and Seattle Angina Questionnaires (SAQ) in addition to the col- 
lection of prospective STS clinical data sets. Factors found significant with bivariate 
analysis or indicated significant from the literature were incorporated Into a logistic 
regression model to assess relative association with prolonged SLOS (>= 7 days). 
Results: “Hospital site” SLOS accounted for the greatest degree of variance. Adjusting 
for “hospital site”, age, gender, comorbid conditions, and pre-op acuity status, analysis of 
other elements wet’e rank ordered in a ‘top 7” decreasing order by the odds of increasing 
SLOS to >= 7days (Table). 
Variable Odds Ratio 95% Cl Beta Wald X’ P Value 
Hospital Site Reference 34.8 0.000 
Pre-Op IABP 3.02 1.15-7.96 1.1056 5.01 0.025 
Clinical CHF 2.71 1.52-4.82 0.9987 ii.63 0.001 
Acuity Status: EmergfSalvg 2.40 1.05-5.48 0.8747 4.31 0.038 
SF-36 Health Perceptions 2.10 1.34-3.27 0.7392 10.52 0.001 
SAQ Angina1 Freq 1.72 1.1 i-Z.65 0.5409 5.96 0.015 
Age > 75 1.54 1.08-2.19 0.4288 5.46 0.018 
Conclusion: The Health Perceptions subscore of the SF-36 and SAQ Angina Frequency 
are significantly associated with prolonged SLOS. Use of these two measures is a sub- 
stantial refinement in risk-adjusting SLOS predictions and may prove to be very powerful 
in predicting length of stay. 
1037-4 Health Status Predicts Long-Term Outcome in Patients With 
Coronary Artery Disease 
Philip G. Jones, John A. Spertus, Mary McDonell, Vincent Fan, Stepha” D. Fihn. Mid 
America Heart lnsfitufe, Kansas Cify, MO 
Background: Health status meawres are being increasingly used as endpoints in clini- 
cal trials and observational studies. Validating these measures against “hard” clinical 
outcomes could improve their acceptability, enhance assessment of health care quality 
and assist in disease management. 
Methods: This study was part of the Ambulatory Care Quality Improvement Project, a 
randomized trial conducted from 1197.12199 in 6 Veterans Affairs medical centers. 5,558 
outpatients with coronary artery disease (CAD) were given the Seattle Angina Question- 
naire (SAQ), a 19-i&m disease-specific health status instrument, and followed for up to 2 
years. The prognostic ability of the SAQ was evaluated for survival and admission for 
acute coronary syndrome (ACS), both univariately and in multivariable models controlling 
for demographic and clinical factors. 
Results: In univariate analyses, SAQ Physical Limitation (PL) and Angina Frequency 
(AF) scores were highly predictive of mortality and ACS. Kaplan-M&r survival by PL 
score is shown in the figure (higher scores imply less limitation). Odds ratios (ORs) for l- 
year mortality for patients with PL scores of O-24, 25-49 and 50-74 were 6.2,2.5 and 1.6 
versus those scoring 75-100 (p<O.OOi). ORs for respective AF ranges were 2.6, 1.8 and 
1 .O (p<O.OOl). These scales remained predictive after controlling for clinical factors (mul- 
tivariate ORs for PL = 4.0, 2.0, 1.5 (p<O.OOl), AF = 1.6, 1.2, 0.8 (p=O.OS)). Independent 
predictors of death in order of decreasing significance included SAQ PL, age (pcO.001). 
CHF (p<O.OOi), cancer (p=O.O3) and SAQ AF. Similar results were found for l-year ACS. 
Inclusion of SAQ scales significantly increased discriminative power over clinical models 
alone. 
Conclusion: SAQ scores are associated with i-year mortality and ACS in outpatients 
with CAD, and provide additional prognostic value over standard clinical predictors. 
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1037-I Predictors of Quality of Life 6 Months and 1 Year After Acute 
Myocardial Infarction 
Christine Beck, Lawrence Joseph, Mark J. Eisenberg, Thao Huynh, Jean G. Diodati, 
Normand Racine, Fran@ Charbonneau, Claude LBvesque, Claude Lauzon, Suzanne 
Carignan, Danielle Dion, Rene Roux, JogI Pouliot, Louise Pilote. Montreal General 
Hospifal, Montreal, PO, Canada 
Background: Quality of life (QOL) is a” increasingly important outcome meawre follow- 
ing hospital admission for acute myocardial infarction (AMI), but the ability to adjust these 
outcomes for pre-admission differences is limited because the predictors of QOL after 
AMI are unknown. Methods: To identify any clinical, demographic and psychosocial 
characteristics of patients at baseline that were independent predictors of QOL 6 months 
and 1 year after AMI, we measured physical and mental QOL (SF-36 Physical and Men- 
tal Component Scores), and ovsrall QOL (EuroQol health perception scale) for a pro- 
spective cohort of 587 patients admitted at 10 hospitals in Quebec. Significant predictors 
of each outcome measure were identified using the Bay&an Information Criterion for 
multivariate linear regression model selection. Results: Mean physical, mental and over- 
all QOL scwes corresponding to the time immediaiely before admission (baseline) were 
45 (SD il), 47 (SD 11) and 70 (SD 21), respectively. By 1 year, mean physical, mental 
and overall QOL scores were close to baseline (45 (SD 1 I), 48 (SD 11) and 73 (SD 18), 
respectively). The predictors of physical, mental and overall QOL were similar at 6 
months and 1 year. The predictors of physical QOL were the corresponding score at 
baseline, age and previous bypass surgery (8 coefficients at 1 year: 0.5, -0.1, -5.3; 95% 
Cls 0.4 to 0.5, -0.2 to -0.1, -9.2 to -1.3, respectively). The predictors of mental QOL 
were the corresponding score at baseline and depression (8 at 1 year: 0.3, -0.3; 95% Cls 
0.2 to 0.4, -0.5 to -0.2, respectively). Predictors of overall QOL included the correspond- 
ing score at baseline and age (8 at 1 year: 0.2, -0.3; 95% Cls 0.1 to 0.3, -0.4 to -0.1, 
respectively). Depression was also a predictor of impaired physical and overall QOL at 6 
months. We did not identify any clinical characteristics related to the severity of AMI or 
treatments received in-hospital that were predictors of QOL. Conclusions: These results 
suggest that age and psychosocial characteristics at baseline are the most important 
predictors of QOL after AMI. Other clinical characteristics and treatments received in- 
hospital do not appear to affect patients’ long-term perceptions of QOL. 
1037-2 A Prospective Cohort Study of Quality of Life After Acute 
Myocardial Infarction at Sites With and Without Coronary 
Angiography 
Louise Pilote, Thao Huynh, Lawrence Joseph, Jean G Diodati, Ncrmand Racine, 
Franqois Charbonneau, Claude L&esque, Claude Lauzon, Suzanne Carignan, Danielle 
Dion, Rem& Roux, Pouliot JoBI, Mark J. Eisenberg. Monfreal General Hospital, Montreal, 
PO, Canada 
Background: Previous international studies suggest that in comparison with the conser- 
vative management of AMI. invasive management is associated with similar mortality 
rates but superior quality of life (QOL) and functional status (FS). However, cultural rather 
than medical care differences could explain these findings. Methods: To compare out- 
comes of a” invasive versus a conservative management within a single country, we 
measured QOL and FS in AMI patients treated in Quebec at 5 sites with (n=334) and 5 
sites without (“=253) availability of angiography. Results: At baseline, clinical character- 
istics, complication rates, QOL and FS were similar at sites with and without angiography. 
During hospitalization, patients treated at sites with angiography were more likely to 
undergo a” invasive procedure than patients admitted at sites without angiography 
(angiography 63% vs 26%, PTCA 35% vs 13% and CABG 11% vs 5%). At 30 days and 6 
months, QOL was slightly superior at sites with angiography but by 1 year, the differences 
disappeared. For example, at 30 days, health perception on a scale of 0 (death) - 100 
(perfect health) was superior at sites with angiography (69 vs 62, 95% Cl: 4-11). At 6 
months, most QOL scores were similar except for the SF-36 role-limitations physical 
(adjusted difference 9, 95% Cl: Z-16) and emotional (12, 95% Cl: 5-20) scores, which 
were higher at sites with angiography. Return to work occurred earlier at sites with 
angiography (at 30 days, 23% vs 12%). but patients at both sites obtained similar scores 
for physical activity. Fewer patients were readmitted for angina at sites with angiography 
within 1 year (12% vs 18%). By 1 year, most measures were back to baseline at both 
sites and were similar between the two groups. Conclusion: At 30 days, QOL of patients 
admitted at sites with angiography was slightly superior compared with patients admitted 
ai sites without angiography. But by 1 year, QOL of patients treated with a conservative 
approach was similar to that of patients treated more aggressively. Differences I” QOL 
were greatest when differences in treatment were greatest, lending support to a positive 
albeit small association between an aggressive approach to post-AM1 care and improved 
QOL. 
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1037-5 Quality of Life Does Not Predict Utilities: Implications for 
Clinical Trials Examining the Cost-Effectiveness of 
Treatment 
John A. Spertus, Philip G. Jones, Robert Nease, Brent D. Bliven, William E. Boden, 
Pamela M. Hartigan, Robert A. O’Rourke, William S. Weintraub. MidAmerica Heart 
Instifute, Kansas City, MO 
program. Patients reviewed a CHF teaching tape as well as received instructions on fol- 
lowing a low salt diet, recording daily weights, using sliding scale diuretkx for > 2 pound 
weight gain or optional outpatient IV diuretics for > 5 pound weight gain to avert erner- 
gency department(ED) visits or hospital admissions. 85% were placed on ace inhibitors 
and 48% were started on beta blocker therapy. Results: The mean age was 56 +I- 14 
years and 48% were female. Follow up was nine months +I- 10 weeks. ED visits for this 
cohort were reduced by 60% as compared to historical control. Length of stay and hospi- 
tal admissions were reduced by 68% and 72%, respectively with a cost savings esti- 
mated at $470,000. Summary: Implementation of a CHF disease management model 
applied to an indigent population was proven both feasible and cost effective, requiring 
no additional institutional expenditures, and resulting in fewer ED visits, fewer hospital 
admissions and reduced length of stay. 
Introduction: Cost-effectiveness(CE) analyses are becoming an increasingly important 
consideration in the design and implementation of clinical trials. Determining CE 
requires an assessment of patients’ utilities (range = O-l where O=death and l=a state of 
perfect health). The gold standard for determining utilities is the Standard Gamble(SG), 
a complicated technique of eliciting patients’ preferences (or willingness) to risk dying in 
order to be rid of their disease. The COURAGE trial, a 3,260 patient trial comparing opti- 
mal medical therapy +/- percutaneous coronary intervention, chose to explicitly mea?.ure 
patients’ utilities with a computerized version of the SG. This analysis was conducted to 
see whether utilities could have been estimated from quality of life (QOL) questionnaires 
and whether the expense of explicitly measuring patient utilities was warranted. 
Methods and Results: Baseline data from the first 191 pts in COURAGE were analyzed 
to correlate QOL measures (the Seattle Angina Questionnaire(SAQ) and SF-36) with the 
SG. To facilitate interpretation, SAQ scores were grouped into the following ranges: O- 
24, 25-49, 50-74 and 75-100. No significant correlations were detected among SAQ 
scores and SG utilities. Whereas patients with the highest ranges of SAQ scores consis- 
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tently had better mean utilities than those in the lowest range, the variability among 
patient groups was large. This was particularly true for the percentage of patients report- 3:oo pm. 
ing a perfect utility of 1. For example, among the 53 patients reporting ‘quite a bit’ to 1002-201 Predicting In-Hospital Mortality in Acute Type A Aortic 
‘extreme’ limitations in their QOL due to angina, 38% would be unwilling to aswme any Dissection: Lessons From the international Registry of 
risk of dying to be rid of their disease (SG utility = 1). Aortic Dissection (IRAD) 
Conclusion: Patients’ preferences for assuming risk to be treated for their coronary dis- 
ease can not be readily predicted from the severity of their disease, This is because 
assessing patients’ willingness to accept risk is far more cognitively complex than deter- 
mining how they feel. Clinical trials seeking to determine the CE of treatment should pro- 
spectivelv collect the SG, as is beinq done in COURAGE, so as to accurately a.w?ss 
Ftajendra H. Mehta, Peter G. Hagan, Tow Suzuki, Eduardo Bossone, Dan Gilon, Alfredo 
Llovet, Jeanna Cooper, Linda Pape, William F Armstrong, David Bruckman, Christoph A. 
Nienaber, Kim A. Eagle. University of Michigan Center for /RAD Investigators, Ann Arbor, 
M/, University Eppendorf, Hamburg, Germany 
patients’ utilities. 
1037-6 Poor Quality of Life in Women With Chest Pain and Normal 
Angiograms: The NHLBI-Sponsored WISE Study 
Marian B. Olson, C. Noel Bairey Merz, Barry Sharaf, Sheryl F. Kelsey, Gerald Pohost, 
Diane Vido, Karen Matthews, Carol Cornell, Angela Cardello, Susan McGorray. 
University of Pittsburgh, Pittsburgh, PA 
Background: Prior work from WISE has documented that some women with chest pain 
and normal angiograms have cardiac ischemia related to microvascular coronary dis- 
ease. The impact of this ischemia on quality of life has not been assessed. Methods: 
The WISE (Women’s lschemia Syndrome Evaluation) is a four center study of women 
undergoing coronary angiography for suspected ischemia. At the baseline visit, WISE 
evaluated the quality of life of 234 women ages 21-83 (mean 56 yrs) who had been 
assessed through traditional noninvasive testing (exercise stress, dobutamine stress, 
radionuclide perfusion). lschemia was defined as a positive response on any test. WISE 
also evaluated 68 ‘normal’ (reference) women of similar ages (mean: 49 yrs, range: 32- 
72)without coronary risk factors or chest pain symptoms. The general quality of life (GR) 
rating was evaluated on a scale ranging from 0 (worst) to 10 (best). Higher Duke Activity 
Status Index (DASI) scores show greater functional capacity while higher scores on the 
psychosocial scales (Beck Depression Inventory, and Speilberger Anxiety) indicate more 
symptoms of depression or anxiety. Results: There was no relationship between the 
quality of life markers and traditional ischemia testing. 
Reference No/Minimal CAD Significant CAD p value 
(Normal) with lschemia with lschemia (=ge- 
(n=68) (n=129) (n=i 05) adjusted) 
General Rating 8.9 6.9 7.4 0.0001 
Duke Activity Sta- 52.4 23.5 19.4 0.0001 
tus Index 
I  I . .  I 
cians in the optimal management of such patients. Methods: We evaluated 474 patients 
Background: Given the high mortality high mortality in patients with type A aortic dissec- 
tion (AAD). oredictive tools to identifv oatients at risk of death are needed to assist clini- 
(mean age 62+14 yrs, males 64%) with acute type A aortic dissection from IRAD col- 
lected from 17 centers from 1996-1997. Univariate associations of mortality and multi- 
variate logistic regression modeling using any variables suggestive of marginal 
association (p ~0.20) were tested. Results: In-hospital mortality occurred in 33% of AAD 
patients. Age >65 yrs, female gender, medical as opposed to surgical management, or 
presenting symptoms of abrupt onset and migrating characteristic of chest pain, systolic 
blood pressure (SBP) < 100 mmHg, pulse deficits, presence of neurologic changes, and 
ECG evidence of new Q waves were identified as univariate predictors of mortality (p c 
0.05 for all). Multivariate predictive model is as shown. The area under ROC for the 
model was 0.758 with an adequate fit (Hosmer-Lemeshaw Chi-square = 2.93, degree of 
freedom 6, and p=O.81) 
Variables At Presen- Overall % Among % Among Model Mortality-odds 
tation Tvoe A % Survivors Deaths P-value Ratio (95%ci) 
Beck Depression 
Inventory 
Speilberger Anxi- 
ety 
4.1 9.4 10.1 0.0001 
16.4 18.7 18.4 0.03 
Conclusion: In contrast to ‘normal (reference) women, women with chest pain and nor- 
mal coronary arteries have similarly poor quality of life ratings as women with CAD. The 
implications of this finding suggest a common pathophysiology for poor quality of life in 
women with and without CAD, possibly due to be myocardial ischemia. 
1037-7 The Experience of a Cost Effective Congestive Heart Failure 
Disease Management Model Applied to an Indigent 
Population 
Kathy A. Hebert, Lee M. Arcement, Liz Duke, Tommy Ferguson, Hector Ventura. Chabert 
Medical Center. Houma, LA, Ochsner Medical Foundation, New Orleans, LA 
Backgroud: Cost effective congestive heart failure(CHF) disease management models 
have been successfully applied in the private health care setting. We sought to determine 
the feasibility, expense and ramifications of applying such a model to an indigent popula- 
tion as a paucity a data exists in this setting. Methods: Chabert Medical Center is one of 
nine hospitals in the LSU statewide public health system and approximately 120,000 out- 
patient visits(76% indigent, 24% Medicare) occur each year including 567 patients identi- 
fied by ICD 9 billing codes as having CHF. Without additional funding or resources, 146 
patients with CHF or asymptomatic left ventricular dysfunction(ejection fraction < 30%) 
were enrolled from July 1997 to October 1999 into a structured teaching and treatment 
I I  
Age >65 years 44.5 40.4 52.9 0.071 1.55 (0.96, 2.49) 
Migrating chest pain 14.3 11.9 19.2 0.012 2.22(1.19,4.11) 
SBP < 100 mmHg 28.7 19.4 47.4 ~0.001 3.20 (1.92, 5.32) 
Any pulse deficit 20.7 14.4 33.1 <O.OOl 2.57 (1.48, 4.46) 
Neurologic deficit 23.6 17.4 36.3 0.043 1.93 (1.02, 3.66) 
Medical (as opposed 22.2 15.0 38.1 <O.OOl 3.56 (2.08, 6.07) 
to surgical) treat- 
ment 
Conclusions: Mortality for AAD can be predicted in practice using clinical predictive 
tools. Our current model provides physicians with a simple tool to assess risks and better 
manage patients with AAD. 
3:12 pm. 
1002-202 True Versus Reported Waiting Times for Valvular Aortic 
Stenosis Surgery 
Bradley I. Munt, Karin H. Humphries, Min Gao, Christopher R. Thompson. University of 
British Columbia, Vancouver, BC, Canada, Centre for Health Evaluation & Outcome 
Sciences, Vancouver, BC, Canada 
Background: No universally accepted definition of waiting time for cardiovascular sur- 
gery exists hampering research and comparison across jurisdictions. The aim of this 
project was to develop a universally acceptable waiting time definition for cardiovascular 
surgery that meets the following criteria: 1. The time interval is representative of the time 
the patient is at risk for morbidity and mortality. 2. The time interval is applicable and 
reproducible across all jurisdictions. 3. The time interval is easily and inexpensively 
tracked (i.e. u$ng existing databases. Methods: All residents of British Columbia (BC)22 
yeari or older placed on the waiting list for valvular aortic stenosis surgery, between Jan- 
uary 1, 1991 and March 31, 1998 were eligible for this study. Dates of physician visits, 
diagnostic cardiac catheterization, echocardiography, and surgery were obtained from 
the BC Cardiac Registries and Medical Services Plan databases. Median waiting times 
from physician visits to diagnostic procedures and surgery were calculated. We com- 
pared current reported waiting times to those obtained using the proposed definition. 
Definitions: Currently reported waiting time is calculated as the interval between book- 
ing for surgery and surgery. For the proposed definition, waiting time is calculated as the 
time interval between the general practitioner visit and surgery. Results: Of the 1,782 
patients booked for aortic valve surgery with a primary diagnosis of aortic stenosis, 1588 
subjects (89.1%) were eligible for analysis after exclusions. Eligible patients ranged in 
JACC February 2001 
age from 22 to 95 years; 36.4 % were female. Using the proposed waiting time definition, 
the median waiting time for surgery was 215 days, 2.8 fold longer than the currently 
reported time of 77 days. Conclusion: True waiting times for surgery for aortlc stenosis 
in 5C are significantly longer than reported waiiing times. We propose that the ‘“waiting 
time” for cardiovascular surgery be n-defined as: “the time interval between the patient’s 
first contact with a medical care provider with symptoms or signs which ultimately lead to 
cardiovascular surgery and the date of that surgery”. 
3:24 p.m. 
1002-203 Marginal Cost-Effectiveness of Amiodarone Targeted to 
High Risk Patients Undergoing Open Heart Surgery 
Trevor D. Thompson, Elizabeth M. Mahoney, Emir Veledar, William S. Weintraub. Emory 
University Atlanta, GA 
Background. Amiodarone (AM) has been shown to decrease the incidence of atrra 
fibriliation(AF) following heart surgery (HS). However. the cost-effective selection of 
patients (pts) to receive therapy (tx)in this setting has not been evaluated. 
Methods. We examined the outcomes and costs of 10,550 pts undergoing CABG and/or 
valve surgery at Emory University hospitals (EUH) between 1194 and 6199. Pts with AF 
on admission were excluded. Logistic regression was used to develop a model to predict 
post-operative AF. Predicted AF probabilities (PAFP) from the model were used as the 
cutoff point for determining the cost-effectiveness at varying levels of underlying risk. 
Hospital cost was determined from hospital bills and cost-to-charge ratios and profes- 
sional costs were estimated using the Resource Based Relative Value Scale methods. 
Mean life years over 5 years of follow-up were calculated from Kaplan-M&r estimates 
Qenerated from 26,247 pts undergoing open HS at EUH between 1980 and 1995 and 
discounted 3% per year. Short term marginal cost-effectiveness (MCE) and long-term 
cost-utility analyses were performed. The MCE ratros are presented as the cost/event 
averted (MCE-E) and the cost/QALY gained (MCE-Q). The effectrveness of tx was 
assumed to be 26% (ARCH trial) and cost $973 (7 amps/day for 2 days at $69.50/amp). 
Utility was assumed to drop 10% in the 1” year for AF pts with full utility thereafter. An 
event averted was assumed to increase survival to that of an event-free patient. 
Results. The overall AF rate was 19.4%. The MCE ratios are presented in the table 
below. If pts with > 30% probability of AF received AM, 16.5% of pts would receive tx at 
$5,149 per event averted and $14,561 per QALY gained compared to treating no one. As 
the PAFP cutoff point IS decreased, additional pts are treated and the MCE rises. 
PAFP(%) %RX %AF Cost MCE-E MCE-Q 
0 100 14.4 524312 $47177 $133423 
10 80 14.8 $24133 $25058 $70868 
15 60 15.4 $23972 $16494 $46648 
20 42 16.2 523840 511788 $33337 
25 28 17.0 S23741 $8680 $24547 
30 17 17.9 $23671 $5149 $14561 
100 0 19.4 523590 - 
Conclusions. A cutoff point of 15 to 20% PAFP may be appropriate. Cost-effectiveness 
analysis can be helpful in selecting pts for AM to prevent AF post HS. 
3:36 p.m. 
1002-204 Gender Differences in Disease Specific Functional Status 
Following CABG 
Mukesh Garg, Brent Sliver?, Phil Jones, John Spertus. MidAmerica Heart/nstifufe, 
Kansas City, MO, Unwersity of Mkwuri - Kansas City: MO 
Background: Little data is available about gender difference in disease specific func- 
tional Status outcomes after CABG. Methods: This study prospectively tracked 217 
patients’ functional status at baseline and at monthly intervals for 6 months after CABG 
.The Seattle Angina Questionnaire (SAQ) was used to asses angina frequency (AF), 
physical limitation due to angina (PL), and disease specific quality of life (QOL). SAQ 
scores range O-100 where higher scores indicate better functioning. Results: Prior to 
CABG, women (n=72) had worse QOL due to angina (mean SAQ QOL score = 47 +/- 20 
“s 57 +/- 23 for males; p=O.O03), and a trend towards more severe physical (mean SAQ 
PL score 60 +/-27 “s 67 +/- 25; p=. 07). Six months after CABG female patients had a 
substantial improvement in QOL to a level comparable to males (Slci- 16 vs 85 +/- 17, p= 
0.29). However, SAQ PL scores did not improve as substantrally and were significantly 
worse in women at 6 months as compared with men (69 +/- 22 “s 83 +/- 22; p=O.O03). 
Females also had more frequent angina at baseline (SAQ AF =61 +/- 28 “s 68 +/- 25; p= 
0.06) and at 6 months a trend towards woree frequency of chest pain remained (mean 
SAQ AF score=90 +/- 12 “s 94 +/- 11 for males) p= 0.055. Baseline characteristics (DM, 
HTN, EF, smoking, prior Ml, PTCA and CABG) were srmilar in both groups except that 
female patients were older (69 + 11 vs 66 + 10, p= 0.03) Conclusion: Upon presentation 
for CABG, female patients have more QOL limitations from angina as compared with 
males. In follow-up, however, they show substantial improvement and achieve a QOL 
similar to males. While the difference in frequency of angina at baseline is clinically signif- 
icant, at 6 months the difference IS no longer clinically important (Clinically significant dif- 
ferences are x5-6 pts). Physical limitation frorm angina does not parallel the QOL or 
symptom improvements after CABG and female patients remain more physically limited 
from angina compared to males. 
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1002-205 Predictors of Atrial Fibrillation Following Open Heart 
Surgery: Implications for Cost-Effective, Targeted, 
Preventive Therapy 
Emir Veledar, Trevor Thompson, Elizabeth Mahoney, Zefeng Zhang, Joy C. Burn&e, 
William S. Werntraub. Emory Center for Outcomes Research, At/an&, GA 
Background. Anti-arrhythmic therapy has been shown to decrease the incidence of 
atrial fibrillation(AF)follo heart surgery. The ability to target this therapy to patients at 
high risk of AF would be beneficial. 
Methods. We exammed the outcomes and costs of 10,550 patients undergoing CABG 
and/or valve surgery at Emory University hosprtals between 1194 and 6/99 (8709 CABG, 
1217 valve, 624 both). Patients with AF on admrssion were excluded. Logistic regres- 
sion techniques were used to develop a model to predict post-operative AF. 
Results. The populatton was 62+12 yrs, 29% female, 29% diabetic, 64% hypertensive, 
13% urgent/emergent, and 11% had prior CABG. The mean e]ection fraction and 
bypass time were 51+12 and 97+39 (min.) respectively. Post-operative atrial fibrillation 
occurred in 2051 (19.4%) patients. Post-operatwe AF was assocrated with 1‘ in-hospital 
cost (28,723 “s 23,310, p<.OOl). The AF model is summarized below. Valve surgery, T 
age, and J EF were associated with ‘? AF. Prior CABG, diabetes, female sex, and smok- 
ing were associated with I AF. There was a significant interaction between the operative 
category and age (p<.OOi) with the age effect being larger among CABG only patients. 
Conclusion: We have developed a model to predict post-operative AF This model can 
be used to estimate the post-operative risk of AF and thus, to target high-risk patients for 
anti-arrhythmrc therapy. The model can also be used to evaluate the cost-effectiveness 
of targeting therapy to patients at various levels of risk for post-operative AF 
Predictors of Post-Operative Atrial Fibrillation 
Factor x2 (df) P-“allIe Odds Ratio 95% Cl 
Age (1‘ 1 Oyrs) 420.52 (3) <.oot 
CABG 1.80 1.69-l .91 
Valve 1.50 1.36-l .66 
Both 1.49 1.25-1.77 
op CataQOry 74.0 (4) <.OOi 
Val “s CBG 1.84 1.57-2.15 
Both “s C5G 1.78 1.40-2.25 
Bypass Tiime (f 30 min) 20.5 (2) <.oot 
< 170 min. 1.13 1.07-l .20 
> 170 min. .91 .84-.98 
EF (7‘ 10%) 10.7 (1) c 001 1.05 1.02-I .09 
Prior CABG 9.6 (1) ,002 .77 .66-.91 
Age*Op Cat. 11.612) ,003 
Smoker 9.2 (2) ,010 
Current “s Former .92 .82-1.03 
Never “s Former .79 .68-.92 
Female Sex 4.6 (1) ,032 .88 .78-.99 
Diabetes 3.4 (1) ,064 .89 .79-1.01 
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1003-206 Virtual Reality Permanent Pacing: Validation of a Novel 
Computerised Permanent Pacemaker Implantation 
Simulator 
Tom Wong, Am Darzi, Rodney Foale, Richard J. Schilling. Department of Cardiology St 
Mary’s Hospital and Imperial College School of Medicine, London, United Kingdom, 
Department of Academic Surgery St Mary’s Hospital and Imperial College School of 
Medicine, London 
Background: Complications and lead dislocation after insertion of a permanent pace- 
maker are related to the training and experience of the operator and experience is tradi- 
tionally gained by trainees performing the procedure under supervision, resulting in 
longerfluoroscopy exposure. We assessed a novel computer based virtual reality simula- 
tion (VRS) of permanent pacemaker lead implantation, the aim of the study being to 
determine if the VRS pacing module reflected operator experience in the implantation 
procedure (P) and fluoroscopy time (F). Methods: The VRS module comprises a com- 
puter linked to a jig with a pacing lead and strllete that can be turned and advanced or 
retracted to simulate lead manipulation. A fluoroscopic view of a beating heart and pac- 
ing wire is activated by a foot pedal and is displayed on screen. Subjects with a range of 
experience in pacing and no previous exposure to the VRS module, were given a stan- 
dard introduction and the mean F and P was recorded for 5 attempted implants of ventric- 
ular (V) and atrial leads (A) Correct lead positioning was judged by fluoroscopic position 
and pacing criteria. Operators were given a maximum P of 600 sacs or F of 300 sacs to 
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complete the implant. Results: High volume operators (>50 pacemaker insertions, group 
a) have shorter P and F for V implantation but not for A implantation when compared with 
low volume operators (c 50 cases, Group b). Group b had shorter P and F for both A and 
V implantation compared with inexperienced operators (no pacing experience, group c). 
Conclusion: Both F and S measured by VRS are related to operator experience. Inter- 
estingly A implantation appears simpler as judged by the difference in F and P times of 
high and low volume operators which reflects most operators experience in practiceThe 
VRS appears to closely reflect the real operation for pacemaker implantation. 
Procedure and Fluoroscopy times (sets) (mean+/-SD) 
P(V) F(V) P(A) F(A) 
Group a (n=lO) 71.2+/-27.1 41.6 +/- 20.8 67.4 +I- 33.4 43.6 +/- 33.9 
Group b (n=iZ) 165.8 +I- 90.9 112.7 +I- 67.3 94.7 +I- 35.7 57 +/- 33.8 
Group c (n=lO) 600 +/- 0 300 +/- 0 505.6 +/- 210 249.2 +/- 113.2 
P value of a vs b 0.006 0.001 0.09 (NS) 0.5 (NS) 
P value of b vs c <O.OOi <O.OOl <O.OOl <O.OOi 
4:12 p.m. 
1003-207 Artificial Neural Networks Can Accurately Discriminate 
Between innocent and Pathological Heart Murmurs 
Curt G. DeGroff, Robin Shandas, Lilliam Valdes-Cruz, Sanjay Bhatikar, Jean Hertzberg, 
Roop Mahajan. UCHSC - The Children’s Hospital, Denver, CO, University of Colorado, 
Boulder CO 
Background: A device which can perform mass screening of heart murmurs would be of 
great value to the pediatric health cars community. Efforts in developing such devices 
that differentiate between innocent and pathologic heart murmurs have to date met with 
limited success. We present a method based on an artificial neural network (ANN) 
approach that resulted in high sensitivity and specificity. 
Methods: Digital heart sound recordings were obtained on 69 pediatric patients (ages 
Iw/o--15~10, mean 2~10; 32 innocent/37 pathologic murmurs) under IRB protocol using 
an electronic stethoscope (40.600Hz) and a personal computer (sampling 44kHz) 
recorded at the left mid-sternal border. Pathology included aortic and pulmonary steno- 
sis/insufficiency, atrial and ventricular septal defects, patent ductus arteriosus and mitral 
regurgitation. Diagnosis was confirmed by a pediatric cardiologist +I- echocardiogram. A 
custom ANN was trained to distinguish between innocent and pathologic murmurs. Input 
to the ANN consisted of spectral information derived from Fast Fourier Transforms of 
recordings from 3 consecutive heart cycles. Differing spectral resolutions (1/3/5Hz) and 
frequency ranges (0.90/150/21OHz) were used. The Jack-Knifing ANN method was 
deployed to evaluate the ANN-based classifier on account of limited data availability. 
Results: 100% sensitivity and specificity were obtained with a spectral resolution of 1 Hz 
and a spectrum of O-210 Hz. In general, finer resolution and larger spectrum yielded opti- 
mal results. 
Conclusions: We have demonstrated that artificial neural networks can be used as an 
accurate diagnostic tool for classification of heart sound data into innocent and patho- 
logic classes. This technology offers great promise for the development of a device for 
high volume screening of children for heart disease. Eventually this work is expected to 
lead to an automatic screening device with additional capabilities of predicting specific 
heart conditions. 
4124 p.m. 
1003-208 Neural Networks a Decision Support in Acute Coronary 
Syndromes 
Sven-Erik M. Olsson, Mathas Olsson, Hans Ohlin, Ewa Mattson, Per Sandkull, Marie- 
Louise Nilsson, Samir Dzaferagic, Lars Edenbrant, Lars Edenbrant. Deparfmenf of 
cardiology, Lund, Sweden, Department of Clinical Physiology Lund, Sweden 
Introduction: Acute myocardial infarction (AMI) are a condition of high morbidity and 
mortality. The introduction of revascularisation like acute-PTCA or Thrombolysis have 
improved prognosis. The EGG is an easily availabel tool to identify transmural ischemia 
(ST elevation). Artificial1 neural networks (ANN) have the capacity to identify different pat- 
terns after a training process. The purpose of this study was to evaluate the influence of 
decision support by ANN to doctors without long experince of ECG interpretation. Meth- 
ods: From a database of 1742 EGG’s with verified acute myocardial infarction (AMl)two 
experienced cardiologists classified the ECG’s as transmural ischemia (TI) or no trans- 
mural ischemia (no TI). The control group of 11086 control EGG’s without any verified 
AMI. ANN was trained with total 3000 EGG (552 TI, 754 not TI and 1694 control). The 
performance of ANN was ROC = 0.9777. For the study the performance of ANN was 
used to label the EGG: TI I Probably / Probably not TI I Not TI. Three doctors (MD) with- 
out long experince of ECG interpretation independently classified 1000 ECG’s (184 TI. 
252 not TI, 564 control)as TI or not TI. The interpretation was made twice, without and 
with the interpretation of ANN. Results: All three MD’s improved as shown in figure. 
Sensitivity increased 26.1 %, 22,8 % and 25 %. Specificity decreased 8,7% 5 % and 3,3 
%.Se figure. Discussion: ANN seems to improves diagnostic performance of doctors 
without long experince of ECG interpretation in diagnosing acute transmural ischemia. 
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1003-209 Artificial Neural Network Predicts Mortality in Patients With 
Acute Myocardial Infarction. Polish Multicenter Web-Based 
Trial on Acute Myocardial Infarction: POL-WEB-AM1 
Jaroslaw Drozdz, lreneusz Zbicinski, Malgorzata Wagner, Jaroslaw Kasprzak, Jaroslaw 
Furmanski, Michal Wroczynski, Maria Krzeminska-Pakula. Medical UniversifL: Lodz, 
Poland, Technical University, Lodz, Poland 
The artificial neural networks become slowly a standard tool in economy, and engineer- 
ing. Application of neural networks enables solving of complex non-linear problems with- 
out profound knowledge of the mechanism of the phenomenon using only noisy and 
sparse data. Artificial neural networks can be defined as a parallel processing structure 
similar to a model of biological nervous system analogous to human brain. Basic ele- 
ments of the neural network, neurons, are connected to each other with different weights. 
The user of artificial neural networks does not have to develop algorithms in the form of 
programs: the network learns itself on the basis of examples: sequences of the inputs 
and related outputs. Computational capabilities of artificial neural networks result from 
their ability to learn, i.e. to form internal representation of process dynamics when 
exposed to experimental data. A study aimed at application of classical static neural 
modeling to predict mortality of patients with acute myocardial infarction. Clinical data- 
base of 568 patients hospitalized between October and December 1999 in 23 centers in 
Poland with in-hospital mortality of 15% (87 patients) was used. Gender, age, risk factors 
for atherosclerosis, treatment (thrombolysis, aspirin, heparin, nitroglycerine) and compli- 
cations appearing during hospitalization were evaluated by 25.question form. Classical 
feed-forward multilayer perception, 13 neurons in input layer (13 variables were selected 
as being potentially useful in the prediction of mortality), 10 neurons in one hidden layer 
and 1 neuron in the output layer was used. The net was working in continuous mode. The 
network was trained on the basis of 480 cases while artificial neural networks validation 
file contained 88 cases. 250 learning epoch led to excellent agreement between pre- 
dicted and training data (one error only). artificial neural networks performance for valida- 
tion set showed overall accuracy of correct predictions of in-hospital mortality equal to 
90%. Conclusions: Artificial neural network can be used for expert, highly accurate pre- 
diction of in-hospital mortality in patients with acute myocardial infarction. 
4146 p.m. 
1003-210 Object Virtual Reality Display of Congenital Malformations 
of the Aorta Imaged by Magnetic Resonance 
Giles W. Vick, Ill, Ricardo H. Pignatelli, John P. Kovalchin, Roxann Rokey. Baylor Co//ege 
of Medicine, Houston, TX, Marshfield C/in., Marshfield, WI 
Background: Congenital malformations of the aorta have many complex spatial charac- 
teristics that can be best appreciated with multidimensional visualization techniques. 
Methods: We have developed techniques for creating three and four dimewonal object 
virtual reality representations of congenital aortic malformations from tomographic mag- 
netic resonance imaging data. These representations can easily be displayed on a stan- 
dard personal computer. After the raw image dataset is acquired, segmentation is 
performed in a semiautomated fashion with a combination of thresholding and seeding 
vascular structures of interest. Sequential computer-generated maximal intensity projec- 
tions and surface-rendered images are then automatically acquired at arbitrary (usually 
10”) increments. A variety of computer lighting and shading techniques are employed to 
enhance the images. The images are then combined to form navigable digital virtual 
“worlds” with multiple navigational degrees of freedom. Varied digital video compression 
codecs are utilized to optimize frame rates to provide adequate persistence of vision for 
various data throughputs. Both gadolinium contrast enhanced and multiphasic gradient 
echo images obtained without contrast have been effectively used as raw datasets. Four 
dimensional displays were produced from the multiphasic datasets. Results: Object vir- 
tual digital representations were made of a variety of congenital malformations of the 
aorta, including coarctation, double aortic arch, right aortic arch with mirror image 
branching, right aortic arch with aberrant left subclavian artery, pseudotruncus with aor- 
topulmonary collateral vessels, truncus arteriosus, and transposition of the great arteries. 
Representations included examples of native malformations and the results of angio- 
plasty and corrective surgical repairs. Conclusion: Object virtual reality displays facilitate 
viewing of congenital aortic malformations. They are excellent tools for presurgical plan- 
ning and teaching. Their compact size and minimal display hardware requirements in 
comparison to alternative display methods are additional advantages. 
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1080-l Software for Quantification of Pericardial Effusion Volume 
by Two-Dimensional Echocardiography 
Richard J. Lucariello, Ying Sun, Prasad Paturu, Salvatore A. Chiaramida. CJurLadyof 
Mercy Universiiy Hospital. Bronx, NY: University of Rhode Island, Kingston, RI 
Background: The pericardial effusion volume (PEV) does not pos- 
sess a known regular shape. Therefore, the standard methods for 
volume estimation based on 2-D echocardiography can not be 
applied. This study was conducted to evaluate a new computer 
algorithm for acoustic quantification of PEV. Methods: Borders of 
the pericardial sac and the heart were identified either by hand 
tracing or with the help of an automated border detection algorithm 
in the apical 4-chamber view. A 3-D disk model was developed to 
represent the pericardium and the heart with stacks of circular or 
elliptical disks along the long axis. Volumes were calculated based on the modified Simp- 
son’s rule. For comparrson the standard area-length method for volume estimation was 
also applied. PEV was determined as the difference between the pericardiai volume and 
the heart volume. The methods were implemented in C++ for the Macintosh computer. 
Results: Preliminary results demonstrated the advantage of the 3-D disk model for 
asymmetric and non-ellipsoidal volumes. For the example shown I” the figure PEV was 
estimated to be 657 ml by the 3-D disk model and 523 ml by the area-length method. The 
actual fluid volume drained was 700 ml. Conclusion: The 3-D disk model does not rely 
on the assumption of symmetrical and ellipsoidal volumes. The software should be useful 
for obtaining an accurate estimate of the pericardial effusion volume by use of 2-D 
echocardiography. 
1080-2 Indexing and Summarization of Echocardiogram Videos 
Shahram Ebadollahi, Shih-Fu Chang, Henry Wu, Shin Takuma. Department of Hectricai 
Engineering, Columbia University New York, NY 
Echocardiograms are being used in analog format without efficient tools for browsing 
their content. Our goal is to automatically annotate and summarize them and to create 
tools for efficient browsing and searching the digital archives of these videos. The first 
step is to segment the Echocardiogram video into its constituent views (e.g., Parasternal 
long axis view, etc.). We have observed from the structure of the Echocardiograms that 
the shape of the ‘Region of Interest’ (ROI) in each view is different from its neighboring 
ones. Based on view type the shape can be ‘triangular’, ‘trapezoidal’, etc. By preprocess- 
ing each frame with appropriate morphological filters and extracting masks for the ROI 
we find their shape. The difference in the shape of the ROI in different views and the 
presence/abscence of color has been exploited to segment the Echocardiograms. The 
next step is to summarize the Echocardiogram videos. There are two types of summa- 
ries: ‘static’ and ‘dynamic’. The static summary is a table of images each representing a 
particular view. Each image is extracted from the view it represents by processing the 
ECG available from the Echocardiogram video. The representative frame corresponds to 
the peak of the Rwave in the ECG. Therefore they show a snap shot of the heart at end- 
d&stole in each view. In the dynamic summary every view is represented by a short seg- 
ment consisting of a few cardiac cycles between two Rwaves at a predetermined dis- 
tance. The segments are concatenated to each other to form the summary. Hence the 
dynamic summary captures the time information and is a good abstract of the entire 
video, while the static summary is useful as a visual cue for randomly accessing the con- 
tent of the Echocardiograms. The method has been tried on ten different Echocardio- 
gram videos. We have acheived 90% accuracy in view segmentation. The 10% failure is 
because of the Parasternal Short Axis views. These are temporally adjacent views with- 
out any other view type in between. The ROI is triangular in all of them, therefore the seg- 
mentation method fails. The current software can be used clinically to help doctors 
access the digital EchocardIograms of patients and browse their content to find view(s) 
they are interested in. 
1080-3 Quantitative Analysis of Hemodynamic Data by Using 
Computer Model Coupled With System Identification 
Method 
Ying Sun, Richard J. Lucariello, Salvatore A. Chiaramida. University of Rhode Island, 
Kingston, RI, Our Lady of Mercy University Hospital, Bronx, NY 
Background: It was shown previously that a computer model can produce physiologi- 
cally relevant hemodynamic data. By incorporating a system identification method, this 
study demonstrates the applicability of the model software to the analysis of clinical car- 
diac catheterization data. Methods: A computer program in C++ was developed for Mac- 
intosh computers to implement a set of differential equations representing the 
cardiovascular dynamics and a simplex-based optimization method for identifying model 
parameters. The hemodynamic data of interest included cardiac output, election fraction, 
and pressure waveforms in right atrium (RA), right ventricle (RV), pulmonary artery (PA), 
pulmonary capillary wedge (PW), left ventricle (LV), and aorta (Ao). Results: Data from 5 
patients were analyzed. For each patient the model was fitted simultaneously to all 
hemodynamic indexes and waveforms. By iteratively applying the optimization algorithm 
under user guidance the model quickly converged to the patient’s data. Figure shows a 
typlcal result of measured (left) vs. modeled (right) waveforms. By lumping all waveforms 
together linear regression analysis yielded: modeled pressure = 0 94 x measured pres- 
sure + 1.2 mmHg; r = 0.994, p < 0.001; n = 1308. Consistent results were observed in all 
5 patients. Conclusion: This study has demonstrated a method of combining a computer 
model and a system identification method to achieve an accurate representation of 
patient’s cardiovascular system. The model parameters allow for quantitative assess- 
ment of clinically meaningful circulatory variables such as contractility, vascular resis- 
tance and capacitance. 
1080-4 The Effects of Image Quality on Three-Dimensional Electron 
Seam Coronary Angiography 
Bin Lu, Bakhsheshi Hamid, SongShou Mao, Nan Zhuang, HideyaYamamoto, Steve C.K 
Liu, Matthew J Budoff. Harbor-UCLA Medical Center, RN-E5, Torrance, CA 
Background: Intravenous electron-beam angiography (EBA) had been confirmed to be 
a promising technique for evaluating coronary luminal stenosis. Our purpose was to (den- 
tify the effects of image quality and analyze the causes for the nonassessability of the 
coronary segments. Methods: One hundred consecutive patients were studied. Con- 
trast-enhanced transaxial coronary images were reconstructed three-dimensionally (3D) 
using Volume Rendering techniques. The image quality of coronary segments was quan- 
tified with a five-point grading system (scaled with O-4, 0 and 1 were nonassessable). 
Image artifacts and other effects were analyzed statistically. Results: Techniques failed 
in 7 patients (7%) due to image artifacts of motion, breathing and arrhythmia. Image 
quality scores were the highest with 3.6 of the left main coronary artery (LM), followed by 
the right coronary artery (RCA) with 3.0, the left anterior descending (LAD) with 2.7 and 
the left circumflex (LCX) coronary artery with 2.6 (p<O.OOl). The scores in proximal coro- 
nary segments were higher than the middle and distal segments (p<O.OOi). The non- 
assessable coroanry segments ware occurred in 3% of LM, 2%, 8% and 5% of proximal 
LAD, LCX and RCA, 24%, 22% and 12% of mid coronary segments, 64% 45% and 20% 
of distal segments of LAD, LCX and RCA, respectively (p<O.O5). Multivariate logistic 
analysis demonstrated that the heart-rate-variance, vessel diameter and contrast attenu- 
ation other than image noise and contrast-to-noise ratio were the effects of the 3D image 
quality (~~0.05, rz0.62). Coronary motion, breathing, poor distal opacification and small 
vessel (<2mm) were the major artifacts and causes for the nonassessability of coronary 
artery segments (p<O.OOl, ~0.87). Conclusion: The mayor limitations of coronary imag- 
ing on EBA ware the suboptimal spatial resolution and artifacts. The effects of 3D image 
quality were analyzed and considered to be improved by using thinner slice-thickness 
(<2mm) with higher contrast-injection-rate and optimal EGG triggering as 40% other than 
80% R-R interval during the cardiac cycle. 
1080-5 Coherent Contrast Imaging Quantification for Myocardial 
Perfusion Assessment 
Manuel Desco, Maria J. Ledesma-Carbayo, Andres Santos, Miguel A. Garcia-Fernandez, 
Pedro Marcos, Norberto Malpica, Jose C. Antoranz, Pedro Garcia-Barreno. Hospital 
General Universitario Gregorio Maration, Madrid, Spain, ET.9 Jebcomunicacion, 
Madrid, Spain 
Interpretation of Contrast Coherent Imaging (Ccl) results is difficult without calculating 
quantitative parametersThis paper presents a new method to quantify myocardial perfu- 
sion contrast studies avoiding artifacts due to heart motion. CCI images are obtained with 
an ACUSON Sequoia scanner. Echo-enhancer is injected during the scan. 150 consecu- 
ttve frames are acquired using low power (low mechanical index) pulses at 20 fps. A burst 
of high mechanical index U/S pulses is used to destroy bubbles, thus allowing to detect 
the contrast wash-in. The study is performed in two conditions: rest and pharmacologi- 
cally induced stress (Dipiridamole). A software tool has been developed to analyse these 
image sequences. It allows to select several ROls within the heart wall. In order to track 
the wall movement along the cardiac cycle, the position of these ROls is automatically 
corrected, on the basis of the gradient field calculated on a selectively filtered image. An 
interactive tool also allows to manually correct ROI positions. Time curves are analyzed 
according to a parametric model that incorporates both contrast inflow rate and cyclic 
variations. A prototype has been completed, tested and deployed to the echocardio- 
graphy department, where a clinical trial is being carried out. Preliminary results on 63 
patients (37 ischemic, 26 non-ischemic) have allowed us to identify normal and patholog- 
ical patterns and to establish the correlation of quantitative parameters with the real diag- 
nosis. Significant differences were found between the two patient groups (Basal: Control 
10.9+-0.4 dB, lschemic 9.4+-0.4 dB, p<O.Ol. Dipiridamole: Control 13.1+-0.4, lschemic 
10.7+-0.4, p<O.OOl) There are two main new contributions in this paper: 1) A robust pro- 
cedure for automatic position correction of wall FiOls, that overcomes the problem of 
heart motion in an efficient way and 2) a parametric analysis of time curves that allows to 
condense results in a few quantitative parameters. 
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1080-6 Segmental Quantitative Analysis of Color Kinesis images 
Using a Bullseye Representation in Normal Subjects 
Luiz 0. Murta-Jr, Evandro E. S. Ruiz, Antonio Pazin-Filho, Andre Schmidt, Oswaldo C. 
Almeida-Filho, Marcus V. SimBes, Jose A. Marin-Neto, Benedito C. Maciel. Medical 
School of Rib&% Prefo, University of S&o Pm/o, Rib&&o Prelo, Brazil 
Despite color kinesis (CK) is a technique developed to display timing and magnitude of 
global and regional wall motion (WM) in real time, there are only a few studies analysing 
the quantitative information of CK imaging. We have previously developed a software for 
quantifying and representing segmental left ventricular (LV) WM documented by CK in a 
bullseye format. In this study, we evaluate LVWM in 20 normal subjects, aged 23-61 
years old (mean: 30). CK images were obtained in two sets of views: 1) apical (AP) (lon- 
gitudinal, 2 and 4 chamber); 2) paraesternal short axis (PSA) (mitral, papilar and apical). 
For each plane, 2 systolic images were recorded in optical disc. For each set of images, 
the software provided: 1) semi-automated division of LV in segments (SEGM) corre- 
sponding to 16 LV SEGM; 2) quantitation of regional fractional area change (FAC) in 
each SEGM; 3) Color and numerical display of the mean FAC for each SEGM in a bulls- 
eye format. 
JACC February 2001 
Results: 1)images ware considered adequate in 18 subjects (90%); 2) Mean * SD FAC 
for each set are displayed in the figure. Conclusions: 1) FAC values are larger and more 
homogeneous in PSA than in AP; 2) Lower values of FAC were observed in apical SEGM 
as a result of the relative larger size of this region on segmentation and the acoustic win- 
dow: 3) this limitation is minimized by using two planes for image analysis; 4) bullseye 
representation of CK images is feasible in a large proportion of subjects and can provide 
quantitative, semi-automated and global evaluation of LVWM. 
1080-7 Automated Stent Border Detection in Three-Dimensional 
Intravascular UltraSound: Improvements Towards 
Automated Border Detection 
Jouke Dijkstra, Gerhard Koning, Joan C. Tuinenburg, Pranobe V. Oemrawsingh, Johan H. 
C. Reiber. Leiden Uinvesdty Medical Center, L&den, The Nefherlands 
Background: IntraVascular UltraSound (IVUS) is a catheter-based technique which pro- 
vides real-time high resolution images of the arterial wall. The technique is used to moni- 
tor the stent placement, to assess the extent of in-stent restenosis, or plaque symmetry 
in case of directional atherectomy or brachytherapy. The automated segmentation of 
lumen, vessel and stent boundaries will reduce the required analysis time and the sub- 
jectivity of the commonly used manual tracing procedure while the three-dimensional 
reconstruction permits an advanced assessment of the morphology. 
Methods: Our (semi-) automated approach is based on a combination of transversal and 
longitudinal contour detection techniques and a model of the morphologic structures. The 
contours in the longitudinal cutplanes are detected simultaneously guided by the shape 
and size of the vessel and the location of the catheter. The stent contour is detected 
based on the high intensity of the stent struts as compared to other structures and their 
expected location in the vessel wall based on an approximately circular model. 
Results: In a set of 240 slices from different pullback series (acquired with Boston Scien- 
tific and EndoSonics equipment) the automatically detected boundaries were compared 
to manually drawn boundaries. The correlation coefficients between the manually traced 
and automatically detected boundaries for the cross-sectional vessel and lumen areas 
were at r-values of 0.99 and 0.98, respectively. In other pullback runs, both post-interven- 
tion and at follow-up, the automatically detected stent boundaries in 120 slices were com- 
pared to the manually drawn stent boundaries and resulted in an r-value of 0.99. 
Conclusion: Due to the flexible use of more than two longitudinal cutplanes and the 
advanced knowledge-guided contour detection approach, the new IVUS analysis system 
has proven to be suitable for clinical research studies. The inclusion of the automatically 
detected stent boundary will support in-stent restenosis studies. 
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1081-l Does Enrollment in a Randomized Clinical Trial Lead to 
Higher Costs for Routine Care? 
J. Peter Weiss, Lori S. Parsons, Nathan R. Every, W. Douglas Weaver, Mark A. Hlatky. 
Sfanford Univeristy Stanford, CA 
Background: Reimbursement for the routine care of patients enrolled in clinical trials has 
become a topic of recent controversy. We, therefore, designed this study to determine the 
added medical costs, if any, due to enrollment in a randomized clinical trial. Methods: 
Retrospective cohort analysis of the Myocardial Infarction Triage and Intervention (MITI) 
Trial and Registry. Univariate and multivariable comparisons of total costs for index hospi- 
talization were performed for patients enrolled in the trial with controls derived from the 
registry who otherwise met major trial entry criteria. Adjustment variables were chosen to 
represent relevant information known prior to trial enrollment and final hospital admis- 
sion, including: initial patient characteristics, comorbidities, hospital of admission, transfer 
status, primary payer type, and year of entry. Results: The 281 Trial patients had lower 
total hospital costs (median $9,300) than the 568 Controls (median $13,700), cost ratio 
0.76 (95%C.I. 0.68-0.84). Costs for Trial patients remained lower after multivariable 
adjustment (0.90, C.I. 0.81-0.98). In analysis limited to patients receiving primary throm- 
bolytic therapy, Trial patients (1x302) again had lower costs than Controls (n=381) in both 
unadjusted analysis (0.72, C.I. 0.64-0.81) and after adjusting for confounders in the mul- 
tivariable model (0.84, Cl. 0.76-0.93). Conclusion: This study found no evidence that 
participation in the MIT1 randomized clinical trial led to higher costs for routine care. 
1081-2 Screening for Hypertrophic Cardiomyopathy in the Pre 
Participation Athletic Exam: Feasibility and Cost Using a 
Hand-Held Ultrasound Device 
Bruce J. Kimura, Mark S. Sklansky, Charles H. Eaton, Ill, Anthony N. DeMaria. University 
of California, San Diego, CA 
Background: Although echocardiography can effectively detect hypertrophic cardiomy- 
opathy, it has been considered too expensive and cumbersome to provide this technique 
for the pre-participation screening of all community student athletes. Since affordable 
hand-held ultrasound instruments are now available, we describe the feasibility and cost 
of performing a brief cardiac ultrasound exam to screen for hypertrophic cardiomyopathy 
in a population of high school student athletes. 
Methods: As part of an annual community high school pre-participation screening, a 
continuous line of student athletes were prepped by a health assistant, and imaged by a 
physician using a hand-held, 2.4 kg ultrasound device equipped with a 4-2 MHz trans- 
ducer. Subjective interpretation of only the pamsternal long axis view was performed ini- 
tially, with additional on-screen measurement, different views, and referral for full echo 
employed when necessary to exclude the diagnosis of hypertrophic cardiomyopathy. The 
total cost of screening was estimated by equipment depreciation, physician labor, and the 
projected costs of the full echo studies generated. 
Results: Two physicians imaged 197 students (106 males, 91 females; mean&D for 
age =14.7y +1.6) in 125 minutes for an average time of 1.3 minutes/exam. Hypertrophic 
cardiomyopathy was excluded by subjective visual analysis in the majority (74%) of 
cases. Septal wall thickness measurements on frozen diastolic images were made in the 
remaining 26%(n=52) and were: ~1 lmm (n=44), 12mm (n=5), 13mm (n=2), 14mm 
(n=l), rl5(n=O). Using a 5-year depreciation of a 515,000 hand-held ultrasound device, 
a 5400-5800 charge for a full echocardiogram when indicated, and physician labor costs 
of $100/h, the average cost of a screening exam was calculated for various thickness cri- 
teria used for referral for full echo: >12mm, $21-$39istudent; >13mm, $8.514istudent: 
rl4mm, 54-$6/student:>l5mm or if no full echo required, 52Istudent. 
Conclusions: In this preliminary study in which a low-risk group was screened, it was 
feasible to perform a limited ultrasound exam to screen for hypertrophic cardiomyopathy 
in a student population at a range of reasonable costs. 
1081-3 Immigration Factors May Confound the Relationship 
Between Insurance Type and Age of Repair for Children 
With Congenital Heart Disease in California 
Oscar J. Benavidez, Jane W. Newburger, Lars C. Erickson. Children’s Hospital, Boston, 
MA 
Background: Recently published data have suggested that Medicaid insurance is asso- 
ciated with later surgical repair for children in California with several types of congenital 
heart disease. We investigated the predictors of later repair (after a year of age) of ven- 
tricular septal defect, tetralogy of Fallot and endocardial cushion defect with particular 
attention to racelethnicity, insurance type and the confounding effects of immigration fac- 
tors. Methods: Records were analyzed for 3,719 children who underwent open heart 
surgery in California for these 3 malformations between 1992-l 996 using California State 
OSHPAD and US Census data. A stepwise multivariate regression model estimated the 
risk of surgical repair after a year of age included terms for racelethnicity, insurance type, 
procedure type, medical comorbidities, and a proxy for socioeconomic status (median 
family inCOma by residential Zip Code). The analysis was stratified by the fraction of for- 
JACC February 2001 
elgn-born residents in each patient’s residential Zip Code. Results: For children from 
areas with few foreign-born residents there was no effect of insurance type on the odds of 
later repair (RR 1.04 [0.94,1 .I 41 p=NSj. For children in high foreign-born areas, however, 
Medlcaid insurance was associated with increased risk of later repair (RR 1.21 
[1.03,1.37] p=.O25). Conclusion: A relationship between Medicaid insurance and later 
repair of congenital heart disease is only observed in areas densely populated by for- 
eign-born restdents. Because the Medicaid system may support a disproportionate num- 
ber of children who have immigrated to the Unlted States after a year of age with heart 
disease, caution must be exercised when evaluating the swcess of the Medicaid pro- 
gram in bringing children to surgery within the recommended time frame. 
1081-4 Long-Term Outcome in African-Americans With Normal and 
lschemic Dobutamine Stress Echocardiograms 
Azad Raiesdana, lrmina Gradus-Pizlo, Adam Greene, J. Marc Overhage, Pat 
Brenneman, Harvey Feigenbaum, Stephen Sawada. lndiana University School of 
Medicine, Indianapolis, IN 
Background: African-American patients are considered to be a high-risk group with 
excess cardiac death (CD). There is llmited information on the prognostic value of stress 
testing in African-American patients. The purpose of this study was to determine the 
long-term prognostic value of dobutamine stress echocardiography (DSE) in African- 
Americans. Methods: Clinical follow-up was obtained in 98% (3191325) of patients (pts) 
who had DSE between 1988 and 1993. The study group had a mean age of 59 years and 
172 (53%) were women. Forty three percent of pts had a history of previous infarction. 
Hypertension was present in 84 %, smoking history in 68%, diabetes in 46 %, family his- 
tory of coronary disease in 41%, and hyperlipldemia in 40%. Two or more risk factors 
were present in 85%. Results: The mean follow-up was 4.7 years and there were 60 
CDs. CD occurred in 13.1 % (20/153) of patients with normal DSE and 22.5% (25/l 11) of 
pts with ischemic DSE (p=O.O6). The CD rate per year of follow-up was 2.8% in pts with 
normal DSE and 4.5 % in pts with ischemic DSE. Survw curves for pts with normal and 
ischemic DSE are shown below. The top line represents survival in pts with a normal 
DSE and the bottom line represents pts with an ischemic DSE. There was no significant 
difference in survival between pts with normal and ischemic DSE at three years of follow- 
up (p= 0.29). With a maximum of ten years of follow-up, there was a trend towards 
improved survival in pts with normal DSE (p=O.O7). In the 20 pts with normal DSE who 
had cardiac death, 11 (55%) had submaximal tests and 6 (30%) had left ventricular 
hypertrophy. Conclusions: At 3 years follow-up, African American pts with normal DSE 
have substantial cardiac mortality with survival similar to that of patients with ischemic 
DSE. After 3 years of follow-up, patients with normal DSE may have a lower risk of CD 
compared to those with ischemic DSE. Patients with normal DSE and CD frequently had 
only submaximal stress. 
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1081-6 Diagnostic Results: Gender Continues to Make a Difference 
Aaron D. Kugelmass, Frank Houser, April W. Simon, Lynn G. Tarkington, Salvatore 
Battaglla, Steven D. Culler, Edmund R. Becker. Emory University Rollins Schoolof Public 
Health, Aflanta, GA, University of Oklahoma, Ok/ahoma Cifl: OK 
Background: As noninvasive diagnostic techniques improve and as gender differences 
are recognized, It IS hoped that the rate of normal cardiac catheterizations for women will 
in fact decrease. The purpose of this study was to examine data from five community 
hospitals to determine the results of diagnostic procedures by gender. Methods: A total 
of 9,238 elective patient encounters from January 1, 1999 thru June 30, 2000 were 
examined. The ACC definitions of disease significance and number of vessels involved 
were utilized to categorize patients. Patients who were diagnosed with valvular heart dis- 
ease were eliminated from the study. Results: The table below reports the extent of dis- 
ease for all patients by gender. Men were more likely to have double-vessel, triple-vessel, 
and left main disease and less likely to have insignificant or single-vessel disease than 
women. The rate of normal cathetetlzation in women remains significantly above men at 
40.4% compared to 22.2% for men, clespite the fact that there was no difference in the 
rate of positive functional test in this cohort (men 42.8% vs. women 42.1%). Furthermore, 
the only difference in clinical presentation or procedure indication for this insignificant dis- 
ease cohort was in angina classification, particularly atypical angina (men 33.9% vs. 
women 37.3%) and no angina (men 25.2% vs. women 19.2%). Conclusion: There 
remains a significant difference in the distribution of extent of disease between men and 
women. This variation is particularly apparent in the insignificant disease cohort. It does 
not appear that more functional tasting is the answer to decrease the rate of normal cath- 
eterization for women. 
Men Women 
!3 qi6 
1081-5 Universal Health insurance Coverage Does Not Eliminate 
Inequities in Access to Cardiac Procedures After Acute 
Myocardial Infarction 
Louise Pilate, Lawrence Joseph, Patrick B&l@, John R. Penrod, Mark J. Elsenberg. 
Montreal General Hospital, Montreal, PQ, Canada 
Background. Marked differences have been observed in the rates of use of invasive car- 
diac procedures according to various demographic factors. Whether socioeconomic sta- 
tus (SES) influences access to rwasive cardiac procedures after acute myocardial 
infarction (AMI) in a universal health care system has not been demonstrated conclu- 
sively. Methods. To evaluate the effect of socioeconomic status (SES) on access to car- 
diac procedure after AMI in a universal health care system. Rates of cardiac 
catheterization (cath), percutaneous transluminal coronary angiography (PTCA) and COT- 
onary artery bypass surgery (CABG) as a function of SES. SES was obtained from cen- 
sus data by IInking postal codes. Results. SES data were available for 62,364 (73% of 
the total) individuals with a first AMI. Of these, 65% were men and the mean age was 
64213 years. Rates of cardiac procedures tended to rise with an increase in several SES 
measures. Patients in low SES areas (median family income: $ 30,809) were less likely 
to undergo cath within 90 days post-AM1 than patlents in high SES areas ($92,169) (men 
: 33%; 95% Cl: 22% to 45% compared with 47%; 95% Cl: 30% to 65%, women: 18%; 
10% to 28% compared with 47%; 27% to 68%). However, among men and women with 
cath, SES was not associated with the use of revascularization procedures. For example, 
PTCA rates in men within 90 days post-AM1 were 26%; 17% to 36% compared with 25%, 
16% to 35% in low and high SES areas, respectively. CABG rates in men were 15%; 8% 
to 22% compared with 19%; 11% to 29% in low and high SES areas respectively. Con- 
clusion. We found that in the universal health care system of Canada, access to cath 
post-AM1 varied according to SES both in 1989 and 1994. After adjustment for individual- 
level predictors of use of cath, the variability was mostly explained by SES variables. 
Among those with cath, SES did not appear to influence further use of revascularization 
procedures. 
Insignificant Disease 
Single-Vessel 
Double-Vessel 
Triple-Vessel 
Left Main Disease 
Patients 
22.2% 40.4% 
16.6% 20.1% 
17.5% 14.2% 
32.4% 19.0% 
11.2% 6.3% 
5,370 3,868 
1081-7 Representation of the Elderly in Cardiovascular Clinical 
Trials 
Patrick Y. Lee, Karen P. Alexander, Bradley G. Hammill, Sara K. Pasquali, Eric D. 
Peterson. Duke University Medica/ Center, Durham, NC 
Background: While patients aged 2-75 years comprise 33% of those hospitalized for Ml 
and over 80% of Ml deaths, in the past, this age group has been underrepresented in 
randomized clinical trials @CT). While this underrepresentation was noted in the early 
1990’s (coincident with the expansion of clinical trials), the extent to which these enroll- 
ment patterns have shifted is unknown. 
Methods: We petiormed a systematic review of the literature from January 1966 to 
March 2000 to identify primary manuscripts of RCT for therapies in the acute coronary 
syndromes (ACS). We determined whether and to what extent patients aged 2 75 yrs 
were enrolled in these trials over time. We reviewed 7,645 ACS abstracts of which 601 
ACS trials met inclusion criteria (primary manuscript, enrollment > 50 patients, primary 
clinical endpoints, and English language publications). 
Results: Overall, 51% of these trials ware performed since 1991, 65% were multicenter, 
and 26% investigated thrombclflic therapy. Table 1 displays by decade of publication, 
number of trials, patients enrolled, average patient age, age exclusions, and the percent- 
age of the overall population aged 275. In the last decade, the number of RCT with age 
exclusions has declined slightly from 61% pre-1991 to 48% since 1991. The enrollment 
of elderly patients in RCTs has risen from 3% pre-1991 to 9% after 1991. 
Elderly in Cardiovascular Clinical Trials 
Decade Trials Patients Age Trials w/Age Patients 
(Id (n) (mean) Exclusions (%) Aae > 75 (%) 
All Years 601 711,114 61 52 7 
1966-1970 29 7,400 60 34 1 
1971-1980 64 40,846 56 44 1 
1981-1990 202 175,579 58 70 3 
1991-2000 306 487,289 62 48 9 
Conclusion: Inclusion of elderly patients in ACS ACTS has increased over time, yet they 
remain highly underrepresented in relation to their prevalence in the treated population. 
As the safety and efficacy of treatments may vary as a function of age, this under-enroll- 
ment of the elderly undermines efforts to provide evidence-based cardiac care. 
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INFOQACC YOUNG INVESTIGATORS AWARDS COMPETITION 
1501 Electronic Record and Clinical Trials 
Monday, March 19, 2001, 9:00 a.m.-l 2:30 p.m. 
Orange County Convention Center, Booth 3163 
Presentation Hour: 9:00 a.m.-l I:00 a.m. 
1501-1 New Frontiers in Assessing Outcomes for Clinical Trials: 
Implementation of Computerized Health Status/Utility 
Assessment in the COURAGE Trial 
John A. Spertus, Kate Hanson, Stanley E. Kaufman, Walton Sumner, Robert Nease, 
Sandra 8. Dunbar, Pamela M. Hartigan, Robert A. O’Rourke, William S. Weintraub. Mid 
America Heart lnsfitute, Kansas City, MO, Emory University, Aflank?, GA 
Background: Medical interventions, i.e. revascularization, give a range of potential ben- 
efits, including the prevention of disease progression (death, MI, hospital admission), 
improvement in health status (symptoms, functioning & quality of life), cost reduction & 
greater satisfaction. Because therapy may improve some outcomes at the expense of 
others, tradeoffs are inherent in the selection of optimal treatment. These tradeoffs are 
facilitated by direct solicitation of pt preferences. The COURAGE Trial is a 3260 pt, 38 
center clinical trial of angioplasty vs. medical therapy. To collect a full range of patient- 
centered data, including pt preferences, a new mechanism of data collection was 
needed. 
Methods: We wrote a JAVA-based program incorporating generic & disease-specific 
health status instruments as well as detailed symptom, mood, self-management & social 
support questionnaires. We incorporated the U-titer TM Standard Gamble utility assess- 
ment. This program is administered to pts on a portable, touchscreen Fujitsu 510 Pentab- 
let computer to facilitate direct entry by the pts themselves. This approach reduces 
transcription errors & skipped questions/instruments in addition to assuring that 
responses fall within a valid range. These data are initially stored in a temporary, locally 
stored database that is backed up dally & sent weekly to the coordinating center for entry 
into the main study database. 
Results: The data collection program has been distributed to all clinical sites & is being 
used successfully among patients enrolled in the trial. Preliminary feedback has been 
uniformly positive & enthusiastic. 
Conclusion: Computer administered outcomes assessments in clinical trials permits a 
broader evaluation of patient outcomes at lower cost & with higher data quality than could 
be accomplished with traditional modes of information acquisition. Only a computerized 
approach enables patient preference data collection for utility assessment in a large trial. 
Future clinical trials should consider similar techniques so that the full ramifications of 
therapies can be more robustly assessed. 
1501-2 The Integrated Paperless Multimedia Electronic Patient 
Record: Improving the Practice of Cardiology 
Ross D. Fletcher, Ronald E Jones, Daniel Fernicola, Ruth A. Dayhoff, Chiao M. Wu, 
Kevin Crawford, Christopher McManus. Department of Veterans Affairs, Washington, DC, 
Georgefown University, Washington, DC 
Background: The practice of Cardiology is transitioning from a paper/film record, to one 
that is electronic. The Department of Veterans Affairs has a high-speed network of multi- 
media workstations to present the patient record with diagnostic images. The Washing- 
ton VAMC is paperless and the complete electronic record is available at over 1500 
workstations. Participating hospitals exchange information through a secure lntranet con- 
nection. An Internet link provides search and reference capabilities with reviews of cur- 
rent guidelines and treatment recommendations. Methods: The network was built using 
standard off the shelf hardware components. The workstations are running Windows NT, 
the VA software, Internet Explorer, and MS Office 98. All textual information is accessed 
from a legacy database using the VA’s Computerized Patient Record System (CPRS) 
program. Images are stored on a three-terabyte jukebox and accessed through the Veter- 
ans Health Information Systems and Technology Architecture (VISTA) imaging software. 
These packages are fully integrated, but can be used individually. Results: The Cardiol- 
ogy database includes records of over 6,710 Caths; 7,268 Halters; 79,650 ECGs; 21,024 
Echocardiograms; 10,402 ETTs; and 1,818 EPs. DICOM streaming images are read 
from a referring hospital’s CD-ROM or from the database. The catheterization lab, which 
produces a Dicom output, has tine films in the electronic record. Database searches 
identify patients at risk for cardiovascular diseases. Reminders are entered in the 
patient’s record to prompt the provider. Similarly, the database can be used to monitor the 
hospital’s compliance with appropriate guidelines. Conclusion: The electronic record is 
available throughout the hospital, in affiliated teaching hospitals and in provider’s homes. 
Cardiologists have the complete patient record available for analysis and review. Auto- 
mated searches identify at risk patients. Streamlined record keeping and reports mini- 
mize the time spent in these efforts. Information flow is enhanced, results are never lost 
or in transit requiring delay or the repeat of a study, and general efficiency has improved 
freeing the physician to care for his patient. 
409 Young Investigators Awards Competition: 
Physiology, Pharmacology, and 
Pathology 
Monday, March 19, 2001, II:00 a.m.-12:15 p.m. 
Orange County Convention Center, Room 414C 
409-I Binding to Hyaluronic Acid Oligosaccharides: A Mechanism 
for Endostatin-Mediated Inhibition of Angiogenesis 
Sean M. Wu, John Parvani, Gourab Bhattacharjee, Salvatore V Pizza Duke Universify 
Medical Center, Durham, NC 
Angiogenesis plays a crucial role in the development of new blood vessels in ischemic 
cardiovascular disease and in tumor growth. Inhibitors of tumor angiogenesis, such as 
angiostatin and end&&in, reduce the growth of metastatic tumors. Despite its potential 
as an anti-cancer agent, the mechanism of anti-angiogenesis by endostatin remains 
unknown. The crystal structure of endostatin suggests that it may bind to extracellular 
matrix proteoglycan. We hypothesize that endostatin may inhibit angiogenesis by binding 
and inhibiting oligosaccharides of hyaluronic acid (O-HAS), enzymatic cleavage products 
of hyaluronic acid produced by tumor-secreted hyaluronidase. O-HAS of 4-25 disaccha- 
ride units are angiogenic in vitro and in viva We demonstrate that both human and 
murine endostatin inhibit hyaluronidase-dependent, o-HA-mediated endothelial cell pro- 
liferation. Endostatin binds minimally to intact hyaluronic acid but brnding is enhanced 
six-fold when the polymer is cleaved to produce angiogenic oligosaccharide fragments. 
Endostatin does not directly inhibit the enzymatic activity of hyaluronidase nor does it 
prevent access of hyaluronidase to its substrate. CD-44, a receptor for hyaluronic acid, 
could mediate the O-HAS angiogenic effects in vitro; however, our studies do not suggest 
a role for CD-44 in o-HAS-mediated endothelial cell proliferation. These data support a 
specific mechanism of angiogenesis regulation involving the direct interaction between 
endostatin and extracellular matrix proteoglycans. In addition, they suggest the involve- 
ment of novel receptor targets in o-HAS-mediated angiogenesis. 
409-Z Cocaine Enhances the Susceptibility of Mice to 
Encephalomycarditis Virus: The Catecholamines 
Hypothesis 
Ju-Feng Wang, Lin Zhang, Clyde S. Crumpacker, Walter H. Abelmann, James I? Morgan. 
Beth lsrael Deaconess Medical Center, BOS~OR, MA 
Many studies have demonstrated that exposure to cocaine may cause potentially life- 
threatening cardiovascular injury. In the present study, we used mice to test our hypothe- 
sis that cocaine can increase the incidence and exacerbate viral myocarditis. BALB/c 
mice were divided into eight groups: saline control, encephalomyocarditis virus (EMCV), 
Cocaine 10 mglkg(Coc-lo), Cocaine 30 mg/kg (Coc90), Cocaine 50 mglkg (Cot-50), 
EMCV+Coc-10, EMCV+Coc-30, EMCVcCoc-50. After inoculation with EMCV, the mice 
were treated daily with cocaine or saline for 90 days. Mice were sacrificed at days 3, 7, 
14, 21, 35, 60, or 90 after EMCV inoculation. Mortality was recorded and myocarditis was 
evaluated by hematoxylin-eosin staining. Whereas, none of the three doses of cocaine 
alone caused death or myocardial damage in control mice, the severity of viral myocardi- 
tis increased in mice exposed to cocaine. The mortality of the myocarditis mice treated 
with cocaine increased significantly, from 22% (EMCV) to 25.7% (Cot-lO+EMCV), 
41.4% (Cot-30+EMCV), and 51.4% (Cot-50+EMCV) (p<O.O5). The incidence of inflam- 
matory cell infiltration and myocardial lesions was higher in cocaine-exposed myocarditis 
mice. Exacerbation of viral myocarditis was more apparent after 21 days of administra- 
tion of cocaine. Moreover, cardiomyopathy could sometimes be demonstrated grossly. 
Exposure to cocaine prior to viral inoculation did not exacerbate myocarditis. Adrenalec- 
tomy ameliorated cocaine’s effect. Norepinephrine (NE) assay showed that cocaine 
exposure significantly increased NE concentration in myocarditis mouse hearts. More- 
over, a b-blocker significantly decreased the effect of cocaine on myocarditis mice. These 
results suggest that catecholamines may be responsible for cocaine’s exacerbation of 
viral myocarditis. In conclusion, cocaine increases the susceptibility of mice to viral myo- 
carditis. Increased catecholamines may be a major factor responsible for this effect. 
409-3 Vascular Regulation of Adipose Tissue Mass 
Maria Rupnick, S Dallabrida, D Panigrahy, C Zhang, B Lowell, R Langer, J Folkman. 
Brigham and Women’s Hospital, Boston, MA 
Tumors are angiogenesis dependent. Adipose tissue growth may require angiogenesis. 
Genetically obese mice (obiob) gained to 73.0 + 1 .O gms with 35.2 + 2.2% body fat at 8 
months. ob mice treated with the angiogenesis inhibitor, TNP-470 (n=234) reduced to 
41.2 + 1.1 gms (~~0.05) with 18.8 + 1.3% body fat (p<O.OOi) and leveled. C57 mice lost 
4.4 gms. (p<O.O5). Heart, lung, and kidney weights were stable. Distinct inhibitors 
(angiostatin, end&&in) and obese models (db, Ay, Cpe, diet-induced) showed similar 
results. Periodic TNP-470 caused cycling of ob weights by +/- 15-25 gms, showing 
reversibility. lmmunohistochemisty showed suppressed endothelial (EC) proliferation 
(median 0% BrdU-labeled ECIHPF) and increased apoptosis (median 11% TUNEL-posi- 
tive EC/HPF) in fat of oh treated mice compared to controls (7.5% BrdU, 0% TUNEL). 
Adipose tissue loss was selective and substantial. Remodeling may be enabled by 
chronic vessel immaturity. In C57 and ob fat, mRNA expression (R%PCR, Northern) of 
vessel immaturity factor angiopoietin-2 was stable, while expression of vessel maturation 
factor angiopoietin-1 decreased in proportion to change in weight. Relative to wildtype 
mice ganing 149 mg/d, ang-1 expression was 17% less in treated C57 mice (losing 263 
mgld); 59% less in control ob mice (gaining 441 mgid), and 74% less in treated ob mice 
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(losing 1352 mg/d) (p<O.O5). Angiopoietin levels in other organs were stable. Adipose 
vascular pliability may be promoted by decreased ang-1, and vessel immaturity. Ob mice 
maintain near normal weight on treatment. Metabolic consequences were examined. 
With chronic treatment, food intake of ob mice was comparable to wildtype. Oxygen con- 
sumption (24.3+0.7 mllglmin) increased wrth TNP-470 (30.0+2.0 mllglmin) indicating an 
elevated basal metabolic rate (pcO.05). Respiratory exchange ratios (VCO2/VO2) of 
treated ob mice decreased from 0.76+0.4 to 0.64+ 0.5, suggesting greater free fatty acid 
use (~~0.05). Conclusions: 1) Adipose tissue growth is angiogenesis-dependent and 
responsive to antiangiogenic agents; 2) Decreased ang-1 levels suggest vessel immatu- 
rity relates to tissue remodeling; 4) Antiangiogenic weight loss is associated with meta- 
bolic adaptions. 
POSTER SESSION 
1116 Computers in Cardiology II: Imaging and 
Diagnosis 
Monday, March 19, 2001, Noon-2:00 p.m. 
Orange County Convention Center, Hall A4 
Presentation Hour: 1:00 p.m.-2:OO p.m. 
409-4 Long-Term improvement of Cardiac Function by 
Transplantation of Embryonic Cardiogenic Stem Cell in 
Post-Infarcted Rats. 
1116-l Toward Practical Digital Echocardiography: MPEGS 
Compression Validation 
Jiang-Yong Min, Yinke Yang, Kimber L. Converse, Ju-Feng Wang, Matt Sullivan, James P 
Morgan, Yang-Fu Xiao. Beth lsrael Deaconess Medical Center, Boston, MA 
S. Suave Lobodzinski, George Prelorentzos, Shelley Shapiro, Monika Kuzminska, 
Leonard E. Ginzton. Harbor-UCLA Medica/ Center, Torrance, CA 
The present study was designed to Investigate the feasibility and potential functional 
benefits of embryonic cardiomyogenic stem (ES) cell transplantation in postinfarcted rats 
with a long-term follow up. MI was created by ligation of the left descending coronary 
artery. Mouse ES cell suspension (30 @I, 106 cells/ml) was separately rnjected Into 3 
drfferent sates (IO ml each) in MI rat hearts at the time of induction of Ml. Control animals 
received the same MI operation but were only injected with an equivalent volume of cell- 
free medium. The sham group underwent surgery wrth neither ligation of the coronary 
artery nor cell transplantation, Survival significantly increased in post-Ml rats with ES cell 
transplaniation during the 32.week follow up. In addition, ventricular function assessed by 
hemodynamics and echocardiographic measurements was improved by ES cell 
transplantation with 32week follow up after Ml (see Table). Characteristic phenotype of 
engrafted ES cells was found in infarcted areas in transplanted MI rats. The viability of 
the implanted ES cells was identified by the strong positive starning to sarcomeric a- 
actln, which is unusual for the adult myocardium. Our data suggest that ES cell 
transplantation improves cardiac function in postrnfarcted rats during a long-term 
observation. Transplanted EM cells are able to survive and form stable grafts in infarcted 
myocardium up to 32 weeks up. 
Background: Digital echocardiography’s(echo) acceptance is hindered by limited study 
length and high archival costs. MPEGP compression(COM) offers potentially increased 
study duration while reducing archived file size. But MPEGP has not been shown to COM 
without unacceptable data loss. Hypothesis: MPEGP echo COM will have the same inter- 
and intra-observer variability as un-COM images. Methods: 35 unselected patrents were 
studied, with a range of diagnoses and image quality encountered in clinical echo. Two 
sets of 250 digital video objects(DV0) of common windows(parasternal, apical, subcos- 
tal) and modalities(M-mode, ZD, pulsed, continuous and color Doppler) were digitally 
recorded and archived. Set 1 was the unCOM(270mbps) files and Set 2 the MPEG2(4 
mbps) COM versions. Clinical truth(normal n=170, abnormal w80) was established 
independently from the medical record. Two readers blinded to COM, each other and all 
other data, read all COM and un-COM images. A confidence factor(l-5) was assigned to 
each statement. The Alternative Free Response Receiver Operating Characteristic 
(AFROC) method was used to calculate the area index AZ under the ROC curve for each 
data set and reader. The differences between data sets’ indices (A, ,= difference of un- 
COM area indexA, for the i-th reader) were computed. Student’s paired t-test tested the 
null hypothesis that the mean of the differences is zero. Results: Computed AFROC 
curves and calculated area indices A, show a mean difference between the Azs of 
=0.024. The t-test’s power was 71% and the 95% confidence interval was -0.086 to 0.00. 
The inter-observer and intra-observer error was the same for un-COM and MPEGP COM 
images. Conclusion: There was no difference in diagnostic accuracy between MPEG2 
COM and un-COM echoes. The smaller MPEG2 file size should allow less expensive 
data archiving and faster data file transfer speeds with no loss of diagnostic accuracy. 
Mean + SE. PW th: relative posterror wall thickness; AW th: relative anterior wall thick- 
ness; En FS: endocardial fractional shortening. * P < 0.05, ‘* P < 0.01 vs. Sham; # P c 
0.05 vs. Ml+Medium 
409-5 Dynamics of Transmural Reentry During Ventricular 
Fibrillation: Anatomical Determinants 
Miguel Valderrabano, Moon H. Lee, Toshihiko Ohara, Hrayr Karagueuzian, Peng-Sheng 
Chen. Cedars-Sinai Medical Center, Los Angeles, CA 
Background: The transmural dynamics of ventricular fibrillatron (VF) remain poorly 
understood due to the lack of a suitable experimental model. Recently proposed mecha- 
nisms of VF suggest the presence of stable intramural reentry. Methods and Results: 
We performed transmural optical mapping studies of VF in Isolated, perfused fibrillating 
swine RV and LV tissues. 9 RV free walls were cut obliquely in their distal edge exposing 
the transmural surface. 6 LV wedge preparations were performed by perfusing the left 
anterior descending coronary artery (N=Z), or the circumflex with the second obtuse mar- 
ginal (N=4). The tissue surrounding either artery was exposed and mapped. Intramural 
reentry was clearly demonstrated in both ventricles, but was spatiotemporally unstable 
and different patterns were seen in a given tissue. In RV, 28144 VF episodes showed 
reentry (82 episodes), with 17% of the activation pathways being reentrant. Reentry 
involved subendocardiai structures -the papillary muscle (PM), and trabeculations- as 
anchoring sites; true intramural reentry was rare (3 cases). In LV, reentry was more fre- 
quent (27127 VFs showed 85 episodes of reentry, accounting for 29.5% of the activation 
pathways, ~~0.05 compared to RV), and truly intramural, also localized frequently in the 
PM. Histological studies showed high degrees of fiber orientation heterogeneity at sites 
of reentry and wave splitting in both ventricles. Conclusions: Intramural reentry in VF is 
frequent but unstable. In the RV, reentry is transmural rather than intramural and requires 
subendocardial structures. The LV has greater incidence of reentry but is similarly unsta- 
ble. Tissue heterogeneity contributes to the maintenance of VF by promoting reentry and 
wave splitting. 
1116-2 Quantification of Regurgitant Orifice Area and Flow Rate 
Using the Centerline Velocity Gradient from Color M-Mode 
Doppler: Computational Fluid dynamics Simulations and In 
Vitro Validation Study 
Dimitri Deserranno, Neil L. Greenberg, Mario J. Garcia, George P. Chatzimavroudis, 
James D. Thomas. Cleveland Clinic Foundation, Cleveland, OH, Cleveland Sfate 
Universitl: Cleveland, OH 
Previous echocardiographic techniques for quantifying valvular regurgitation (PISA) are 
limited by factors including uncertainties for the location of the orifice and a hemispheric 
convergence assumption that often results in over- and underestimation of flow rate (Q) 
and regurgitant orifice area (ROA). While centerline velocity profiles V(r) from Color M- 
mode (CMM) images have been investigated for improved quantification, the peak veloc- 
ity through the orifice (vmax) has not been included in attempts to determine Q, but only 
as a means to calculate ROA. The purpose of this study was to investigate the combina- 
tion of V(r) and Vmax using computational fluid dynamics (CFD) models and in vitro vali- 
dation. Methods: CFD steady flow simulations using various orifices (5.Emm in 
diameter) were obtained for different flow rates (40.155mUs). The centerline Vmax and 
V(r) through the flow convergence zone were extracted from each simulation. CFD 
results were evaluated using an in vitro model of steady-state flow through the same size 
orifices. Q was adjusted to match CFD simulations and Vmax was compared by CW 
Doppler. V(r) was extracted from CMM images obtained and compared with CFD data. 
Results: V(r) from CFD data for a given Vmax demonstrate unique gradients for different 
orifice areas. This shows the ability to determine Q and ROA based on velocity gradient 
and Vmax. CFD velocity profiles for D=8,7,6 and 5mm (Q=i55,125,99 and 66mlis) with 
Vmax=500 cm/s (graph) agree well with CMM (SEE= 0.17+/-0.048 cm/s). Similar results 
were obtained for other values of Vmax. This analysis validates the results obtained by 
the CFD simulations. Conclusions: Q and ROA can be determined by fitting the mea- 
sured CW and CMM Doppler data to the CFD data, without assuming hemispherical sur- 
faces or an orifice location. Further validation using unsteady flows and more complex 
geometries is required for practical application in vim 
0.45 0.35 0.25 0.15 0.05 
Distance from orifice (cm) 
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1116-3 Improvement of the Computer-Assisted Differential 
Diagnosis for Wide QRS Premature Complexes 
Takao K&oh, Tadaaki Ohno, Kenji Yodogawa, Hirokazu Hayakawa, Masaki Kanazawa, 
Shigeru Shimizu. NipponMedical School, Tokyo, Japan, NEC Co. Ltd., Tokyo, Japan 
Background: Therapeutic strategies for ventricular and supraventricular arrhythmias are 
quite different in the clinical setting. However, differential diagnosis among wide QRS pre- 
mature contractions was often inaccurate or not established in widely used ECG 
machines with automatic computer-assisted diagnosis. Swallowing the computer diagno- 
sis whole may bring us serious problems. So, the purpose of the present study was to 
improve the automatic differential diagnosis between premature ventricular contraction 
(PVC) and supraventricular contraction with aberrant conduction (A-PSC). Methods: 
Consecutive 180 ECG with wide QRS premature contractions ware picked up from our 
3723 ECG data bases. 166 ECG were diagnosed as PVC, while remaining 14 were con- 
firmed as A-PSC by expert doctors. Our newest algorithm consisted of following simple 
steps: Detection of Wide QRS Complex+Second Derivative-tAbsolute V.alue+Smooth- 
ing+T Wave Subtraciion+P’ Detection, was compared with conventional algorithm 
using QRS morphological analysis and P’ algorithm without T wave subtraction. Then, 
another 1345 EGG from other hospital were analyzed as an external sample for valida- 
tion of the new algorithm. Results: The quality of our new algorithm was evaluated as 
how much improved the diagnostic accuracy for A-PSC. As the results, rate of false posi- 
tive was reduced step by step (22.3% in co&entlonal QRS algorithm, 7.8% in P’ without 
T subtraction algorithm and 3.0% in P’ with T subtraction algorithm), resulting in marked 
increase of diagnostic accuracy from 77.2% to 90.6% and 95.0%, respectively. Sensitivity 
stayed at 71.4% among these three algorithms. In general population with external sam- 
ples, the newest algorithm showed 77.8% sensitivity, 99% specificity and 98.9% accuracy 
for diagnosis of A-PSC. Conclusion: Our P’ algorithm for differential diagnosis of wide 
QRS complexes was so simple but reliable with high diagnostic accuracy that it can be 
applied not only to 12-lead ECG machine with computer-assisted automatic diagnosis 
but also to Halter monitoring system at the forefront of clinical practices. 
camera (GCA-OSOOAIHG, low-energy general purpose collimation, 360.degree circular 
orbit, 60 projections of 90 sac each, 10 frames/cardiac cycle, 64X64 pixel image matri- 
ces). Patients were injected with 740 MBq Tc-99m labeled red blood cells for BPGS, and 
740 MBq Tc-99m tetrofosmin for QGS. Results: QGS and BPGS end-diastolic volumes 
(EDV) and end-systolic volumes (ESV) exhibit a high correlation (EDV: y=l.O6x-2.76, 
wO.92, s.e.e.=38ml; ESV: y=1.04x+5.91, wO.93, s.e.e.=36ml), and ejection fraction val- 
ues show a good correlation (y=O.76x+O.O4, r=O.88) over a wide range of volumes (g&d 
perfusion SPECT EDV: range 61-305ml, average 149ml). Conclusion: Automatic quanti- 
tative assessment of BPGS appears to be accurate for absolute LV volume as well as 
ejection fraction measurements, potentially adding to the clinical role of blood pool imag- 
ing. 
1116-6 Quantitative Assessment of Right Coronary Artery 
Foreshortening in 100 Patients Using 3-D Coronary 
Reconstruction 
John C. Messenger, Robert Liao, S. Y. James Chen, John D. Carroll. University of 
Colorado Health Sciences Center, Denver, CO 
1116-4 Objective Assessment of Diastolic Dysfunction in Patients 
With Left Ventricular Hypertrophy Using Time-Warped 
Averaging of Acoustic Quantification Signals 
Enrico G. Caiani, Kirk T. Spencer, Lynn Weinert, Roberto M. Lang, Victor Mar-Avi. 
Ur~iversify of Chicago, Chicago, IL 
Background: Quantitative assessment of coronary artery foreshortening (FS) during 
coronary angiography has been limited by the 2-D display of current imaging systems. 
“Traditional” views based on expert opinion and individual operator experience are felt to 
minimize FS and vessel overlap. Methods: We developed a computerized 3-D recon- 
struction algorithm using two single-plane angiograms to create an accurate patient-spe- 
cific 3-D coronary reconstruction. We analyzed the RCA from 100 patients undergoing 
angiography (mean age 56.7 yrs, 63% male). Using the 3-D reconstruction, segments of 
the RCA were identified using CASS nomenclature (PROX, MID, DISTAL, and PDA). The 
model was rotated on a Silicon Graphics workstation to three “standard” projections 
(RAO 30 CRAN 0, LAO 45 CRAN 0, and LAO 30 CRAN 20) used for the RCA. Length 
and percent FS of each segments was measured. Results: There was substantial fore- 
shortening in optimal “traditional” views, ranging from O-60%, O-75%and O-82% for the 
pro& mid and distal RCA in the three views. The percentage foreshortening for each seg- 
ment are listed in the table below. Conclusions: Using 3-D coronary reconstruction we 
were able to quantify segment length and percent FS between views and patients. “Tradi- 
tional” angiographic views provide inferior images in terms of segment foreshortening 
when compared to tailored, patient-specific 3-D reconstructions. This computer algorithm 
provides unique data which optimizes angiographic viewing angles for individual patients 
in diagnostic and interventional procedures. 
Signal averaged acoustic quantification (SAAQ) allows quantitative assessment of LV 
performance. However, beat-to-beat heart rate variability may affect the morphology of 
SAAQ waveforms and hinder the identification of diastolic phases. We hypothesized that 
signal averaging with time-warping (TW) may better preserve the morphology of SAAQ 
waveforms and thus improve the detection of diastolic dysfunction (fig. A). Methods. 
Pulsed-wave Doppler mitral and pulmonic vein flows and LV area signals were obtained 
(HP 2500) in 40 patients with concentric LV hypertrophy (LVH, age 30.70 yr, 10 pts in 
each decade) and 40 age-matched normal subjects. Doppler indices included: mitral 
peak velocity of rapid and atrial filling and pulmonic vein peak systolic, diastolic and atrial 
reversal velocities, as well as the corresponding velocity-time integrals and their ratios. In 
each subject, LV area signals were averaged (16 consecutive beats) using a time-warp- 
ing technique. Average waveforms were used to identify the phases of LV filling and cal- 
culate: end-systolic and end-diastolic areas, peak rapid and peak atrial filling rates 
normalized by end-diastolic area, % rapid and % atrial filling, and heart-rate corrected 
duration of diastasis. In each patient with LVH, Doppler and SAAQ indices were corn- 
pared with the mean of the corresponding age-matched subgroup of 10 normal subjects. 
For both methods, the presence of diastolic dysfunction was determined when at least 
two indices were outside the meanr2SD of this control (75% confidence interval). 
Results. Signal averaging with TW improved the definition of diastolic phases. Doppler 
indices identified diastolic dysfunction in 29140 (73%) pts, whereas SAAQ with time- 
warping showed abnormalities in 34/40 (85%) pts’(fig. B). Conclusion. This technique 
may allow the diagnosis of diastolic dysfunction in patients with LVH and normal Doppler 
flow patterns. 
Length and % foreshortening of RCA segments in “standard” projections 
“SSei Length (ml, LAO 45 CRAN II (% RAO 30 CRAN 0 (% LAO 30 WAN 20 (% 
Segment * SEM) * SEM) f SEM, 
Proximal RCA P.85 * 0.68 12.6 * 9.8% 26.3 * 13.5% 11.1 f 9.7% 
Mid RCA 2.92 *II 67 7.8 * 9.6% 7.9 + 7.5% 14.5* 10.1% 
Distal RCA 4.49 I 1.30 4.9 3 4.6% 43.2 * 13.8% 10.6 * 8.4% 
1116-7 Comparison of Automated Border Detection for Contrast 
Ventriculograms Versus Human Interobserver Variability 
Florence H. Sheehan, Lei Sui, Robert M. Haralick. University of Washington, Seattle, WA 
Background: Although the ejection fraction (EF) is the most powerful prognostic indica- 
tor, it is usually visually estimated due to the cost of manually tracing the endocardium for 
quantitative analysis. Methods: We developed a method for automated border detection 
(ABD) of contrast ventriculograms that utilizes knowledge of heterogeneity in 1) LV size, 
shape, function, and location on the image and 2) ventriculogram image quality, chamber 
opacification, gray scale range, etc. This knowledge derived from analyzing the images 
and manually traced borders from 375 studies in a diverse patient population. LV shape 
was characterized by principal component analysis of these 375 studies. Our method has 
3 parts. A pixel classifier segments the LV region from the background to produce a raw 
boundary. A shape regressin corrects the classifier results. A rejection classifier identifies 
studies unlikely to produce reliable results. To operate the algorithm, the user selects the 
end diastole and end systolic image frames and manually enters the ends of the aortic 
valve and the apex on each. To test the algorithm, an independent test set of 18 studies 
was manually traced by observer (obs) 1 at a core laboratory and the images were sub- 
mitted for ABD. The automatically detected borders were reviewed by obs 2 and edited 
manually. Results: Variability between the ABD results and obs 1 did not differ signifi- 
cantly from human interobserver variability. Conclusion: ABD by a knowledge based 
method produces results comparable to human tracing. Accurate ABD requires a mas- 
sive database of training data to handle heterogeneity in ventriculogram presentation. 
Variability 
1116-5 Validation of Quantitative Left-Ventricular End-Diastolic 
and End-Systolic Volumes From Gated Blood Pool SPECT 
Serge Van Kriekinge, Asit Kr. Paul, Shinji Hasegawa, Tsunehiko Nishimura, Daniel S. 
Berman, Guide Germane. Cedars-Sinai Medical Center, Los Angeles, CA, Osaka 
University Medical School, Osaka, Japan 
Background: Left ventricular (LV) volume IS an important prognostic indicator in patients 
with heart disease, but is not widely measured with standard planar blood pool imaging. 
Our group previously developed a completely automatic algorithm that measures LV and 
right-ventricular volumes and ejection fractions from blood pool g&d SPECT (BPGS) 
short axis datasets, and demonstrated good correlation of BPGS-derived ejection frac- 
tion values against a planar blood pool standard (Circulation 1999;100(18):1-26). Meth- 
ods: In the current study we report the results of quantitative LV volume comparisons in 
15 patients who underwent a gated myocardial perfusion SPECT study (QGS) as well as 
a blood pool g&d SPECT study. All studies were acquired on a Toshiba triple detector 
ABD-Obsl ABD-ObsZ p, paired t 
EDV, ml -15 +/- 18 -9 +I- 9 NS 
ESV, ml -8 +I- 18 -4 +I- 6 NS 
EF. % -1 +I- 9 -0 +I- 5 NS 
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1502-l An Intelligent On-line Multicenter Database Created for the 
Greater New York Heart Failure Consortium Registry on 
Heart Failure With Preserved Left Ventricular Systolic 
Function 
Foss Tighe, Marc Klapholz, Julia Nisbet-Brown, Stuart Katz, Patti Nash, Matthew Maurer, 
Jay Meisner, Marrick Kukin, Judith Mitchell, David Baran, Rachel Bijou, Jill Kalman, 
Richard Steingart, Robert Phillips, Thierry LeJemtel. New England Research Institutes, 
Watertown, MA, Saint Vincents Hospital and Medical Center, New York, NY 
The Greater New York Heart Failure Consortium has developed a multi-center Web- 
based registry to define the clinical characteristics of patients hospitalized with heart fail- 
ure and normal left ventricular systolic function. Twenty-one centers in the Greater New 
York area are linked via a dedicated secure Web page developed and housed at New 
England Research Institutes. Each site accesses the registry within the Web page via 
user defined passwords and directly enters their data on-line. The data is immediately 
stored into an Oracle database using JavaScript and Active Server Pages. Embedded in 
the registry on the Web page is a tool that provides immediate feedback to the investiga- 
tor including validations, over-ride options, edit reports and data entry status. The valida- 
tions include range checks of values and logical checks of information. Additionally, the 
database has been designed so that variable rigidities can be assigned to each variable 
based on the importance of the variable to the database. The three levels of ‘rigidity’ are: 
A. ‘Cannot proceed’, B. ‘Cannot complete’ or C. ‘Over-ride acceptable with reason’. Data 
forms are automatically tracked with immediate feedback from all sites to the overall 
database coordinator and study PI and from individual sites to the site PI through the web 
page. The tracking information Includes the number and basic demographics of all 
patients enrolled and the status of information for any given patient and are categorized 
as either ‘expected’, ‘pending edits’ or ‘complete’. Site generated ID numbers are specific 
to a site and generated in sequence for each site. The Web-based access to this site will 
be reviewed and sample data will be entered into the registry to demonstrate the function 
of this multicenter Internet-based registry. 
1502-2 The Italian National Cardiological Database: Integration of 
Internet, Smart Cards and Remote Databases for a 
Standardized Hospital Cardiological “e-Record” and 
Application Enviroment 
Domenico Cianflone, Marco Tubaro, Pierfranco Ravizza, Fabio Fonda, Andrea 
Marchesini, Giancarlo Carini. on behalf of the GBCardio-ANMCO Project, Rome, I&/y 
Background. In the framework of the G&CARD10 “Global Cardiovascular Databases” a 
joint initiative was started together with the ANMCO to design, develop and distribute a 
standardized national cardiological database to all cardiology centers throughout the 
country .The project builds upon the current initiative of the National Registry of CCU 
involving >130 hospltals that accruits core data elements from a CCU clinical manag- 
merit db application into a national db accessible over the internet. 
Methods. The joint GECARDIO-ANMCO Committee for Information Technology and an 
extended panel of experts from working-groups have defined both the core and the 
extended data elements for all clinical, diagnostic, therapeutic and interventional areas of 
cardiology and cardiac surgery. The application includes the ACC-NCDR “1.1 and the 
STS cardiac surgery core data. Sector specific data elements have been also endorsed 
by ihe relevant national scientific society. Valid ranges were defined for quantitative vari- 
ables, while for each qualitative variable a relevant set of allowable expressions was 
defined. An SQL application for the complete clinical management for cardiac patients 
was hence developed and freely distributed. A common national SQL db is located in a 
data warehouse and accumulates all local databases; the national db is securely acces- 
sible via IF? Patients’ and professionals’ smart cards, compliant with the G8CardslEuro. 
cards recommendations, were also developed and their use embedded into the 
applicaiion. Each physician and each patient in the participating centers are provided 
with the cards. The combination of both professional and patient cards provides a secure 
access to the shared GBCardio-ANMCO db. 
Results. As a result patients can be treated at multiple sites, in the event of transfer or 
readmission, by accessing the e-Records in the national db, with no need to rewrite the 
medical history with the inevitable gaps of reliable information. 
Conclusion: The overall resulting application permitted, for the first time worldwide, the 
creation of a shared care infrastructure, the development of a unique nationally available 
hospital e-Record and an enabling tool for the continuity of care. 
412 Young investigators Awards Competition: 
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Orange County Convention Center, Room 414C 
412-l Functional and Molecular Adaptations in Skeletal Muscle of 
Myoglobin Mutant Mice 
Annette Meeson, Robert Grange, Eva Chin, James Stull, R. Sanders Williams, Daniel J. 
Garry. University of Texas Southwestern Medical Center, Dallas, TX 
Myoglobin is a cytoplasmic hemoprotein that is restricted io cardiomyocytes and oxida- 
tive skeletal myofibers and facilitates oxygen delivery during periods of high metabolic 
demand. Myoglobin content in skeletal muscle increases in response to hypoxic condo- 
tions. However, we previously reported that myoglobin-null mice are viable and f&la In 
the present study, we define important functional, cellular and molecular compensatory 
adaptations in the absence of myoglobin. Mice without myoglobin manifest adaptations in 
skeletal muscle that include a fiber type transition (Type I to II), increased expression of 
the hypoxia inducible transcription factors, HIF-la and ePAS, stress proteins such as 
hsp27 and the angiogenic growth factor VEGF as well as increased nitric oxide metabo- 
lism. The resulting changes in angiogenesis, nitric oxide metabolism and vasomotor reg- 
ulation are likely to account for preserved exercise capacity of animals lacking myogiobin. 
These results demonstrate that mammalian organisms are capable of a broad spectrum 
of adaptive responses that can compensate for a potentially serious defect in cellular 
oxygen transport. Further examination of the cellular and molecular mechanisms of this 
powerful adaptive response ultimately could lead to advances in therapy of patients with 
myopathy or vascular disease. 
412-2 Activated Monocytes Induce Smooth Muscle Cell Death- 
Role of M-CSF in Coronary Plaque Instability: Molecular 
Mechanisms in Vitro 
Puvi N. Seshiah, Dean Kereiakes, Sanjay S. Shanker, Neuza Lopes, Pascal J. 
Goldschmidt-Clermont. Emory Universif~: Atlanta, GA, Duke University Medical Center, 
Durham, NC 
Background: Plaque rupture is the inciting event for coronary thrombosis and acute coro- 
nary syndromes. Multiple factors influence plaque rupture, including loss of vascular 
smooth muscle cells (VSMC) and matrix proteins induced by monocyteslmacrophages 
(MM). The mechanism of VSMC destruction by MM is unknown. We hypothesized that 
M-CSF (Macrophage Colony Stimulating Factor) may promote killing of VSMC by MM. 
We studied the effect of MM activation with M-CSF, on VSMC co-cultured with MM. Meth- 
ods: MM were freshly isolated from donor huffy coat & added, in a ratio of 3:1, to VSMC. 
M-CSF at concentration of 100nglml was added to initiate killing. Controls were set up for 
VSMC; without M-CSF or MM, with unstimulated MM, VSMC with M-CSF without MM. 
After 72hr incubation, VSMC death index was estimated as a percentage of apopiotic 
VSMC to total VSMC using fluorescent imaging. Results: VSMC apoptosis was unaf- 
fected by M-CSF (i&67+1.48) or MM (20.66+3.32) alone compared to Control VSMC 
(13.22t2.14). However, programmed cell death of VSMC was markedly increased in the 
presence of both M-CSF & MM (58.78r3.25). pf0.000047 and pf0.000004, relative to 
controls VSMC plus M-CSF without MM or VSMC plus MM without M-CSF, respectively. 
We also found that MM cell contact was required for M-CSF stimulated killing of VSMC 
and MM displayed an M-CSF dose dependent killing effect. Abciximab (ASX) has been 
shown to block Mac-l (CDllbICD18) on MM. We found that when added to VSMC 
exposed to MM & M-CSF, ABX (7mg/mi) reduced significantly VSMC apoptosis 
(26.51~4.69)pfO.O0026, relative to controls in the absence of ABX. We also found that 
equivalent doses of Tirofiban (0.35mgiml) and Eptifibatide (5mg/ml), which inhibit Gpllb/ 
llla but not Mac-l, did not block activated MM induced VSMC apoptosis, 65.03k3.39 and 
51.25i2.52 respectively. Conclusions: These data suggest a novel mechanism of plaque 
destabilization involving VSMC apoptosis triggered by MM & physiological concentra- 
tions of M-CSF, which could be efficiently antagonized by Abciximab. 
412-3 Modulating the Thrombogenic Balance in a Murine Model of 
Vascular Remodeling: a Role for TFPI 
Ripudamanjit Singh, Shuchong Pan, Timothy Peterson, Cheryl Mueske, Tyra Witt, Laurel 
Kleppe, Jean-Yea Chang, Noel Caplice, Robert Simari. Mayo Clinic, Rochester, MN 
Background: Tissue factor (TF) is a small-molecular-weight glycoprotein that initiates 
the extrinsic clotting cascade and is considered a major regulator of arterial thromboge- 
nicity. Tissue factor pathway inhibitor (TFPI) IS a ma/or physiological inhibitor of TF-initi- 
ated coagulation. Expression of TFPI in human atherosclerotic plaque is associated with 
reduced TF activity. To define the complex interplay between TF and TFPI, a murine 
model of vascular remodeling was studied. Methods and Resuks: To determine the lev- 
els and pattern of vascular expression of TF and TFPI associated with vascular remodel- 
ing, C57BU6 mice underwent unilateral common carotid artery ligation. Mice were 
sacrificed at 1, 2, 3 and 4 weeks. Quantitative analysis of homogenates of ligated carotid 
arteries for TF and TFPI expression by immunoblotting revealed increased TF, (up to 3. 
fold at 2 weeks) but unchanged TFPI expression compared to normal carotids. TF activity 
of the ligated arteries increased at 1 and 4 weeks following ligatron (p<O.OS). To deter- 
mine the role of TFPI in this thrombogenic state, eighteen mice were treated with intra- 
vascular adenoviral delivery of either 1.33~108 PFU of Ad-mTFPlmyc, Ad-DeltaEl 
(without cDNA insert) or saline for twenty minutes. Overexpression of TFPI in the Ad- 
mTFPlmyc group was observed compared to the control groups by immunoblotting. Vas- 
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cular TF activity was decreased in the Ad-mTFPlmyc group as compared to the two con- 
trols (p<O.Ol). Conclusion: Vascular remodeling associated with flow cessation results 
in increased TF expression without a concomitant increase in TFPI. This imbalance 
results in increased vascular TF activity. Overexpression of murine TFPI attenuates this 
enhanced thrombogenicity. Strategies to regulate TF activity may thus provide a unique 
mechanism to affect the thrombogenicity and perhaps the structure of remodeled arter- 
ies. 
ORAL CONTRIBUTIONS 
412-4 Gene Transfer of Endothelial Nitric Oxide Synthase (eNOS) 
to the Lung of the Mouse in Vivo: Rescue of Bleomycin- 
Induced Pulmonary Hypertension in eNOS-Deficient Mice 
803 Featured Oral Abstract 
Session:Outcomes Research - Key 
Studies From Large Databases in 
Coronary Artery Disease 
Monday, March 19, 2001, 2:00 p.m.-3:30 p.m. 
Orange County Convention Center, Room 304E 
Hunter Champion, Trinity Bivalacqua, Thomas Giles, Stanley Greenberg, Albert Hyman, 
Philip Kadowitz. Johns Hopkins Hospital, Baltimore, MD, Tulane University New Orleans, 
LA 
The effects of transfer of the endothelial nitric oxide synthase (eNOS) gene to the lung 
were studied in mice deficient in eNOS. eNOS deficient mice exposed to the fibrogenic 
agent had an augmented increase in pulmonary arterial prassure and right ventricular 
free wall weight when compared to eNOS+/+ mice. Tan days after intratracheal adminis- 
tration of AdRSVeNOS, eNOS protein levels, calcium-dependent NOS activity, and 
cGMP levels in eNOS-I- mice were significantly greater than levels in eNOS-I- mice 
transfected with AdRSVbgal and were similar to levels in eNOS+/+ mice. Baseline pul- 
monary arterial prassura and pulmonary vascular resistance, which are elevated in 
eNOS-/- mice were, significantly lower in mice transfected with AdRSVeNOS and were 
similar to eNOS+/+ mice at baseline. In contrast, the elevated systemic arterial pressure 
in eNOS-/-mice was not altered after transfection with AdRSVeNOS. Pulmonary vasode- 
pressor responses to bradykinin and the type V cGMP-selective phosphodiesterase 
inhibitor zaprinast were significantly reduced in eNOS-/- mice, but were restored to near 
control levels after transfection with AdRSVeNOS. lntratracheal administration of AdRS- 
VeNOS attenuated the augmented increase in pulmonary arterial pressure, right ventric- 
ular hypertrophy, and pulmonary vascular remodeling in eNOS-I- mice exposed to the 
frbrogenic agent bleomycin. These data suggest that in viva gene-transfer of eNOS to the 
lung can partially restore pulmonary arterial pressure to control levels in eNOS knockout 
mice and prevent the augmented response to bleomycin-induced pulmonary hyperten- 
sion. Moreover, these data suggest that in viva gene transfer may be a useful therapeutic 
intervention for the treatment of pulmonary hypertensive disorders in which endogenous 
NOS activity is reduced. 
803-2 
2:15 p.m. 
Potential Bias in the Use of Combined End Points in Quality 
Assessment of Percutaneous Coronary Interventions: An 
Analysis of the Relationship Between History of Prior CABG 
and MACE 
Mauro Moscucci, David J. Malenka, David E. Wennberg, David Share, Michael J. 
O’Donnell, Anthony DeFranco, Eva Kline-Rogers, Adam B. Greenbaum, Ann Maxwell- 
Eward, William L. Meengs, Kim A. Eagle. University of Michigan Medical Center, Ann 
Arbor, MI 
412-5 Inhibition of Cardiac Hypertrophy by 3-Hydroxy-3- 
Methylglutaryl (HMG)-CoA Reductase Inhibitors 
Background: Traditional end points used in quality assessment of Percutaneous Coro- 
nary Interventions (PCI) include, among others, the combined Major Adverse Cardiac 
Event (MACE) end point of death, Q-wave myocardial infarction and emergency CABG. 
The possibility that a referral bias against emergency CABG could affect this end-point 
cannot be excluded. To assess this, we evaluated the relationship between a history of 
prior CABG and MACE, as well as its relationship to each individual end point. 
Methods: Data were prospectively collected from 10,726 consecutive PCI in a consor- 
tium of 7 hospitals in Michigan. End points analyzed included the traditional MACE, and 
each one of the individual end-points. The same analysis was performed on data col- 
lected in Northern New England (Northern New England registry). 
Results: When compared to no history of prior CABG, a history of prior CABG was asso- 
ciated with a similar incidence of MACE. However, a history of prior CABG was associ- 
ated with a significantly higher incidence of Q-MI and non-QMI. The mortality rate was 
similar, while the emergency CABG rate was significantly lower in the group of patients 
with prior CABG. An analysis of data from the NNE registry gave similar results. 
Variable Prior CABG No prior CABG P 
Masao Takemoto, James K. Liao. Cardiovascular Division, Brigham & Women’s Hospital 
and Harvard Medical School, Boston, MA 
Background: Cardiac hypertrophy is a major cause of morbidity and mortality world- 
wide. Evidence suggests that cardiac hypertrophy is mediated, in part, by the small GTP- 
binding proteins, Rho. We hypothesize that 3.hydroxy-3.methylglutaryl (HMG).CoA 
reductase inhibitors or statins, which block isoprenoid synthesis, may attenuate cardiac 
hypertrophy by inhibiting Rho isoprenylation. Methods and Results: Primary neonatal 
rat cardiac myocytes were treated with angiotensin-II (Angll, 1pM) with and without simv- 
a&tin (Sim I-1OpM). Sim decreased Angll-induced total protein content, [SH]-leucine 
incorporation, and atrial natriuretic factor (ANF) promoter activity by 85r8%, 83+12%, 
and 94i5%, respectively. These effects of Sim ware reversed by L-mevalonate or gera- 
nylgeranylpyrophosphate, but not by farnesylpyrophosphate or low-density lipoprotein. 
Indeed, treatment with a geranylgeraniol transferase inhibitor, but not a farnesol trans- 
ferase inhibitor, completely inhibited Rho geranylgeranylation and Angll-induced cardiac 
myocyte hypertrophy. To determine which Rho proteins mediate the anti-hypertrophic 
effect of statins, dominant-negative Rho proteins (N17 or Nl9) were overexpressed in 
cardiac myocytes. N17Racl completely inhibited Angll-induced cardiac myocyte hyper- 
trophy while NlSRhoA partially inhibited and N17Cdc42 had no effect. In viva treatment 
with Sim (20 mg/kg) inhibited Angll (200 ngikglmin, 14 d)-induced Rho activity and car- 
diac hypertrophy in rat hearts without significant effects on systemic blood pressure. 
Conclusion: These findings indicate that statins inhibit Rho-mediated cardiac hypertro- 
phy, and suggest a novel, non-vasodilatory strategy for treating cardiac hypertrophy. 
Mace 2.75% 2.85% n.s. 
Death 1.6% 1 ..s% n.s. 
Q-MI 1.41% 0.47% co.oo1 
Non-Q Ml 2.7% 1.4% <O.OOl 
Emergency CABG 0.16 1 .Ol <0.001 
Conclusion: 1) When measuring MACE, prior CABG does not appear to be associated 
with worse outcomes. 2) However, this finding is due to a tendency for patients with prror 
CABG not to be referred for subsequent CABG, and it may represent an important 
tradeoff between emergency CABG and Ml. 3) This example illustrates the potential pit- 
falls of the use of combined end-points such as MACE. 
803-3 
2:30 p.m. 
Trends in Survival Following a New Admission for Heart 
Failure 
Paul A. Heidenreich, Christopher Kagay, Mark McClellan. Palo Alto VA, Palo Alto, CA, 
Stanford University Stanford, CA 
Background: Life prolonging therapies for heart failure are increasingly used, however, it 
is unclear if there has been a corresponding decline in mortality from heart failure. Meth- 
ods: We evaluated Medicare claims data for a random sample (5%) of patients hospital- 
ized in the US. with a principal diagnosis of heart failure between 1984 and 1995. The 
patient’s index admission for heart failure was defined as the first heart failure admission 
(principal diagnosis) following three or more years of enrollment without a heart failure 
admission (primary or secondary diagnosis). The Charlson comorbidity score was calcu- 
lated for the index admission. Readmission rates and survival over the subsequent 5 
years were determined. Results: The sample included 111,721 patients (1987 through 
1994) with mean age of 75 * 7 years, 42% male and 90% white. Between 1987 and 1994 
there was little change in mean age (79.3 vs. 79.6 years) and fraction of male gender 
(42.1% vs. 42.1%). However, the Charlson comorbidity score increased from 1.8 f 1.2 to 
2.1 + 1.3 (p<O.OOOl) indicating more comorbid conditions in 1994. Mean readmissions 
for heart failure at 1 year increased from 0.31 to 0.35 par year (p<O.OOOl). Age and gen- 
der adjusted survival increased at 30 days and 1 year (Figure). 
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decreased from 55% to 50%, and total cholesterol > 5 mmolll from 67% to 59%. 
Reported aspirin use increased from 81% to 84%; beta-blockers from 54% to 66%; ACE 
inhibitors from 29% to 43%; and lipid-modification drugs from 32% to 63%. AntIcoagulant 
use was similar (7%). Wide variations still exist in the use of the prophylactic drug thera- 
pies between countries. 
Conclusions: Adverse trends in lifes?& characteristics are observed and most patlents 
are still not achieving blood pressure and lipid goals, despite an overall increase in anti- 
hypertensive and lipid-modification therapies. There is still considerable potential through 
lifestyle intervention, and appropriate use of prophylactic drugs, to reduce the risk of 
recurrent coronary events. 
3:15 pm. 
803-6 Evolution of the Diagnosis of Acute Myocardial Infarction 
JoAnne M. Foody, Deron H. Galusha, Jennifer M. Lewis, Dale R Burwen, Martha J. 
Radford, Harlan M. Krumholz. Qualidigm, Middletown, CT Health Care Financing 
Administration, Baltimore, MD 
Background: Recent consensus guidelines from both ACC and European Society of 
Cardiology incorporate the use of cardiac troponins (Tn) Into the diagnosis of acute myo- 
cardial infarction (AMI). Yet, little is known regarding these changing diagnostic trends or 
their impact on the spectrum of patients labeled with AMI. Recent national studies of AMI 
by HCFA provide a unique opportunity to evaluate the contemporary use of this new 
diagnostic standard. 
Methods and Results: A national sample of medical records drawn from Medicare AMI 
hospitalizations in 1998-1999 (w35713) was abstracted. In more than half of these 
cases, Tn was measured. Overall, 7.1% of AMI diagnoses were made principally on the 
basis of elevated Tn levels. Significant geographic variation existed in the documented 
use of troponin ranging from 33% in New England to 67% in the North Central Region. In 
15,921 cases, both Tn and CKMB were available for analysis. Consistent wth prior stud- 
ies, patients with a elevated Tn levels were consistently at higher risk for in-hospital mor- 
tality irrespective of creatine kinase MB fraction (CKMB). Cases with an elevated Tn but a 
negative CKMB had the highest in-hospital mortality ( 13.2%). Conversely, cases with a 
negative Tn even in the face of a positive CKMB were at lowest risk. 
Conclusion: Tn is being used commonly to diagnose AMI and is the principal diagnostic 
criterion for about 7%, identifying a higher risk subset of AMI cases. When comparing 
trends in AMI care and outcomes, changes in diagnostic criteria should be considered. 
In-Hospital Mortality by CKMB and Troponin 
Troponin (+) n (%) Troponin (-) n Total 
total tested (%) total tested 
CKMB (+) n (%) total tested 1186 (11.2) 10570 158(9.3) 1696 1344(11.0)12266 
CKMB (-) n (%) total tested 362 (13.2) 2743 95 (10.4) 912 457 (12.5) 3655 
Total f548(11.6)13313 253 (9.7) 2608 1801 (11.3) 15921 
100% 
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These data correspond to a relative decline in 30.day mortality between 1987 and 1994 
of 26% and in l-year survival of 18%. Five-year survival was poor but increased slightly 
from 21% in 1987 to 22% in 1990 (pi-0.02) Conclusions: Short-term mortality following 
a new admission for heart failure has declined by 20% to 25% among Medicare patients 
from 1987 to 1994. 
803-4 
2:45 p.m. 
Applying the Evidence in Acute Coronary Syndromes: A 
Report Card From the Global Registry of Acute Coronary 
Events 
Christopher Granger, Jos& L6pez-Sendbn, Frans Van de Werf, Eva Kline-Rogers, 
Frederick A. Anderson, Jeanna Johnson, lmmad Sadiq, Werner Klein, Kim A. Eagle, for 
the GRACE Investigators. Duke University Medical Center, Durham, NC, University of 
Michigan Health System, Ann Arbor, Ml 
Background: In the past 10 years, there has been great success in defining effective 
therapies in large randomized clinical trials in acute coronary syndromes (ACS). Haw- 
ever, broad integration of these therapies into clinical practice has been relatively unsuc- 
cessful. A first step in improving care though better application of therapies is to 
accurately measure how they are being used. We measured the use of evidence-based 
therapies in ACS in the Global Registry of Acute Coronary Events (GRACE). 
Methods: Between April 1999 and June 2000, 8213 patients with ACS have been 
enrolled at 94 hospitals in 14 countries in the GRACE registry. Hospitals were chosen to 
reflect a broad and representative cross-section of medical care. Of the patients enrolled, 
7664 had a discharge diagnosis of ACS, 4773 of whom had acute myocardial infarction. 
Five therapies were chosen to evaluate the use of evidence-based medicine: aspirin 
post-ACS for patients without serious bleeding and not on warfarin or another antiplatelet 
therapy; beta blockers for patients post-myocardial infarction without atrioventricular 
block or severe heart failure; ACE-I for patients post-myocardial infarction with congestive 
heart failure or reduced ejection fraction and without shock or renal insufficiency; reperfu- 
sion therapy for patients with ST elevation or left bundle branch block within 12 hours of 
symptom onset and without clear contraindication; and either low-molecular-weight hep- 
win (LMWH) or intravenous GP Ilb/llla inhibitor for patients with ST depression or posi- 
tive cardiac markers. 
Results: 
Therapy Eligible patients Use in-hospital Use at discharge 
Aspirin 4828 93.0% 89.3% 
Beta blocker 4267 80.9% 70.5% 
ACE-inhibitor 3068 63.7% 56.2% 
Reperfusion therapy 2151 63.4% NA 
LMWH/GP llbillla inhibitor 3551 56.3% NA 
Conclusion: In this broad and representative population of patients with ACS, evidence- 
based use of selected effective therapies ranged from 56 to 93% revealing both success 
and opportunity for improvement. Analysis of factors assoaated with use and lack of use 
of proven therapies will provide further insight into approaches to improve care. 
803-5 
3:00 p.m 
Changes in Lifestyle, Risk Factor Management and Use of 
Prophylactic Drug Therapies Between the EUROASPIRE I 
and EUROASPIRE II Surveys 
Euroaspire Steering Group. Cardiac Medicine, National Heart and Lung Institute, 
London, United Kingdom, Department of Public Health, Ghent University, Ghent, Belgium 
Background: The European Society of Cardiology conducted a survey (EUROASPIRE 
I) in 1995-1996 in 9 European countries showing a high prevalence of modifiable risk fac- 
tors in patients with CHD. EUROASPIRE II was undertaken in 1999-2000 in the &ax 
centers of these countries to determine whether preventive cardiology practice has 
improved. 
Methods: Medical records were reviewed of consecutive patients < 71 years of age with 
the following diagnoses: (1) coronary artery bypass graft (CABG); (2) percutaneous 
transluminal coronary angioplasty (PTCA); (3) acute myocardial infarction: and (4) acute 
myocardial ischaemia; survivors were invited for an interview and risk factor screening at 
least 6 months after hospitalization. 
Results: 3,569 patients in EUROASPIRE I and 3,379 in EUROASPIRE II were inter- 
viewed. The distribution of age, sex and diagnostic categories did not differ between the 
surveys. Cigarette smoking increased from 19% to 21%, and obesity (BMI 1 30 kgim2) 
from 25% to 33%. Raised blood pressure (SBP t 140 mm Hg and/or DBP 2 90 mm Hg) 
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1148-I Renal Dysfunction and Cardiac Disease Associated With 
High Mortality in Patients With Renal Artery Stenosis and 
Stent Placement 
Mark W. Burket, David J. Kennedy, KC. Kurian, Sadik Khuder, William J. Thomas, 
Christopher J. Cooper. The Medical Coliege of Ohio, Toledo, OH 
Background: Renal artery stenting has become a frequently used method for treating 
patients with renal artery stenosis (RAS). However, the late outcomes of patients under- 
going stenting are not well understood. The current study was conducted to identify rate 
of late mortality and the characteristics associated with mortality after stenting. Method: 
There are 232 patients with 320 renal arteries stented that have been followed prospec- 
tively at 6 months and yearly thereafter. Thirty nine percent of patients have bilateral dis- 
ease (31%) or disease in a solitary kidney (BDISK). At all follow-up visits, blood pressure 
(BP), serum creatinine (Cr), and antihypertensive medications are assessed. Abnormal 
CR is defined as CR >1.6 mg/dL. Results: Systolic BP decreased significantly after 
stentlng for the entire cohort (1701t28 vs. 147+27 mmHg, p<.OOOl). At 6 month follow-up, 
a significant decrease in CR was seen in 50% of patients with baseline renal insufficlency 
(RI). Over 191-20 months, 40 deaths occurred (17%). The following characteristics were 
noted when comparing deceased vs. living patients. increased baseline Cr (2.1~1.2 vs. 
1.4+1.1 mg/dL. p<O.O5), increased follow-up Cr (2.4il.6 vs. 1.5tl.O mg/dL, p<.OOOl), 
increased BD/SK (55% vs. 36%, p&05), decreased follow-up systolic BP (137+27 vs. 
149227 mmHg, p<O.O5), increased history of CHF (68% vs. 29% pc.OOOl), and 
increased history of Ml (53% vs. 29%, ~~0.05). Cox Proportional Hazards analysis dem- 
onstrated that RI was highly associated with mortality (p=.OOOl) despite the influences of 
CHF (p=.OO28), previous Ml (p=.O361), and age (p=.l963). Kaplan-Meier survival analy- 
sis yielded the following order of decreasing survival rates for the following categories of 
baseline and follow-up Cr: Normal-Normal; Abnormal-Normal; Abnormal-Abnormal; Nor- 
mal-Abnormal (Logrank p<.OOOl). Conclusion: Late mortality is high in patients with 
RAS treated with stents despite improved BP control, especially if RI, CHF, or a history of 
504A ABSTRACTS - Special Topics JACC February 2001 
prior MI is present. Patients undergoing renal artery stenting who present with RI have 
higher late mortality than patients presenting with normal renal function, even if renal 
function normalizes after the procedure. 
1148-2 Are Reperfusion Therapies of Acute Myocardial Infarction 
Impacting the Community? A Population Based Study in 
Olmsted County, MN 
Veronique L. Roger, Steven J. Jacobsen, Susan Weston, Tauqir Y. Goraya, Thomas E 
Kottke. Robert L. Frve. Barbara P. Yawn. Guv S. Reeder. Maw Clinic, Rochester, MN 
Background: &perfusion trials have indicated a substantial improvement in the mortal- 
ity of myocardial infarction (MI) with such therapies, resulting in changes in the clinical 
practice. There is little data on the impact of these therapeutic changes on population 
trends in MI case fatality. The inconsistencies in reported trends are likely to be related to 
differences in populations, inconsistent Use of standardized MI validation criteria or vari- 
able determination of incidence status. This study was undertaken to test the hypothesis 
that there had been no change in MI 28.day case fatality rate in Olmsted County between 
1979 and 1994. 
Methods: Hospitalized Mls were classified using standard epidemiological criteria based 
on enzyme values, chest pain and Minnesota coding of the EGG. The entire community 
medical record available via the Rochester Epidemiology Project was reviewed to deter- 
mine incident status. 
Results: Over the tertiles of the time period, the 28-day CFR overall and by sex and age 
is shown in the table. Proportional hazards regression was used to calculate the RR of 
death within 28 days after an incident Ml in 1994 vs 1979. After adjustment for age and 
sex, the RR (95% C&for death in 1994 was 0.85 (0.53, 1.33). 
Conclusion: Thus, in Olmsted County population between 1979 and 1994, after a vali- 
dated incident MI, no change in the 28.day CFR was detected in the overall population. 
However, there was a favorable downward trend in 28-day CFR in person ~75 years 
(nominal P for trend = 0.043). This period corresponds to a time frame during which rep- 
erfusion therapy was implemented in clinical practice pointing towards its effectiveness in 
younger persons while underscoring the continuing burden of death related to MI in eld- 
erly persons. 
Overall Men Women 
25-74 yrs 75+ yrs 25-74 yrs 75+ yrs 25-74 yrs 75+ yrs 
1979-84 8% 19% 7% 21% 11% 17% 
1985-89 7% 24% 5% 23% 12% 24% 
1990-94 5% 23% 4% 19% 6% 25% 
1148-3 Has the Incidence of Myocardial Infarction Changed Over 
Time? A Population Based Study in Olmsted County, MN 
Veronique L. Roger, Steven J. Jacobsen, Guy S. Reeder, Tauqir Y. Goraya, Susan 
Weston, Thomas E. Kottke, Barbara P. Yawn, Robert L. Frye. Mayo Clinic, Rochester, MN 
Background: There are few data on trends in incidence of myocardial infarction (MI). 
While some studies have suggested only a modest decline in the incidence of MI, this 
matter, central to the understanding of the effectiveness of primary prevention of coro- 
nary disease, needs to be examined in other populations. This study was undertaken to 
test the hypothesis that there had been no change over time in the incidence of Ml 
among Olmsted County residents between 1979 and 1994. 
Methods: MIS were validated using standard epidemiological criteria with enzyme val- 
ues, chest pain and Minnesota coding of the ECG. The entire community medical record 
available via the Rochester Epidemiology Project was reviewed to determine incident sta- 
tus. 
Results: In 1979, the age-adjusted incidence rate (95%CI) for MI was 227 per 100,000 
(183-171); in 1994, the rate was 237 per 100,000 (196-275). Poisson regression indi- 
cated that the trends differed accordinQ to age and sex. The stratum-specific RRs (95% 
Cl) for the occurrence of an incident Ml in 1994 vs 1979 are shown in the table below. 
Conclusion: This indicates that in Olmsted County MN, there has been no Change ovar- 
all in the incidence of Ml. However, the incidence of Ml decreased in middle aged men 
while it increased in elderly women suggesting a shift in the burden of disease. Further 
studies are needed to understand the determinants and implications of these trends. 
Men Women 
40 yrs old 0.85 (0.60-1.20) 1.18 (0.80-1.73) 
60 yrs old 0.79 (0.62-1.00) 1.09 (0.82-l .44) 
80 yrs old 1 .OO (0.76-I .32) 1.39(1.06-1.81) 
1148-4 Premature Coronary Artery Disease: 15-Year Follow-Up in 
Patients Under the Age of Forty 
Joseph I. Miller, Ill, Laurence S. Sperling, Abdolreza Agahtehrani, Chris Nell, William S. 
Weintraub. Secfion of Prevenfive Cardiobgy, Division of Cardiology, Emory Univerisifx 
Atlanta, GA, Emory Center for Oufcomes Research, ANanfa, GA 
Background: Coronary artery disease(CAD) is typically seen in older individuals. Regis- 
try databases of myocardial infarctions estimate that only l-2% involve patients 
under age 45. Traditional cardiac risk factors in this group have been studied. However, 
little data is available on their long term follow-up. Methods: We identified 843 patients 
under age 40 with documented CAD by angiography between 1975-l 985. The query was 
stopped in 1985 to allow at least 15.years of follow-up. Data was available on 823 
patients. Each was evaluated for death, hypertension, sex, prior MI, diabetes, congestive 
heart failure(CHF) on presentation, angina class, number of vessels involved, ejection 
fraction(EF), Q wave MI, hospital death, and initial therapy whether medical, angio- 
plasty(PTCA), or coronary artery bypass surgery(CABG). Results: The mean age at 
presentation was 35 for women and 36 for men. Of the original 843 patients, 253 have 
died. There were 94 women and 729 men in the group. Average EF was 55-57%. Both 
men and women predominately had single vessel disease(55.60%). Only 2% had left 
main disease. 10% of the patients were diabetic and more likely to be women(26% v. 6%; 
p<O.OOOi). Diabetics had more underlying hypertension(50% v. 25%; p<.OOOi), had CHF 
on presentation(l4% v. 4.3%; pc.OOl), and presented with a CI wave M1(5% v. 
0.14%;p<0.0001). 80% referred for PTCA had single vessel disease(p~0.0001) and 67% 
Undergoing CABG had two or three vessel disease(p<O.OOOl). EF was comparable for all 
treatment groups(52-60%). During follow-up, the greatest predictor of long-term mortality 
was prior Ml(odds ratio of 1.6; 95% confidence interval 1.24 to 2.08; pcO.00029). Indlvld- 
uals treated bv PTCA or CABG, rather than medical theraw, had a lower lona-term mor- 
tality(odds ratio of 0.7; 95% confidence interval 0.63 to 0.86; p<O.O0012). Using this 
model, patients with a prior MI had a 15.year mortality of 40.5O%(p<O.O001). Conclu- 
sions: This large cohort of young patients with angiographically documented CAD had a 
mortality of 30% over 15 years. The greatest predictor of long-term mortality was prior 
MI. Also, patients undergoing revascularization had a lower mortality. 
1148-5 Out-of-Hospital Coronary Heart Disease Mortality: Is 
Prevention Effective? 
Tauqir Y. Goraya, Steven J. Jacobsen, Thomas E. Kottke, Robert L. Frye, Susan A. 
Weston, Veronique L. Roger. Mayo Clinic, Rochester, MN 
Background: Despite a steady decline in CHD mortality, little is known about the charac- 
teristics of decedents and importantly, the proportion of out-of-hospital (OOH) CHD dece- 
dents with antemortem diagnosis of CHD, yet this is important to understand the impact 
of prevention. 
Hypothesis: 1) BetWeen 1979 and 1994, the decline in CHD mortality has been less in 
the OOH location and the elderly: 2) Proportion of OOH-CHD decedents with antemor- 
tern diagnosis of CHD has not changed over time. 
Method: CHD mortality (ICD-9 codes 410.414) in Olmsted County was studied for OOH 
and in-hospital (IH) deaths. Antemortem diagnosis of CHD was established from com- 
munity medical records made available via the Rochester Epidemiology Project. 
Results: The total number of CHD deaths was 2375 (47% women; 62% >=75 years). 
Overall mortality per 100,000 (95% Cl), adjusted to 2000 population, declined from 335 
(313, 357) in period 1979-84 to 221 (217, 252) in period 1990-94. For the same tertiles, 
IH-CHD mortality declined sharply from 157 (142, 172) to 90 (79, lOI), whereas, OOH- 
CHD mortality exhibited a more modest decline from 178 (162, 194) to 145 (131, 159); 
increasing the proportion of OOH-CHD deaths from 53% to 62% (PcO.001) and increas- 
ing the RR of OOH versus IH death from 1.13(0.98, 1.29) in 1979 to 2.30 (1.98,2.67) in 
1998. The RR of death in CHD death in 1998 compared to 1979 by age and location cat- 
egories is presented in the table. 
Relative Risk By Age And Location With 1979 As Reference For Each Category 
In Hospital Out-Of-Hospital 
60 year old 80 year old 60 year old 80 year old 
1998 0.23 (0.18,0.30) 0.37 (0.31,0.46) 0.47 (0.38,0.60) 0.76 (0.65,0.89) 
The proportion of OOH-CHD decedents with an antemortem diagnosis of CHD was 44% 
in 1979 and did not change over time. 
Conclusion: 1) In Olmsted County, between 1979 and 1994, IH mortality declined more 
than the OOH mortality suggesting a greater contribution to the decline in CHD mortality 
from improvement in acute treatment of CHD then by prevention measures. 2) Less than 
half of the OOH-CHD decedents had an antemortem diagnosis of CHD raising questions 
about the effectiveness of primary prevention. 
1148-6 The Role of the Mediterranean-Type of Diet to the Risk of 
Developing Coronary Heart Disease: Principles and Results 
From CARD102000 Epidemiological Study. 
Demosthenes B. Panagiotakos, Christos Pitsavos, Christine Chrysohoou, K&as 
Tzioumis, George Rembelos, Christodoulos Stefanadis, Pavlos Toutouzas. University of 
Athens, School of Medicine, Athens, Greece 
Background: The traditional Mediterranean-type of diet (MTD) is inversely associated to 
the risk of developing coronary heart disease (CHD). Additionally, East Mediterranean 
men show a longer life expectancy than men from other European countries or from 
North America. Aim of our study is to investigate the mechanisms that MTD contributes 
to the reduction of the aforementioned risk, with respect to other risk factors. Methodol- 
ogy: CARD102000 project is a retrospective case-control study for the prevention of 
CHD in Greece. Stratified sampling consisted of 554 randomly selected CHD hospital- 
ised patients and 550 paired-controls without any clinical suspicion of CHD. All subjects 
were becoming from various socioeconomical levels and regions of Greece. Nutritional 
habits such as: olive oil; fresh fruits and vegetables; legumes; white cheese; traditional 
salads; fresh fish and wine consumption: were recorded in addition to the other known 
risk factors. The wastigation of the MTD in the aetiology of CHD was based on multivari- 
ate statistical analysis. Results: Based on the estimated dose-response risk function we 
found that: conservative daily use of olive oil in cooked meals and salads reduces 21% 
(O&0.79, P = 0.012) the risk of developing CHD. Also, fresh fish consumption (3-5 
times/ week), instead of meat, cooked with olive oil, adds a reduction of 12% to the afore- 
mentioned risk (P=O.O03). A combination of traditional MTD with physical activity (+3 
times/ week), normal body mass and lack of cigarette smoking (at least 5 years) sug- 
gests a path of a “healthy” lifestyle that reduces 33% (OR=0.67, P=O.OOl) the risk of 
developing CHD. Conclusion: Intake of olive oil seems to be beneficial in the prevention 
of CHD. Fish consumption, instead of meat, cooked with olive oil reduces even more the 
coronary risk. A path of healthy lifestyle includes the traditional MTD with systematic 
physical exercise, lack of smoking and normal body mass. Our findings are in accor- 
dance to other epidemiological studies from South Europe and therefore they suggest a 
special population-group for the prevention of CHD. 
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1148-7 Risk Factor Changes in a Population: How Much Impact Will 
They Have? 
Lambert A. Wu, Thomas E. Kottke, Mark J. Brekke, Lee N. Brekke. Mayo Clinic and 
Foundation, Rochesfer, MN 
Background: Recent reports indicate that risk factor trends in the United States are not 
favorable. We conducted this analysis to determine the potential population impact of 
unfavorable risk factor trends on the one hand, and achieving Healthy People 2010 goals 
on the other. 
Methods: Four plausible risk factor scenarios were defined for what the levels might be 
in the year 2020. The scenarios were based on current and past risk factor levels and 
current national goals. They are as follows: 1) Current risk factor levels in Olmsted 
County, MN; 2) Continued rise in diabetes and smoking rates; 3) #2 plus loss of blood 
pressure and cholesterol control; 4) Population meets Healthy People 2010 goals. For 
each scenario, risk factors were assigned stochastically to today’s (year 2000) Olmsted 
County, MN population, ages 30-83. Framingham-based risk functions were then used 
to calculate the CHD and CVD event rates under the scenario 
Results: 
Scenario 1 Scenario 2 Scenario 3 Scenario 4 
Diabetes (incidence per 1000) 36 48 49 20 
Smoking (incidence per 1000) 189 535 536 0 
Mean systolic pressure (mm Hg) 129.0 129.0 138.9 All <130 
Mean diastolic pressure (mm Hg) 79.9 79.9 NA All < 85 
Mean Cholesterol (mgidl) 202.6 202.6 229.3 All < 200 
CHD (incldence per 1000) 5.86 7.07 9.16 3.29 
% change in CHD rate relative to -- +21% +56% -44% 
Scenario 1 
CVD (incidence per 1000) 8.34 10.99 14.56 4.27 
% change in CVD rate relative to -- +32% +75Yo -49% 
Scenario 1 
*Not used. Increased rate of hypertension !n model was based on systolic pressure only. 
Conclusion: If diabetes and smoking continue to rise and hypertension and cholesterol 
rise to historically high levels, CHD and CVD rates could rise as much as 56% and 75%, 
respectively. Meeting Healthy People 2010 goals would reduce CHD and CVD rates by 
44% and 49%. respectively. 
413-2 
ABSTRACTS - Special Topics 505A 
Catecholamine Provoked T Wave Lability (TWLI): 
Identification of a Novel Index for Risk Stratification in 
Congenital Long QT Syndrome 
Michael J. Ackerman, Jan Nemec, David J. Tester, Joseph Hejlik, Win-Kuang Shen. Mayo 
Clinic, Rochester, MN 
Background: Macrovoltage T wave alternans (TWA) is seen infrequently in patients with 
congenital long QT syndrome (LQTS). Microvoltage T wave alternans (WV-TWA) at low 
heart rate (HR) is a marker of arrhythmic risk in many conditions, but its significance in 
LQTS has not been established. 
Methods: 23 genotypically diverse patients with LQTS and 16 control subjects were 
studied during phenylephrine and dobutamine provocation. Genotyping was established 
by PCR amplification and DNA sequencing of the three most common LQTS genes- 
KVLQTl (LQTl), HERG (LQT2), and SCNBA (LQT3). Presence of PV-TWA was deter- 
mined by Fast Fourier transformation. Aperiodic, beat-to-beat Twave lability during cate- 
cholamine provocation was discovered in some patients. This lability was quantified 
using a newly derived T wave lability index (TWLI) baaed on a determination of the root- 
mean-square of the differences in T wave amplitude at each isochronic point. 
Results: Precluded by ectopy, pV-TWA could not be assessed in 8 of 23 patients with 
LQTS. In the remaining 15 patients with LQTS, FV-TWA occurred at lower HR in LQTS 
than in controls (117 * 49 vs 153 + 37 bpm; p<O.O5). Patients with LQTS developed 
TWA at H&z150 bpm more often than controls (10115 vs 2/16; p<O.Oi). Dramatic cate- 
cholamine provoked T wave lability was observed in a 14.year-old male with F339del- 
KVLQTl (LQTI) prior to onset of sustained polymorphic ventricular tachycardia. This 
aperiodic T wave lability was significantly higher in LOTS (TWLI = 0.0945 I 0.0517 vs 
0.0445 i 0.0123; p<O.O02). Marked T wave lability (TWLI 2 0.095) was detected in all 
three LQTS gentoypes (10/23), but in no control subjects. There was no correlation 
between the TWLI and baseline OTC. All high-risk patients having either a history of out- 
of-hospital cardiac arrest or syncope plus at least one sudden death in the family had 
TWLI > 0.095 (p<O.O02). 
Conclusion: *V-TWA occurs at lower HR in patients with LQTS than in healthy people. 
Striking non-alternans T wave lability (TWLI) occurs in patients with LQTl, LQTP and 
LQT3 during catecholamine provocation. This novel phenomenon of catecholamine pro- 
voked T wave lability may identify patients harboring high-risk genetic substrates. 
413-3 Abnormalities in Nitric Oxyde Synthase Function Induced 
by Nitroglycerin 
Tommaso Gori, John D. Parker. Mount Sinai Hospital, Toronto, ON, Canada 
Background: Recent data suggest that therapy with nitroglycerin (GTN) causes endot- 
helial dysfunction. We set out to investigate the effect of GTN therapy on nitric oxide syn- 
thase (NOS) and endothelial function in viva in healthy humans. Methods and Results: 
Sixteen male volunteers (26+/-6 years old) were randomized to receive no therapy or 
continuous GTN, 0.6 mglhr, for 6 days in an investigator-blind, parallel design study. 
Forearm plethysmography was used to measure flow responses to brachial artery infu- 
sions of acetylcholine (Ach, 7.5, 15, 30 microgr/min), N-monomethyl-I-arginine (L-NMMA, 
2, 4, 8 micromollmin) and sodium nitroprusside (SNl? 0.8, 1.6, 3.2 microgrimin). After the 
induction of tolerance to GTN, the absolute flow responses to Ach were significantly 
blunted as compared to the no treatment group (P<O.O02; two-way ANOVA). The 
response to L-NMMA was also blunted in the GTN group, with paradoxical vasodilation 
observed in response to the lowest infusion rate (PcO.001: fig) The response to SNP did 
not differ between groups. Conclusions: therapy with GTN causes evidence of endothe- 
lie.1 dysfunction, while it does not seem to affect the relaxation in response to an endothe- 
lium-independent vasodilator. The responses to L-NMMA suggest that GTN therapy 
induces abnormalities in NOS function. The vasodilation seen during L-NMMA lnfusion in 
the GTN group suggests that the endothelial dysfunction observed during GTN therapy is 
associated with NOS-medlated vasoconstrictor production, possibly superoxide anion. 
YOUNG INVESTIGATORS AWARDS COMPETITION 
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413-I Homocysteine Induced Impairment of NO Synthase: Role of 
ADMA 
Markus C. Stuehiinger, Phil S. Tsao, Masumi Kim&. John P Cooke. Stanford University 
School of Medicine, Stanford, CA 
Hyperhomocysteinemia is a putative risk factor for cardiovascular disease. Homocysteine 
also impairs endothelium dependent vasodilation. A number of other risk factors for car- 
diovascular disease and endothelial dysfunction may exert their adverse effects on the 
vessel wall in part by elevating plasma levels of asymmetric dimethylarginine (ADMA), an 
endogenous inhibitor of nitric oxide synthase (NOS). Accordingly, we determined if 
homocysteine could increase ADMA levels. When cultured, human endothelial cells 
(ECV 304) were exposed to L-methionine or to DL-homocysteine, ADMA concentration in 
the cell culture medium increased in a time and dose dependent fashion. This effect 
appeared to be mediated by a reduced degradation of ADMA. Specifically, DL-homocys- 
teine inhibited the activity of dimethylarginine dimethylaminohydrolase (DDAH), the 
enzyme, which degrades ADMA to cltrulline and dimethylamine. In the presence of the 
antioxidant PDTC DDAH activity could be preserved, and ADMA accumulation in the 
medium could be blocked. DDAH protein expression however did not change by incuba- 
tion of endothelial cells with homocysteine or PDTC. To further investigate the affects of 
homocysteine on DDAH activity, DDAH was cloned, expressed and purified and DDAH 
activity was measured in absence and presence of DL-homocysteine in a cell free sys- 
tem. Also under these conditions, homocysteine, but not L-methionine dose dependently 
inhibited the activity of recombinant DDAH. Moreover DL-homocysteine directly bound to 
recombinant DDAH and this effect again could be preserved in part by PDTC. We con- 
clude that the effect of homocysteine to impair endothelium dependent vasodilation may 
in part be due to its inhibition of DDAH, leading to accumulation of the endogenous NO 
synthase inhibitor ADMA. 
413-4 Experimental Induction of Endothelial Dysfunction by 
Methionine Reduces Conduit Artery Compliance in Humans 
Geetha Fiaghuveer, Roger L. Browning, Christine A. Sinkey, William G. Haynes. 
University of Iowa College of Medicine, lowa Ciru. IA, - 
Background: Decreased arterial compliance increases cardiac work and alters coronary 
perfusion. Oral methionine loading increases plasma homocysteine and impairs endot- 
helial function in healthy subjects. We tested whether oral methionine impairs brachial 
artery compliance. Methods: Arterial distensibility was measured 8 hours after oral 
methionine (IOOmglkg) or vehicle in 14 subjects without risk factors for atherosclerosis. 
Conduit vessel endothelial function was assessed as flow-mediated dilatation of the bra- 
chial artery using reactive hyperemia as a stimulus. Ultrasound images of the brachial 
artery were digitized for 15 seconds. An automated neural network based method for 
near and far wall border detection was used to measure arterial diameter. Arterial disten- 
sion was calculated as percentage change in arterial diameter from systole to diastole. 
Distensibility Index (DI) was calculated as 1000 X % distension/mmHg mean arterial 
pressure (MAP). The reproducibility of this technique is good with correlation coefficient 
of 0.901 (P<O.OOl) for two recordings of distensibility index in the same subjects. 
Results: Methionine administration increased plasma homocysteine concentrations from 
8.5 ? 1.3 to 32.8 ? 4.4 mmol/L after 8 hr, with no change occurring on the placebo day. 
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Methionine significantly attenuated flow mediated vasoditatation of the brachiai artery 
(Placebo = 6.8%; methionine = 3.0%; P = 0.002). There were significant decreases in 
distensibility index (Placebo = 7l%/mmHg.l000; methionine = 31%/mmHg.1000; P = 
0.02). Linear regression analysis revealed significant association between flow-mediated 
dilatation and distensibility index (R = 0.638; P = 0.002). The change in flow-mediated 
dilatation between the two study days was significantly correlated with change in disten- 
sibility index (R = 0.535; P = 0.04). Conclusion: Experimental hyperhomocystinemia 
reduces arterial compliance in humans. The changes in distensibility are closely associ- 
ated with changes in flow mediated dilatation, an index of conduit vessel endothelial func- 
tion. Impaired arterial compliance may contribute to the cardiovascular complications of 
homocysteine. 
413-5 The Origin and Significance of the Inflammatory Response 
in Unstable Angina 
Michael R. C&sack, Michael S. Marber, Simon R. Redwood. St. Thomas’ Hospital, 
London, United Kingdom 
Background. Systemic inflammation is an important component in the pathogenesis of 
Unstable Angina (UA). However, the origin of the inflammatory response in this condition 
remains unclear. Tumour Necrosis Factor (TNF), Interleukin-6 (IL-6) and C-reactive pro- 
tein (CRP) are key components of the inflammatory process. Our aim was to identify the 
site of IL-6 and TNF production in UA and to study their effect on prognosis. Methods. 
We studied 91 patients (age 66.9 +/- 11.4 years, 59% male) with Braunwald IllB UA. TNF, 
IL-6, CRP and cardiac Troponin-T (cTnT) levels were measured at 0, 6, 24, 48 hours and 
7 days following admission. In those who underwent cardiac catheterization, blood was 
sampled from the coronary sinus (CS) and aortic root prior to angiography. In patients 
proceeding to coronary intervention (PCI), blood was also sampled within the coronary 
artery distal to the culprit lesion. Results. IL-6, CRP and cTnT were consistently elevated 
following admission in those who went on to have an in-hospital major adverse cardiac 
event (MACE) during the first 30 days compared with those who did not. In those under- 
going angiography (n=36; age 64.8 +/- 8.1 years; 68% male), CS levels were greater than 
Aortic levels for both TNF (20.4 +/- 6.9 v. 17.2 cl- 7.1 pg/mL respectively, p<O.Ol) and IL- 
6 (11.5 +I- 4.1 v. 7.9 +/- 3.2 pg/mL, pcO.01) suggesting intracardiac production of these 
cytokines This intracardiac gradient was found to occur principally in those who were 
cTnT positive. In those proceeding to PCI (n=8), no differences were found in the levels 
of TNF or IL-6 between the proximal and distal coronary artery. Conclusions. Adverse 
events in UA are associated with elevation of IL-6, CRP and cTnT. Both TNF and IL-6 are 
actively generated within the heart in UA and this inflammatory process occurs principally 
in those with evidence of myocardial necrosis. As no cytokine release could be demon- 
strated from the culprit coronary lesion, the inflammatory response observed may be due 
to the myocardial micro-infarction known to occur in these patients. 
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1181-1 A Population-Based Analysis of Coronary Angioplasty and 
Coronary Stenting Outcomes in California 
David L. Brown. Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, 
NY 
Background: Coronary artery stenting has been proven to result in superior clinical out- 
comes compared to coronary angioplasty (PTCA) in relatively few clinical situations. Nev- 
ertheless, coronary stenting has generally supplanted PTCA for percutaneous treatment 
of coronary disease. However, the outcomes achieved by coronary stenting outside of 
the settings of narrowly focused clincal trials remain largely unknown. We sought to 
assess the characteristics and outcomes of patients undergoing PTCA or stenting in Cal- 
ifornia in 1997. Methods: Discharge data on all patients undergoing a PTCA or stent pro- 
cedure during 1997 was obtained from the California Office of Statewide Health Planning 
and Developent database. Record linking numbers of patients treated in the first 6 
months of 1997 were linked to admissions in the second 6 months of 1997 to determine 
readmission and revascularization rates. Results: In 1997, 44,276 percutaneous coro- 
nary interventions were performed in California, of which 18,940 (43%) were PTCA and 
25,336 (57%) were stent procedures. PTCA patients were more often female (35% vs. 
32%, P<O.OOl), non-white (18% vs. 15%. P<O.OOl), older (65.4 years vs. 64.4 years, 
PcO.001) and diabetic (25% vs. 21%, P<O.OOl) compared to stent patients. More PTCA 
patients presented with an acute myocardial infarction (AMI) (29% vs. 26%, P<O.OOl) or 
COngeStiVe heart failure (9.7% vs. 8.4%, P&001). Overall unadjusted in-hospital mortal- 
ity was 2.1% for the PTCA patients and 1.4% for stent patients (PcO.001). PTCA patients 
Were more likely to undergo bypass surgery on the day of their procedure than stent 
patients (2.1% vs. 1 .O%, P<O.OOl). Readmission occurred in 43% of PTCA patients com- 
pared to 40% of stern patients (PcO.001). However, there was no difference in the cardio- 
vascular readmission rate (30% vs. 28%, P=NS) or readmissions for AMI (2.2% vs. 2.4%, 
P=NS). A revascularization procedure was performed during readmission on 21% of 
PTCA patients and 20% of stent patients (P=NS). Conclusion: PTCA patients have 
more high-risk characteristics than stent patients and a higher rate of in-hospital adverse 
events. However, during follow-up PTCA and stent patients have similar outcomes. 
1181-Z Analysis of the Coronary Stent Volume-Outcome 
Relationship for Hospitals in California 
David L. Brown. Albert Einstein Cokge of Medicine/Montefiore Medical Center, Bronx, 
NY 
Background: An inverse relationship exists between the annual number of percutaneous 
transluminal coronary angioplasty procedures performed in an individual hospital and 
mortality rates. Now that the majority of percutanous coronary interventions involve stent 
placement, it is important to understand whether a similar relationship exists for coronary 
stent procedures. Methods: The California Office of Statewide Health Planning and 
Development database was queried to obtain discharge data on all patients in California 
hospitals treated in 1997 with a coronary stent. Hospitals were categorized as low (~200 
stent procedures), intermediate (200-400 stent procedures) or high volume (>400 stent 
procedures) institutions. Primary outcome measures were in-hospital mortality, referral 
for coronary bypass surgery (CABG) on the same day as the stent procedure and length 
of stay (LOS). Results: In 1997 there were 25,336 stern procedures performed in Califor- 
nia. Of the 130 hospitals that performed stent procedures in 1997, 79 (54%) were low vol- 
ume, 36 (28%) were intermediate volume and 15 (12%) were high volume. Low volume 
hospitals performed 27%, intermediate volume hospitals performed 38% and high vol. 
ume hospitals performed 34% of stent procedures. Low volume hospitals tended to treat 
younger patients (63.7 years vs. 64.9 years vs. 64.3 years, P<O.OOl). The frequency of 
female gender, diabetes or congestive heart failure was not different between the differ- 
ent hospital groups. Low volume hospitals treated more patients with a principal diagno- 
sis of myocardial infarction (32% vs. 27% vs. 23%, P<O.OOl). However, All Patient 
Refined Diagnosis Related Group (APR.DRG) measures of disease severity and risk of 
mortality did not differ across hospital volume groups. Unadjusted mortality was 1.6%, 
1.5% and 1.1% for low, intermediate and high volume hospitals, respectively (P=O.O2). 
Same day CABG rates were l.l%, 1.2% and 0.8% (P=O.O14). Mean LOS was 3.7+/-4.0 
days, 3.4+/-3.6 days and 3.0+/- 3.5 days (P<O.OOl). Conclusion: In California, hospital 
stent volume appears to be significantly inversely related to in-hospital mortality, same- 
day CABG rate and LOS for patients undergoing stent placement. 
1181-3 The MAHI Appropriateness Criteria: a New Method for 
Quantifying the Indications for PCI 
John A. Spertus, Radhika Tripuraneni, Warren B. Johnson, Philip G. Jones, Steven P. 
Marso, James L. Vacek, Brent D. Bliven, Ben D. McCallister. Mid America Heartlnstitute, 
Kansas City MO 
Background: Physicians need to take a leadership role in defining appropriate metrics 
with which to quantify quality in cardiovascular care. Quality percutaneous coronary inter- 
vention (PCI) is predicated upon selecting ‘appropriate’ patients for PCI. Yet, efficient 
mechanisms of quantifying ‘appropriateness’ are unavailable. We developed a new 
method for measuring PCI appropriateness assuming that the primary indication is either 
life-prolongation in the setting of an acute Ml or improving quality of life (QOL). 
Methods: On 2/8/99, we began prospectively evaluating all patients presenting for PCI 
with the Seattle Angina Questionnaire (SAQ), a 19.item measure that quantifies physical 
limitations (SAQ-PL), angina frequency (SAQ-AF) and QOL (SAQ-QOL). SAQ scores 
range from O-100 with higher scores indicating better functioning. We defined a QOL indi- 
cation for PCI as being a score of <=50 on SAQ-PL or SAQ-QOL scales(corresponding to 
a moderate to severe limitations in functioning or QOL) or a SAQ-AF score c=60(corre- 
sponding to angina occurring weekly or more often). Analyses were performed using 
baseline data through 4123199 and included B-month follow-up scores. 
Results: 19(7%) of 263 PCls were performed in the setting of an AMI. Of the 217 
patients with available baseline SAQs, 75% had a QOL indication for their procedure. 6. 
month improvements for patients with a QOL indication were significantly greater than 
those without (+9.7 vs. -2 for SAQ-PL; +33 vs. +10.5 for SAQ-AF; ~28 vs. +I2 for SAQ- 
QOL: p<O.O03 for all). Substantial variability in identifiable indications for PCI were 
detected among 14 interventionalists (55% to 100% of cases had identifiable indications 
for PCI). 
Conclusion: As part of an ongoing quality improvement initiative, a novel method for 
identifying ‘appropriate’ cases for PCI was created. This measure had substantial vari- 
ability among interventionalists and the benefits of PCI among those patients classified 
as ‘appropriate’ was substantially greater than those who were not. As the burden of jus- 
tifying the quality and indications for PCI grows, our technique may be an important step 
towards the rational use of resources in interventional cardiology. 
1181-4 Active Pharmacovigilance Efforts Compared to the FDA’s 
Medwatch Drug Surveillance Program for the Detection of 
Ticlopidine- and Clopidogrel- Associated Thrombotic 
Thrombocytopenic Purpura 
Mrak J. Ricciardi, Charles J. Davidson, Kristin Knox, Charles L. Bennett. Northwestern 
University Medical School, Chicago, IL 
No cases of ticlopidine- or clopidogrel-associated thrombotic thrombocytopenia purpura 
were reported in phase Ill clinical trials. Subsequently, the FDA’s MedWatch program 
identified 36 cases and our active surveillance program an additional 13. As ticlopidine is 
the most common drug reported to the FDA associated with thrombotic thrombocytope- 
nia purpura, concern exists that clopidogrel, a structurally similar agent, would also be 
associated with thrombotic thrombocytopen~a purpura. We evaluated the success of 
MedWatch and our active surveillance program in capturing information on the first 
reported cases of clopidogrel-associated thrombotic thrombocytopenia purpura. 
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Methods: Cases of clopidogrel-associated thrombotic thrombocytopenia purpura were 
identified by an active surveillance method. Medical directors of blood banks, hematolo- 
gists, and the manufacturer of clopidogrel were contacted. 
Results:The FDA’s MedWatch program contained information on 1,192 serious adverse 
events with clopidogrel; 77% were obtained from the US. Sources of information 
included physiclaw (21%), serious adverse events reported from the pharmaceutical 
supplier (36%), and periodic summary reports from the supplier (41%). Of the 1,192 seri- 
ous adverse drug reactions, 7 were for clopidogrel-associated thrombotic thrombocy- 
topenia purpura, making clopidogrel the third most commonly reported drug associated 
with thrombotic thrombocytopenia purpura. In contrast, our active surveillance program 
identified 13 cases of clopidogrel-associated thrombotic thrombocytopenia purpura and 3 
cases were reported in the published Ilterature. Annual rates of identification of ticlopi- 
dine- and clopidogrel-associated thrombotic thrombocytopenia purpura (lo/year) was 
identical. Incidence estimates based on numbers of case reports and numbers of unique 
users are approximately 1 in 3,000 for ticlopidine and 1 in 15,000 to 30,000 for clopi- 
dogrel. 
Conclusions: The MedWatch program must be augmented by active surveillance efforts 
in order to ensure rapid identification of rare, but serious adverse drug reactions such as 
thrombotic thrombocytopenia purpura. 
118-i-5 Public Reporting and Operator Volume Standards for 
Percutaneous Transluminal Coronary Interventions in 
South East Michigan: Regional Trends Toward the High 
Volume Concept 
Smoker (%) 57 59 50 58 
STEMI (%) 18 36 41 60 
Non-STEM1 (%) 28 30 44 28 
Unstable angina (%) 54 33 16 12 
in-hospital death (%) 3.5 6.1 a.7 5.9 
CHF (%) 15.9 20.5 4.7 4.0 
Major bleed (%) 2.7 3.3 5.3 3.5 
ChrOnlC ASAIAI-’ was UtIlIZea m bbyb ot AtiS patlents with prior heart alsease ana 11% o+ 
those without prior heart disease. Patients on ASA’AP were older, more likely to have 
diabetes or hyperlipidemia, and much less likely to present with an ST-elevation Ml. For 
patients with prior heart disease, multivariate analysis controlling for clinical and demo- 
graphic variables revealed chronic ASA use to be protective against in-hospital death 
(OR 0.64, 95% Cl 0.48-0.84) or CHF (OR 0.79, 95% Cl 0.68-0.93) compared with those 
not on ASA/AP therapy. 
Conclusions: The findings from GRACE indicate that evidence-based guidelines for 
chronic ASA/AP use are only partially met. Most patients without a history of heart dis- 
ease were not on chronic therapy but such therapy was markedly underutilized in 
patients with prior heart disease. Patients presenting with an ACS who were previously 
on ASAIAP were less likely to present with an ST-elevation Ml, develop CHF, or die in- 
hospital. 
Mauro Moscucci, Robert L. Parrish, Joan Rodney, Kim A. Eagle. University of Michigan 
Medical Center, Ann Arbor, tvl/ 
1181-7 Are Glycoprotein Ilb/llla Antagonists Cost-Effective in Acute 
Coronary Syndromes: Potential Impact of Tirofiban in the 
United Kingdom 
The relationship between operator volume and outcomes for percutaneous coronary 
interventions (PCI) has led national organizations to institute guidelines for operator vol- 
ume. The implementation of these guidelines remains, however, uncertain. We report 
here recent trends in operator volume for PCI in SouthEast Michigan, and the potential 
relationship between public reporting and compliance with these guidelines. 
Methods. In 1996, 11 hospltals with an active PCI program in South East Michigan ware 
asked for the first time to submit data on total hospital volume and individual operator vol. 
ume to the South East Michigan Heart Consortium for calendar year 1995. The data 
were then released for public reporting. The same hospitals were asked to resubmit data 
for calendar year 1998. 
Results. The number of operators performing ~75 PClIyear decreased from 41% (481 
117) in 1995, to 19% (23/122) in 1998 (p<O.Ol). This decrease was independent from the 
number of “new” operators who had just moved in the area. Of 22 “low volume’ operators 
in 1995 and still pelforming procedures in 1998, 13 were reported as high volume in 
1998. The decrease in number of low volume operators was consistently observed in 91 
11 hospitals. In 1 of the 2 hospitals where an increase was observed, that increase was 
secondary to 1 new operator who started performing procedures in the middle of the 
year. 
Ameet Bakhai, Marcus Flather, Julian Collinson, Warren Stevens, Charles Normand, 
Brian Ward, Rami Ben-Joseph. Royal Brompton and Hareffeld NHS Trust, London, 
United Kingdom, Merck and Co., Inc., Whitehouse Station, NJ 
Background: In the UK 120,000 patients with acute coronary syndromes (ACS) without 
ST elevation (unstable angina [UA] or suspected non Q-wave Ml [NQMI]) are admitted 
each year. Glycoprotein llbillla antagonists such as tirofiban reduce the risk of Ml and 
refractory angina (RFA) in these patients. We estimated the cost of ACS patients in the 
UK and modeled the impact of :irofiban on this. 
Methods: Treatment patterns were obtained from the Prospective Registry of Acute 
lschemlc Syndromes in the UK (PRAiS-UK) which enrolled 1,046 ACS patients from 56 
UK hospitals during 1998-99 and followed them up to 6 months. Costs of hospital stay 
and major diagnostic and therapeutic procedures were calculated for each patient using 
a top-down model derived from the large CHKS database of cost information from 120 
UK hospitals. Risk reductions for MI and RFA were derived from the PRISM-PLUS trial 
which randomized 1,570 patients with ACS, treated with aspirin and heparin to tirofiban 
or placebo. Cost of tirofiban was f438 (5635) for 72h treatment. 
Results: In PRAIS-UK, death or Ml occurred in 12.2% and death, MI, RFA and readmis- 
sion for UA occurred in 30% of patients by 6 months. Treatment of the 88,500 ACS 
patients given heparin was estimated to be f216 ($313) million. Adding tirofiban to treat 
all patients would add f34 (549) million (16%) to the total cost. Targeting patients at high- 
est risk (those with ST depression, bundle branch block [BBB] or NQMI on admIssIon) 
would add 6% to the total cost. About 30,000 (40%) such patients are admitted each year 
and their risk of an adverse outcome is twice that of the average patient. Treating this 
group would avoid about 80% of the events avoided by treating the whole cohort. 
Conclusion: The use of tirofiban in the UK to treat high risk ACS patients such as those 
with ST depression, BBB or Ml on admissiol provides an important therapeutic advan- 
tage at a modest extra cost. 
Conclusions. 1) These data support consistent regional trends toward higher operator 
volumes for PCI. 2) In view of the known relationship between operator volume and out- 
comes, these trends could be considered as indirect markers of an improvement in the 
quality of care in the region. 3) Whether public reporting was the matn driving force 
behind these trends is unknown, but we believe that it played a role. 
1181-6 Patterns in Prior Antiplatelet Therapy and Impact on 
Outcome in Patients With ACS. Results From the Global 
Registry of Acute Coronary Events 
Frederick Spencer, Joel M. Gore. Robert J. Goldberg, Keith A. A. Fox, Mauro Moscucci, 
Cynthia M. Sullivan, Kami White. Enrique Gurfinkel, for the GRACE Investigators. 
University of Massachusetts Medical School, Worcester, MA. Buenos Aires University, 
Buenos Aires, Argentina 
Background: Substantial evidence supports the chronic use of aspirin (ASA)/antiplatelet 
(AP) therapy in patients with heart disease to reduce the risk of subsequent acute coro- 
nary syndromes (ACS). It is less clear whether this therapy is associated with lower mor- 
bidity and mortality if patients develop an ACS despite its use. It has been suggested that 
these patients are “ASA resistanl’ and as such represent a high-risk group with poor out- 
comes. Using data from the Global Registry of Acute Coronary Events (GRACE), we 
sought to identify patterns rn prior ASA use and their associated outcomes. 
Methods: Baseline characteristics, ACS type, and In-hospital events were compared for 
patients enrolled in 94 hospitals in 14 countries with or without a history of heart disease 
and whether or not they had been on ASAIAP prior to enrollment. 
Variable 
Mean age (years) 
Male (%) 
Diabetes (%) 
Hyperlipidemia (%) 
History of History of HD- No history of No history of 
H&prior no prior ASA! HD -prior ASA/ HD-no prior 
ASAIAP AP AP ASAJAP 
“Z2899 n=2354 n=174 rl=l438 
67 65 71 62 
65 65 57 72 
28 24 23 17 
57 37 36 27 
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1503-I Telemedicine in Cardiology 
Didier Carrie, Meyer Elbaz, Robert Lavayssi&res*, Abderrahim Marcil-, Pierre Pouget*, 
Jacques Puel. CARDIOLOGY PURPAN HOSPITAL, TOULOUSE, France, 
CARDIOLOGY, RODEZ HOSPITAL, RODEZ, France 
The telecommunications network used is the French integrated services dlgital network 
(RNIS), the first telecommunications network to provide general-purpose access for 
voice, data and image transmission. The equipment used for cardiology telemedicine 
communications is videoconference equipment enabling simultaneous, real-time trans- 
mission of images, notably moving images, sound and data. Videoconferencing permits 
conviwal, interactive exchanges: the participants can see and speak to each other and 
transmit all the medical information needed for remote medical practice in real time. 
Since telemedicine was initiated between the hospital center in Rodez and Toulouse Uni- 
verslty Hospital, 833 patients’ files have been dealt with (April 1996 - December 1999) by 
telemedicine in cardiology and parbcularly coronary artery disease. For the transmission 
of angiographic images (moving medical imagery), the RNIS connections operate at 384 
Kbits/s, which provides sufficient quality for image dynamics. The physicians in Rodez 
can thus show cardiologists in Toulouse the sequences performed on their pabents (pre- 
viously recorded in S-VHS format), whilst viewing them themselves. This enables the ini- 
tial diagnostic approach to be discussed and validated in full partnership and brings the 
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benefit of the university hospital team’s experience for a concerted, collegial decision on 
optimal treatment (medical treatment, angioplasty or coronary artery bypass surgery). Of 
the 833 cases discussed in this way, 317 patients (38%) were transferred to Toulouse 
University Hospital for myocardial revascularization (angioplasty or surgery). The tele- 
medical exchanges have an influence of about 25%, depending on the physician request- 
ing the conference, on the decision as to whether to transfer patients. These discussions 
are also of interest in many other domains, such as the confidence felt by patients who 
are transferred for very specific treatment, continuous two-way exchanges of medical 
Information, and a strengthening of the confidence the medical teams have in each other. 
1503-2 A New Device for Electronic Connection With the 
Anticoagulation Clinic 
Giovanni Melandri, Samuele Nanni, Giovanni Bracchetii, Luca Rossi, Mario Benassi, 
Remo Row, Angelo Branzi, Bruno Magnani. lnsfitute of Cardiology, University of 
60/0gm, i3o/ogna, Italy 
Background: The increasing number of patients on warfarin treatment results in a sub- 
stantial burden for antlcoagulation (A) clinics. Methods: In this study we evaluated a new 
device for the electronic transmission of A regimen and the management of appoint- 
ments. The computer-aided prescription (PARMA 4 system) is received by the patient 
through a pocket-size device with a display and a key-board allowing an easy-to-use 
interaction with patients, including those with low-level of informatic knowledge. The 
hardware plate is governed by a microchip enriched by an internal modem; the software 
is completely personalized. 20 patients were followed over 9 months, during which their A 
treatment was managed through this device after a preliminary teaching taking on aver- 
age 30 minutes. Results: Overall, there ware more than 400 prescriptions and the elec- 
tronic transmission was efficient in 98% of cases. The time in the therapeutic range was 
more than 70%. Electronic changes in appointments ware satisfactory with none of the 
patients complaining for wrong data transmission. The device was greatly appreciated by 
patients, including retired ones and those of advanced age (>75 years old). Conclu- 
sions: We conclude that the electronic management of A prescription (as well as of oth- 
ers medical data) is feasible, well-accepted by patients and efficient. 
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1214-l Impact and Treatment of Diabetes (Type I and II) on 
Prognosis in Acute Coronary Syndromes: Results From the 
Global Registry of Acute Coronary Events 
Joel M. Gore, Frederick A. Spencer, Michel Maw, Robert J. Goldberg, Werner Klein, 
Rachel S. Kasper, Andrzej Budaj, Tomek Mazurek, Ph Gabriel Steg, for the GRACE 
Investigators. University of Massachusetts Medical School, Worcester, MA, H@ita/ 
Bichat, Paris, France 
Background: Diabetes mellitus (DM) is associated with worse outcomes in patients with 
acute coronary syndromes (ACS). It has also been suggested that diabetics have not 
experienced the improvement in outcomes seen during recent years in non-diabetics with 
ACS. Frequently, insulin (Type 1) and non-insulin dependent (Type II) diabetes are ana- 
lyzed together. Less is known about the impact of each specific type of diabetes on hos- 
pital outcomes in patients with ACS. Methods: Baseline characteristic, treatments used, 
and outcomes were compared for patients with Type I and II DM and those without DM in 
the GRACE Registry (Global Registry of Acute Coronary Events)enrolled at 94 hospitals 
in 14 countries. Results: Patients are presented by type of ACS; ST-segment-elevation 
Ml (STE-MI), non-STE-MI, or unstable angina (UA), in relation to the presence and type 
of diabetes. 
(-)DIABETES TYPE I DIABETES TYPE II DIABETES 
STE-MI NON STE-MI “A STE-MI NON STE-MI “A STE-MI NON STE-MI !,A 
N ,994 1575 2104 124 205 198 333 334 425 
Male sex(%) 73 69 62 51 57 52 69 66 61 
HX MI(%) 20 31 42 40 45 5s 30 40 47 
HX CHF(%) 6 I, 13 21 P9 31 9 20 1s 
Medicamns (in-hospital) 
Aspirin(%) 94 92 so 90 90 87 9P 89 90 
IV GP Ilblllla(%) 19 1s 5 23 21 10 20 18 8 
Beta Blockeels 80 7s 7s 72 7s 68 77 70 75 
ACE Inhibitors 62 52 47 62 73 63 65 67 so 
hi+(%) 17 P7 37 28 37 55 20 30 3s 
In-Hospital Events 
Imp Class I(%) 82 81 87 65 5s 75 74 70 86 
Caldlac C.ah(%, 52 54 38 55 52 42 5s 53 44 
PCI(%) 3s 28 1s 38 27 14 34 2s 1s 
CHF(%) 8 6 4 11 18 9 10 11 5 
Death(%) 7 5 2 13 7 4 11 6 2 
JACC February 2001 
A multivariate regression model revealed that both Type I (OR 2.1) and Type II (O.R. 
1.8) DM Is strongly predictive of in-hospital mortality and the development of heart failure 
or shock. Conclusion: Diabetes is associated with increased morbidity and mortality in 
patients with ACS. There is a difference in outcomes for Type I and Type II DM, and pool- 
ing diabetics together obscures this important difference. 
1214-2 Fat or Fit: Does It Matter What Women Weigh? The NHLBI- 
Sponsored WISE Study 
C. N. Bairey Merz, Marian B. Olson, B. D. Johnson, Carl J. Pepine, Steven E. Reis, 
William J. Rogers, Nathaniel Reichek, Barry L. Sharaf, Sheryl F. Kelsey, George Sopko. 
Cedars-Sinai Medical Center, Los Angeles 
Background: Increasing attention is being paid to obesity as a risk factor for coronary 
artery disease. Prior obesity studies have not adequately measured physical activity, 
leaving the role of fatness, as opposed to fitness, as an independent risk factor 
unresolved. Methods: We evaluated 566 overweight (body mass index [BMI] >25) 
women enrolled in the NHLBI-sponsored Women’s lschemia Syndrome Evaluation 
(WISE) study undergoing coronary angiography for suspected ischemia. All women 
underwent complete coronary risk factor and physical activity assessment using the 
Postmenopausal Estrogen-Progestin Intervention physical activity questionnaire (PEPI- 
Q). Results: When stratified by a high level of physical activity (PEPI-Q score 29, con- 
sistent with moderate to heavy activity at work, home and leisure), active-overweight 
women comprised 13% of this overweight population and were younger than inactive- 
overweight women (52+9 vs 58111 yrs, p=O.OOOi). Comparison of traditional coronary 
risk factors, with age-adjusted p values, demonstrated similar risk profiles (including dia- 
betes 9% vs 15%, p=O.34), between the active and inactive groups, respectively. Inactive 
women, however, showed greater evidence of markers consistent with insulin resistance 
(Table). 
Variable Active (1x73) Inactive (n=483) p 
Triglycerides (mgidl) 127+88 167&l 33 0.01 
Fasting blood sugar (mgldl) 104*35 123*58 0.04 
Waist-hip ratio o.F34+0.09 0.87+0.11 0.08 
Coronary artery disease (%) 21 37 0.14 
Coronary artery disease=>50% stenosis in sona epicardial coronary artery. 
Active=PEPI-Q >9 consistent with moderate to heavy activity. 
In a multivariate model which included age, BMI, and physical activity, low levels of phys- 
ical activity predicted insulin resistence, defined by a fasting blood sugar >I 10 mgldl and 
triglycerides >150 mg/dl (Odds ratio=0.88, p=O.O9). Conclusion: Among overweight 
women undergoing coronary angiography for suspected myocardial ischemia, low physi- 
cal activity level is associated with increased markers of insulin resistance. These data 
suggest that fitness may be a key modulator of the coronary risk of fatness in women. 
1214-3 Assessing the Relationship Between Obesity and Long- 
Term Clinical and Economic Outcomes in Coronary Artery 
Disease Patients 
Eric L. Eisenstein, Linda K. Shaw, Charlotte L. Nelson, Kevin J. Anstrom, Zafar Hakim, 
Daniel B. Mark. Duke University Medical Center, Durham, NC, Roche Global 
Pharmacoeconomics Research, Palo A/to, CA 
Background: NHLBI guidelines suggest pharmacologic therapy for weight loss may be 
warranted in coronary artery disease (CAD) patients with a body mass index x27. How- 
ever, the long-term clinical and economic burden of higher body mass index in CAD 
patients has not been established. Methods: We estimated CAD patient survival and 
inpatient medical costs to IO years using clinical information from the Duke Cardiovascu- 
lar Databank and economic information from US GUSTO lib patients. The population 
included patients with an index cardiac catheterization 1988.1997, recent Ml (~6 weeks) 
or unstable angina, and significant CAD. Patients with previous revascularization proce- 
dures or a diagnosis of congenltal or valvular heart disease were excluded. Follow-up 
was 95% complete. Results: Higher body mass index was associated with younger age, 
female gender, minority race, greater prevalence of cardiac risk factors (hyperlipidemia, 
hypertension, and diabetes), and less severe CAD. Higher body mass index patients had 
dissimilar unadjusted (p = 0.001) but similar adjusted (p = 0.615) lo-year survival as 
patients with a body mass index c 30, with higher IO-year cumulative inpatient medical 
costs. Conclusions: Although obese and vary obese patients with CAD are younger 
than CAD patients with lower body mass indexes, their incremental survival is similar and 
they have greater medical costs. These findings highlight the need for and value of 
weight management as an essential element in primary and secondary CAD prevention 
programs. 
Variable Normal Ovenwioht Obese Verv Obese 
N= 2951 3950 1694 
BMI 1 8.5-24.9 25.0-29.9 30.0-34.9 
Age(median) 66 62 59 
Hyperlipidemia(%) 39.0 42.9 49.1 
Hypertension(%) 49.6 55.9 64.8 
Diabetes(%) 18.5 24.9 34.2 
Severe CAD(%) 31.3 27.9 25.3 
White race(%) 85.9 82.7 79.2 
Male gender(%) 62.6 71.1 62.0 
Smoking(%) 66.5 67.1 62.2 
Family History of CAD(%) 44.0 46.4 48.1 
30.Day Death(%) 4.3 3.1 3.2 
812 
>=35.0 
58 
xxxx 
xxxx 
xxxx 
xxxx 
XxXx 
XxXx 
XxXx 
xxxx 
3.1 
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IO-Year Death(%) 44.9 36.6 37.7 45.9 
30.Day Costs($) 25,207 23,063 21,724 21,159 
lo-Year Costs($) 46,422 47,250 54,176 55,751 
1214-4 Anticoagulation for Stroke prevention in Survivors of Acute 
Myocardial infarction With Ventricular Dysfunction 
Dennis T. Ko, Ayumi Kamina, Louis Fiore, Judy Lichtman, Lawrence Brass, Harlan M. 
Krumholr, Michael D. Ezekowitz. VA Cooperafive Siudy Group, West Haven, CT 
Background. Stroke prevention with oral anticoagulation is recommended by the 
National Stroke Association for patients with ventricular dysfunction after acute myocar- 
dial infarction (AMI), however, the ACCIAHA guidelines did not endorse this practice due 
to the lack of prospective studies. We sought to determine whether warfarin and aspirin 
are more effective than aspirin for stroke prevention in survivors of AMI with depressed 
ejection fraction (EF) enrolled in the Department of Veterans Affairs Cooperative Studies 
Program: “Combination, Hemotherapy and Mortality Prevention” (CHAMP). 
Methods and Results. We compared pts in the CHAMP database, a group randomized 
to warfarin (mean INR 1.8) and aspirrn (Slmgid) or aspirin (162mg/d) monotherapy after 
AMI and followed for 2.7 yrs. Of the 5,059 pts enrolled in the study cohort (mean age 61.7 
yrs, 99% male, 81.5% white), 168 strokes occurred during follow-up. There were 15 hem- 
orrhagic strokes in the combination group and 14 hemorrhagic strokes in the aspirin 
group. Among the 3,173 pts (64.2%) with EF assessment, 79 strokes occurred in 2,175 
pts (3.6%) with normal or 2 40% EF and 36 strokes occurred among 1,099 pts (3.2%) 
with EF < 40%. in multivariate analysis, combination therapy with warfarin and aspirin 
provided a trend towards stroke reduction in pts with moderately depressed EF (RR = 
0.75, 95% Cl:O.38-1.45) but not in all pts after AMI (RR = 0.93, 0.68-1.28). 
Conclusion. Combination therapy with low-intensity walfarin wth aspirin did not 
increases the risk of hemorrhagic strokes and maybe beneficial for stroke prevention in 
survivors of AMI with ventricular dysfunction. 
1214-5 More Acute Myocardial Infarctions During Spring and a 
Higher Mortality Dependent on Climate in Germany: Results 
of the MITRA-Registry 
Anselm K. Gitt. Steffen Schneider, Klaus Bucher, Harm Wienbergen, Tobias Heer, Martin 
Gotpuik, Jochen Senges, Rudolf Schiele. Herzzentrum Ludwigshafen, Ludwigshafen, 
Germany, Deutscher Welferdienst, Freiburg, Germany 
Background: Seasonal and climatical influences on the frequency of acute myocardial 
infarction (AMI) have been discussed controversially based on results of different 
regional observations. Methods: MITRA is a registry of 54 clinics in Southwest-Ger- 
many, in which consecutive patients (pts) with AMI have been enrolled to document 
actual clinical practice and clinical outcome. We examined the relation between seasons 
and AMI-frequency. Because of the homogenous cliinate in this area we matched the 
daily meteorological data and the data of AMI-pts of July 1994 to January 1996. Based 
on 13 biosynoptical climate classes we defined stable (class l-3 and 8-13) and unstable 
(class 4-7) climate (UC). We examined the influence of the UC and the perceived temper- 
ature on frequency and hospital mortality of AMI. Results: During the observational 
period 3327 pts (median age 66 y, 67% male, prehospital delay 165min) with AMI had 
been enrolled. The frequency of AMI was higher during spring than during other seasons 
(6.5r2.8/day vs 5.5t2.4iday, p&01). UC was present on 2201580 days (38%). We did 
not find any difference in dally AMI frequency between UC and stable climate (5.9A2.6 vs 
5.9+2.6, p=O.29). There were no differences in pts characteristics (age, gender, prehos- 
pital delay, anterior wall AMI, reinfarction) on the days with UC as compared to stable cli- 
mate. We did not find any relation between the perceived temperature or the 
biosynoptical climate classes and the frequency or outcome of AMI. However, the multi- 
variate analysis identified the UC as an independent determinant of inhospital mortality 
(OR 1.47, 95%CI 1.10-1.97). Conclusion: During spring the frequency of AMI was 15% 
higher than during all other seasons. UC did not influence the frequency of AMI. Pts at 
risk for AMI dependent on climate could not be identified. UC on the day of AMI was 
associated wth a marked increase of inhospital mortality after AMI. 
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1214-6 Six-Month Compliance After Hospital Discharge in Patients 
With Acute Coronary Syndromes 
Akhil Gulati, Eva M. Kline-Rogers, Obli C. M. Mani, Deepak Venkat, Jeanna V. Cooper, 
Gwen E. Kearly, Elizabeth Nolan, Robert J. Cody, Steven R. Erickson, Rajendra H. 
Mehta, Kim A. Eagle, The University of Michigan Heart Care Program. University of 
Michigan Health Systems, Ann Arbor, MI 
Background: Evidence based medicine with agents such as beta blockers(BB), aspi- 
rin(ASA), angiotensin converting enzyme(ACE)inhibltors, and lipid lowering agents 
has been shown to decrease morbidity and mortality in patients with both ST-segment 
elevation myocardial infarction (STEMI), non ST-segment elevation myocardial infarction 
(NON-STEMI) and unstable angina (UA). Few data exist on intermediate and/or long- 
term compliance to these medications. 
Methods: We evaluated 6-month medication compliance in all patients with acute coio- 
nary syndromes discharged alive from our hospital between 5199 and 112000 through a 
telephone interview. At least 5 attempts were made to contact each patient. At follow-up 
(F/U). compliance to various discharge quality indicators was assessed. 
Results: 4181472 patients were reachable via telephone. 31 patients had died, leaving 
387 patients with F/U data. Medications at hospital D/C and at 6 month F/U are as 
shown. 
Treatment STEMI (n=106) Non-STEM1 (n=iOZ) UA (n=179) 
DIG F/U D/C F/U D/C F/U 
ASA’ 
BB 
ACE inhibitors 
LL agents 
97.2% 90.6% 98% 91 .2% 90.5% 88.8% 
84.9% 82% 84.3% 79.8% 73.2% 72.8% 
72.6% 59% 47.1% 49.5% 39.1% 44% 
67% 72% 70.6% 69.1% 73.7% 68.8% 
* Includes other anti-platelet and/or anti-coagulant drugs 
Conclusions: Compliance with key discharge medications at B-month follow-up is high 
in-patients discharged from our institution. These results reflect higher compliance rates 
for most quality indicators than in prior published reports. Patient education and empow- 
erment along with direct communication with patient’s primary physician at the time of 
discharge, focusing on goals for long-term management, may explain the high adherence 
to quality care. 
1214-7 Short Course Cardiac Rehabilitation Programme Improves 
Long-Term Quality of Life in Patients With Acute Myocardial 
Infarction and After Coronary Angioplasty: A Highly Cost- 
Effectiveness Therapy 
Cheuk-Man Yu, June Chau, Sarah McGhee, Bernard M. Y. Cheung, Chu-Pak La”, 
Leonard S. W. Li. The University of Hong Kong, Hong Kong, Hong Kong 
Background: This study investigated the long-term benefit of cardiac rehabilitation and 
prevention program (CRP) on quality of life and its cost-effectiveness in patients with 
acute myocardial infarction (AMI) and after percutaneous coronary angioplasty (PTCA) is 
unknown. Methods: An open-labeled, randomized, controlled study was performed to 
evaluate 150 patients (67 + 11 yrs, 72% male) who had completed all four phases of 
CRP (total of 2 years) in a University hospital. Demographics, clinical and quality of life 
assessments on individual patients were performed at the end of each phase. Staff sal- 
ary, equipment, hospitalizations, investigations, interventions, clinic visits, and drugs 
were included in the calculation of incremental cost of the program. Quality adjusted life 
years (QALYs) and cost per QALY gained were estimated by using the time trade-off 
method. Results: Among them, 110 had recent AMI while 40 had PTCA performed. 
They were randomized to the study group (n = 100) who consists of twice weekly exer- 
cise and education program for 8 weeks or controls (conventional therapy, n = 50). In the 
study group, 6 out of 8 SF-36 dimensions were significantly improved after phase 2 and 
were maintained at phase 4 (physical & social functioning, vitality & physical role, all p < 
0.001; emotional role & mental health, both p < 0.05). However, in the controls, only 1 of 
them was improved after phase 2 and up to 4 dimensions after phase 3 and 4. Patients in 
the study group also became less anxious, more relaxed and more contented (all p < 
0.05). There was a trend of persistent net gain in mean TTO in the study group (+O.Oli) 
when compared to phase 1, but was persistently decreased in the controls (-0.024). The 
net QALY galned by CRP was 0.57. The total cost calculated per patient was lower in the 
study than control group (US$15,292 Vs $11,907), primarily due to the lower cost spent 
in PTCA. The estimated cost was $5,828 less per QALY gained. There was no difference 
in mortality (8% Vs 10%) and hospitalization rate between the two groups. Conclusions: 
Short course of CRP results in faster and better improvement in quality of life up to at 
least 2 years after AMI or PTCA. This management strategy also appears to be highly 
cost-effective. 
INFO@ACC 
1504 Computer Applications in 
Echocardiogoraphy 
Tuesday, March 20, 2001, 130 p.m.-500 p.m. 
Orange County Convention Center, Booth 3163 
Presentation Hour: 1:30 p.m.-3:30 p.m. 
1504-l A Model for an Internet-Based Echocardiography Atlas 
Paolo Barbier, Marina Alimento. Cenfro Cardiologico “Monzino’: /WCS, Milano, My 
Background: Limited allocations of economic resources for teaching projects by medical 
institutions may limit growth of these projects on the World Wide Web (Web) which is a 
unique, widely available media. We designed a Web-based echocardiography reference 
atlas using low cost Web hosting and off-the-shelf commercial software. Cross-linking of 
similar projects by different teaching institutions may provide a readily available inter- 
institutional information tool for clinicians and students. Methods: The components of the 
Web site are: 1) Detailed atlas of still-frame M-mode, 2D and Doppler images; 2) M- 
mode, 2D and Doppler normal value database from published studies; 3) Referenced 
database of standard methods and formulas; 4) Echocardiography reporting guidelines; 
5) Links to echocardiography sites, Medline@ and specialty journals. During a 2-year 
period, we selected 400 studies based on content and image quality, digitized with an 
analog (s-VHS output of ultrasound equipment) to digital PC video card. Results: We 
optimized the ‘clinical information/download time” ratio for each image, using 350x250 
pixels, 8 bit compressed JPEG format, eliminating redundant data with image editing 
software; mean download time (56K modem) was 11 s. The Web site was optimized for 
800x600 pixel monitors and inter-browser compatibility. Tree-structured and cross-linked 
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summaries were provided to index images and facilitate browsing, based on respectively 
anatomical and functional (following a standard echocardiographic exam), and diagnostic 
paths. Conclusion: Taking advantage of simple to use, low cost technology, and non 
commercial Web hosting we propose a model of ‘“on-line” echocardiographic image data- 
base which may provide the basis for a wider, cross-linked inter-institutional echocardio- 
graphy image database. 
864-2 
2:15 pm. 
Death Associated With Platelet Glycoprotein Ilb/llla Inhibitor 
Treatment 
David L. Brown. Albert Einstein College of MedicirwMontefiore Medical Center, Bronx, 
NY 
1504-2 Acquisition Times for Echocardiographic images: 
Comparison Between Analog and Digital Recordings 
Paolo Barbier, Marina Alimento, Giovanni Berna, Silvia Perlangeli. Centro Cardiologico 
“Monzino”, /RCCS, Mila70, /k/y 
Background: Transition from analog to digital echocardiography ensures stability of 
stored image quality, shortens image retrieval time, eases side-by-side comparisons, 
optimizes laboratory management. However, acceptance of a digital system that requires 
on-line image “clinical compression” (with similar learning curves for all operators), is 
conditioned by its ease of use. We have tested the hypothesis that utilization of a digital 
acquisition and archival system prolongs echocardiographic study time. Methods: We 
randomized 785 consecutive studies from our outpatient laboratory (4600 exams/year) to 
analog (433, s-VHS recordings) or digital (352, commercial analog to digital video PC 
acquisition card and custom software) acquisition and archiving, performed by a single 
operator with an HP 2000 system. Diagnosis groups included: normals (Gr.1, 154), arte- 
rial hypertension (Gr.2, 78), ischemic (Gr.3, 149), or dilated cardiomyopathy (Gr.4, 29), 
aortic (Gr.5, 74), mitral (Gr.6, 96), or mixed valve disease (Gr.7, 44), valve prosthesis 
(Gr.8, 113), hypertrophic cardiomyopathy (Gr.9, 1 l), congenital heart disease (Gr.10, 
13), pericardial disease (Gr.11, 9). Results: Age and exam quality were similar for ana- 
log and digital acquisitions. At the end of the learning curve, when compared by diagnos- 
tic group, acquisition times were similar for both systems, though experience was shorter 
with the digital technique. Archival costs were halved in the latter (s-VHS: 0.14 $/patient, 
CD-R: 0.08). 
Background: Randomized clinical trials have suggested a low complication rate follow- 
ing treatment with parenteral platelet glycoprotein llbillla inhibitors (GPI). However, such 
trials generally enroll relatively low risk patients. The safety profile of these agents in 
patients treated outside of the setting of clinical trials is unknown. Methods: Post-market- 
ing adverse event reports made to the FDA for tirofiban, eptifibatide and abciximab from 
January 1, 1999 to December 31, 1999 were obtained under the Freedom of Information 
Act. All reports of death related to the use of these agents were selected for analysis. 
Results: There were 79 deaths associated with GPI treatment reported. Females com- 
prised 61% of these patients. The mean age was 72.6 years. Myocardial infarction 
occurred in 19% of cases. Thrombocytopenia was present in 5% of cases whereas hem- 
morhage was described in 66% of reports The central nervous system and gastrointesti- 
nal tract were the most common sites of hemmorhage occurring in 25% and 27% of 
patients, respectively. In addition retroperitoneal (10% of patients), pulmonary (1 O%), 
oropharyngeal (8%), arterial (8%) and pericardial (6%) hemmorhages were also 
described. Conclusion: Despite underreporting, da@ from the FDA’s post-marketing 
surveillance demonstrates a significant number of deaths reported in patients treated 
with GPI. The fatalities usually involve older women and are frequently related to serious 
hemmorhagic complications of treatment. 
864-3 
2:30 pm. 
Hospital Costs for Acute Coronary Syndromes in the 
TACTICS-TIM118 Trial 
Gr.1 Gr.2 Gr.3 Gr.4 Gr.5 Gr.6 Gr.7 Gr.8 Gr.9 Gr.10 Gr.11 
Analog lo+2 10r2 13*3 15+3 13&Z 12*3 15+6 15r2 23~7 18& 14*3 
Diaital lOt2 llr3 13&2 i6i7 14+3 l&5 15+2 15+3 16+3 19+3 15+4 
Elizabeth M. Mahoney, Claudine T. Jurkovitz, Haitao Chu, Karen M. Parker, Steven 
Culler, Laura A. Demopoulos, Paul DeLucca, Debbie H. Robertson, Peter DiBattiste, 
Christopher Cannon, William S. Weintraub. Emory University, At/an&, GA 
Background: The TACTICS-TIM1 18 Trial tests the primary hypothesis that in patients 
with unstable angina/non-Q-wave MI (UAINQWMI) treated with tirofiban and heparin, an 
early invasive strategy will reduce the combined incidence of death, MI and rehospitaliza- 
tion for acute coronary syndromes (ACS) when compared to an early conservative strat- 
egy at 6 months. The secondary hypothesis is that the two treatment strategies will 
result in equivalent total cardiovascular related costs at 6-months. The trial enrolled 
2220 patients between 1997 and 1999; the six-month followup was completed in June, 
2000. 
Methods: We present preliminary results examining the influence of in-hospital (IH) 
death, IH MI, sex, age, diabetes and length of stay (LOS) on initial hospitalization 
(IHOSP) costs. Hospitalization charges were obtained from UB92s for US/Non-VA 
patients. Charges were reduced to costs using Medicare cost-charge ratios. Multivari- 
able linear regression (LR) was used to examine the independent effect of each of the 
factors on costs. 
Results: Mean (median) LOS was 5.4 (4) days. Mean and median costs are presented 
below, as well as p-values from Wilcoxon rank sum tests of the effect of each factor. 
Mean Cost ($) Median Cost (5) p-Vd”e* 
Overall (I-l=1 146) 10,148 7,017 . . 
IH Death: no 9,786 6,929 .0003 
Yes 35,714 18,534 
IHMI: no 9,853 6,710 <.OOOl 
Yes 18,762 15,466 
Sex: male 10,201 7,373 ,060 
female 10,061 6,479 
Age: <65 yrs. 8,973 6,338 ,001 
>65 yrs. 11,534 7,818 
Diabetes: no 9,753 6,907 ,080 
YeS 11,201 7,247 
* Wilcoxon rank sum test 
LR examining the influence of the five clinical and demographic factors revealed that IH 
death, IH Ml and age (continuous) were independently associated with IHOSP costs, 
though only a small amount of the variability in costs was explained (R’=.lO). When LOS 
was added to the model the R2 increased to .71, though only IH death and LOS 
remained as significant independent predictors of costs. 
Conclusion: The cost of treating ACS varies with clinical and demographic factors. The 
effect of an invasive vs. conservative strategy will be presented. 
864-4 
2145 p.m. 
Percutaneous Coronary Intervention Mortality Measures: In- 
Hospital, Thirty-Day and Procedural 
Daniel J. CYRourke, David J. Malenka, David E. Wennberg, Samuel J. Shubrooks, Mirle 
A. Kellett, Jr., Matthew W. Watkins, William A. Bradley, Peter N. Ver Lee, Michael A. 
Hearne, Bruce D. Hettleman, The Northern New England Cardiovascular Disease Study 
Group. Dartmouth-Hitchcock Medical Cenfer. Lebanon, NH, Veterans Affairs, White River 
Junction, VT 
Background: The optimal period during which to assess mortality after percutaneous 
coronary intervention (PCI) is unclear. In-hospital mortality is easily obtainable and verifi- 
able, however, will miss deaths occurring after hospital discharge. 30-day mortality pro- 
vides a constant time interval but is not always obtainable. Procedural mortality, capturing 
all in-hospital and 30.day deaths, also presents problems with complete ascertainment. 
Using a large regional database we compare these mortality measures. Methods: Data 
were collected prospecfively on 18,800 consecutive PCI patients between 1990-1996 at 
Acquisition times minutesrSD. Number of acquired frames was similar but that of 
dynamic loops lower (10.7*3.4 vs. 12.3k3.6, pc.001) with the dig&al technique. Conclu- 
sion: The need to use “clinical compression” during echocardiographic digital acquisition 
does not increase workload on the operator. Given the superiority of digital compared to 
analog systems relative to management of stored images, digital acquisition systems are 
feasible and necessary components of an efficient, though busy, echocardiography labo- 
ratory. 
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864-l Recovery of Physical Function After Revascularization: 
Temporal Patterns Following PCI and CABG 
Michael Borkon, John A. Spertus MD MPH, Brent Bllven PhD MSc, Phillip Jones MSc, 
Kasem Akhras PharmD, Joseph Tooley PharmD. Mid America Heart Institute, Kansas 
City, MO 
Background: The time course of functional status improvement following PCI and CABG 
would be useful in counseling pts and has been incompletely evaluated. Methods: We 
prospectively tracked pts monthly functional status recovery in 354 consecutive pts 
undergoing PCI (n=l84) and CABG (n=l70). The Seattle Angina Questionnaire (SAQ) 
was used to quantify physical limitation due to angina. SAQ scores range O-100 where 
higher scores indicate better functioning. Results: PCI and CABG pts had significant 
mean B-month improvement in physical limitation: PCI = 5.9 (i-22); CABG = 12.4 (527) 
(p<O.OOl, both groups). CABG pts experience an initial 20% drop in physical limitation 
during the first month of recovery prior to improving. Although after 6 months, the physi- 
cal limitation mean change was higher among CABG pts than PCI pts (p=O.O15), a simi- 
lar proportion of patients experienced a minimal clinically important difference in scores 
(66% PCI and 68% CABG improved by >5 points). The time to maximal improvement in 
the PCI cohort was 2.7 months (+I .6) as compared with 3.5 months (-tl.6) among CABG 
pts. This was statistically significant (pcO.001). CABG pts were significantly older, had a 
higher frequency of EFc40%, and more multi-vessel disease (pc.05 for all). Conclu- 
sions: Our data demonstrate significant benefits of PCI and CABG in 6.month physical 
limitation recovery. Recovery appears to be more rapid among pts receiving PCI, per- 
haps due to the more invasive nature of CABG. Despite the decrement in function at one 
month, the magnitude of recovery after 6 months was greater among CABG pts. This 
information can assist physician efforts to sufficiently prepare pts for near-term recovery 
following revascularization and align expectations with empirical evidence. 
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6 northern New England medical centers. The data set was linked to the National Death 
Index and used to calc~iate mortalitv measures. Results: The number of deaths. the 
morialiiy rates and their 95% confidence intervais are summarized in the following table. 
Mortality Measures 18,600 PCI patients Total Num- Mortality Confidence 
ber of Deaths Rate (%) Interval (95%) 
in-hospital mottal~ty (during mdex admission) 200 1.08 0.93-1.22 
SO-day mortahty (in or at of hospital) 241 1.30 1 .I 3-1.46 
Procedural mxtailty (during ,nLien admission or 30. 260 1.40 1.23-l .57 
day mortality) 
The in-hospital mortality rate was the lowest and the procedural mortality rate was the 
highest, a relative effect that was consistent over the 6 years of study and across instltu- 
tions. Of the 260 deaths contributing to the procedural mortality rate, 241 deaths 
occurred within the first 30 days, either in or out of the hospital, and 19 deaths occurred 
in-hospital but during a >30 day stay. Conclusions: Each mortality measure has its 
intrinsic advantages and disadvantages. However, for all of them the mortality rate asso- 
ciated with PCI was low and the differences among them did nol appear io be clinically 
significant. Using in-hospital mortality may be advantageous as it is conveniently and reli- 
ably obtained. 
3:oo p.m. 
864-5 A Comparison of Stenting and Conventional Coronary 
Angioplasty: Long-Term Survival and Rehospitalization in 
the Department of Veterans Affairs Medical Centers 
Charles Maynard, Nathan R. Every, Steven M. Wright, James L. Ritchie. Deparfment of 
Veterans Affairs Puget Sound Health Care System, Seattle, WA, Massacf~usetts 
Veterans Epidemiology Research Information Center, Boston, MA 
Background. While the short-term benefits of stenting have been established, less is 
known about long-term outcomes. This study compares short and long-term outcomes 
for stenting and conventional PTCA in veterans undergoing percutaneous interventions 
(PCI) in Veterans Affairs (VA) Medical Centers.Methods. We used the VA patient treat- 
ment file to identify 27,224 veterans who had PCls between October 1994, and Septem- 
ber 1999. Patients were divided into those with and without a principal or primary 
diagnosis of AMI. Hospital mortality and same admission coronary artery bypass surgery 
(CABG) ware assessed, as were long-term vital status and rehospitalization. Multivariate 
statistical methods were used to adjust for patient differences when comparing stents 
with conventional PTCA. Results. Stent use increased from 40% in 1996 to 79% in 1999: 
overall 49% of veterans received stents. Baseline characteristics were similar for stents 
and conventional PTCA groups with (22%) and without (78%) AMI. In the AMI group, 
hospital mortality was 2.9% for stents and 4.8% for conventional PTCA (p<O.OOOl), 
whereas for no AMI, hospital mortality was not different (1.2% vs. 1.4% p=O.l2). For 
AMI, same admission CABG rates were lower m the stent group (0.7% vs 3.2%, 
pcO.OOOl). The same was also true for the no AMI group (1.2% vs 3.3%, p<O.OOOl). 
These differences did not change after adjustment for covariates. Two year survival was 
better for stenting in both AMI (90% vs 88%, ~~0.006) and no AMI (92% vs 91%, 
p=O.OOS). For AMI, one year rehospitalizalion rates for conventional PTCA (2.2% vs 
6 3%, pcO.OOOi), CABG (3.2% vs 4.9%, p=O.O01), or unsiable angina (12.6% vs 17.5% 
p<O.OOOl) were lower in the stent group. In the no AMI group, one year rehospitalization 
rates for conventional PTCA (3.7% vs 8.4%, p<O.OOOl), CABG (3.8% vs 5.7%, 
p<O.OOOl), or unstable angina (17.0% vs 22.7%, pcO.0001) were also lower in the stent 
group. These differences did not change as a result of covariate adjustment.Conclusion. 
Veterans who underwent stenting had lower hospital mortality, reduced rates of same 
admission CABG, marginally better survival, and lower rates of rehaspitallzation than 
their counterparts who had conventional PTCA. 
3:15 p.m 
7 804-6 Preventing Major Bleeding in Acute Coronary Syndromes: 
Lessons Learned From the Global Registry of Acute 
Coronary Events (GRACE) 
Mauro Moscucci, Keith A. A. Fox, Christopher P. Cannon, Werner Klein. Kami White, 
Jo& L6pez-Senddn, Gilles Montalescot, Robert J. Goldberg, for the GRACE 
Investigators. University of Michigan Health System, Ann Arbor. M/, University of 
Massachuseffs Medical Schooi, Worcesfer, MA 
Background: The development of major bleeding is currently the most common noncar- 
disc complication of contemporary therapy for acute coronary syndromes. To date, there 
have been no systematic studies that have attempted to identify predictors of major 
bleeding in these patients. The objective of the study was to develop a prediction rule for 
the identification of patients with acute coronary syndromes who are at higher risk of 
major bleeding. 
Methods: Data on 8,010 patients from the Global Registry of Acute Coronary Events 
(GRACE) were analyzed. Predictors of major bleeding were identified using logistic 
regression analysis. 
Results: The overall incidence of major bleeding was 2.9% (4.4% ST-segment elevation 
myocardial infarction, 3.6% non-ST-segment elevation myocardial infarction, 1.2% unsta- 
ble angina and 1.8% other diagnosis). Table shows the odds ratios for different clinical 
characteristics. 
Variables Odds ratio 95% Cl p 
Age >80 years 2.4 1.68-3.45 <0.0001 
Female gender 1.8 1.32-2.44 0.0002 
Renal insufficiency (creatinine>2) 2.8 1 X7-4.39 <0.0001 
History of bleeding 2.4 1.37-4.45 0.0026 
Killip Class IV 2.4 1.28-4.63 0.0066 
Thrombolyws 2.0 1.45-2.79 <0.0001 
Diuretics 2.2 1.60-3.25 <0.0001 
PA catheters 4.4 3.05-6.42 <0.0001 
Cardiac catheterization 2.4 1.77-3.39 <0.0001 
Advanced age, female gender, history of bleeding, and renal insufficiency were the base- 
line clinical characteristics that were independently associated with a higher risk of bleed- 
ing (all pcO.01). This association remained after adjustment for other variables including 
hospital therapies and performance of invasive procedures (Table). 
Conclusions: Baseline clinical characteristics identify patients with ACS who are at 
higher risk of bleeding. Meticulous management of anticoagulation, and careful weighting 
of the risk/benefit ratio of therapeutic interventions and diagnostic procedures, may be 
potential targets for decreasing major bleeding in these patients. 
POSTER SESSION 
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1247-i Congestive Heart Failure in the Community: Missed 
Diagnosis and Missed Opportunities 
Kwame 0. Akosah, Karen Moncher, Ana Schaper, Paul Havlik, Rajah Sundaram. 
Stephen Devine. Gundersen Lutheran Medical Cenfer. La Crosse, WI 
Background: Heart failure is a major cardiovascular disease with increasing prevalence, 
mortality and economic burden. Limitations exist in optimal management of congestive 
heart failure: 1) many congestive heart failure patients do not receive recommended or 
adequate medications, 2) recent reports suggest underdiagnosis of congestive heart 
failure. Our objective was to determine the degree of missed diagnosis and examine its 
impact on mortality. 
Methods: We reviewed the medical records of patients admitted to the medical service I” 
1998 with a chief complaint of shortness of breath, without a diagnosis of congestive 
heart failure. We selected those with left ventricular ejection fraction -40% and applied 
the Framingham criteria for congestive heart failure to determine those patients who 
were missed (Group 1). We also examined the clinical characteristics of patients admit- 
ted during the same time period with a diagnosis of congestive heart failure (Group 2) 
and compared the clinical features and one year mortality of the two groups. 
Results: 100 of 225 (44.7%) in Group 1 had low left ventricular ejection fraction and 51 
(51%) met the Framingham criteria for diagnosis of congestive heart failure. Compared to 
Group 2 (n=240), resting tachycardia (Heart rate >120), and S3 gallop occurred more fre- 
quently in Group 1. However, symptoms and signs suggestive of fluid overload including 
peripheral edema, pulmonary rales, hepatomegaly, orthopnea, paroxysmal nocturnal 
dyspnea and jugular venous distention occurred less often in Group 1. Cardiomegaly on 
chest x-ray was present at the same rate (65% vs 64%), and mortality at the end of one 
year was high (17% vs 34%) in Group 1 and Group 2, respectively. 
Conclusion: The extent of missed diagnosis of congestive heart failure is high (51%). 
Physicians are more likely to diagnosis patients with signs and symptoms suggestive of 
fluid overload. Mortality at one year is high in patients who are not diagnosed. Many 
patients who meet Framingham criteria for congestive heart failure are not diagnosed, 
and thus, even less likely to receive recommended treatment. This represents a missed 
opportunity for improving outcomes in congestive heart failure. 
1247-2 Is Ramipril Cost-Effective as Well as Clinically Useful in 
Reducing Cardiovascular Risk? 
lqbal S. Malik, Vmay K. Bhatia, Jaspal S. Kooner. Hammresrnith Hospifal, NHLl at /CSM, 
London, United Kingdom 
Introduction: The HOPE trial showed that ramipril therapy significantly reduced the inci- 
dence of myocardial infarction, stroke or cardiovascular death (relative risk 0.78) and also 
reduced total mortality (relative risk 0.84) versus placebo in patients 255 years with ath- 
erosclerotic disease or diabetes mellitus plus an additional risk factor. Implementation of 
these findings would entail treating over 5% of the US population. We assessed the cost- 
efficacy of ramipril therapy in patients at risk of CHD events. 
Methods: We estimated the cost efficacy (cost/life-year gained) of ramipril therapy over 5 
years and with lifetime therapy. The gain in life-years (l-y) on therapy was the difference in 
total I-y between placebo and ramipril groups, calculated using the life-table method. Net 
cost of the therapy was the saving made from reduced health care needs subtracted from 
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the cost of drug treatment. Ramipril was estimated to cost $liday for a 1Omg dose. Drug 
costs and savings were separately assessed at 50.200% of initial values to account for 
regional price variations. The effect of discounting gain in I-y and costs at G%/year was 
estimated. The HOPE trial reported on a population with a mortality rate of 2.44%/y&w. 
We used our model to predict the cost efficacy for low (1.5%/y&z mortality), medium 
(4.5%) and high (7%) risk groups. 
Results: Cost efficacy of ramipril therapy in the HOPE trial population is $30,100/l-y 
saved at 5 years and $6100/1-y for lifetime treatment ($32,800 and $8300 with discount- 
ing, respectively). Lifetime cost efficacy varied between $1600-$15,000/l-y saved depen- 
dant on estimates of drug costs/savings. Lifetime cost efficacy is $11,000, $1000 and . 
51400/1-y (a reduction in cost) for those with low, medium and high risk respectively. 
Conclusions: Ramipril is cost effective treatment for patients with proven vascular dis- 
ease or diabetes mellitus plus an additional risk factor. Even for patients at lower risk, 
cost efficacy for lifelong therapy is substantially below $50,000/l-y, the value at which 
treatment is considered acceptable. 
1247-5 Baseline Results of the Heart Failure Practice Improvement 
Effort (HF PIE): A Pilot Health Care Financing 
Administration (HCFA) Initiative to Improve Out-Patient Care 
Neal D. Traven, Jane I? Taylor, Risa K. Hayes, Christine L. Mulgrew, Harlan M. Krumholz, 
Diana L. Ordin. Health Care Financing Administration, Boston, MA, Northeast Health 
QuaGty Foundation, Dover, NH 
1247-3 Determinants of Mortality from Co-Morbid Conditions in a 
Population Based Follow-up of 39,710 Newly Diagnosed 
Heart Failure Patients in Ontario, Canada 
Erika Vowinckel, Philip Jong, Peter Liu, Jack Tu. Heart & Stroke/Richard Lewar Centre of 
Excellence, Toronto, ON, Canada, Institute for Clinical Evaluative Sciences, Toronto, ON, 
Canada 
Prognosticators of mortality in heart failure have focused mainly on cardiovascular fac- 
tors. To determine how co-morbid conditions may influence heart failure mortality in the 
entire Ontario population, we sought to determine predictors of one-year mortality from 
all heart failure patients requiring hospitalization between 1994-1997. All patients admit- 
ted with a new primary diagnosis of heart failure (ICD-g-CM code 428) between 1994. 
1997 were included. Co-morbid conditions examined included myocardial infarction, 
peripheral vascular disease, cerebrovascular disease, dementia, chronic obstructive lung 
disease (COPD), diabetes mellitus, renal disease, malignancies, and demographic vari- 
ables. 
Of the 39,710 new patients diagnosed with heart failure during this period, multivariable 
analysis of the significant univariable co-morbid conditions contributing to the one-year 
mortality were as follows: 
Variable Odds Ratio p-value 
Age 75 and over 4.41 <0.0001 
Dementia 1.89 co.ooo1 
Malignancy 1.84 <0.0001 
Cerebrovascular disease 1.67 <0.0001 
Renal disease 1.56 <0.0001 
Peripheral vascular disease 1.53 <0.0001 
Rheumatologic diseases 1.43 0.0002 
Diabetes mellitus 1.28 <0.0001 
COP0 1.11 0.0002 
We conclude that elderly age and major co-morbid conditions are important predictors of 
one-year mortality following heart failure diagnosis on a population wide basis. Heart fail- 
ure often occurs in conjunction with other chronic diseases of the elderly. Concerted pop- 
ulation based prevention or treatment strategies may improve the outcome of heart 
failure on a broad basis. 
Background: Heart failure (HF) is a chronic disease treated largely in the outpatient set- 
ting, yet there are few reports of Systematic efforts to assess and improve quality of out- 
patient HF care. HCFA and Peer Review Organizations (PROS) in 11 states (CO, DE, 
KS, ME, NV, NY, NH, PA, UT, VT, WV) have begun a pilot project to develop quality indi- 
cators and identify effective practice improvement strategies for outpatient HF care. 
Study Design: 6-20 primary care and cardiology practices in each state volunteered to 
participate. Quality indicators (Qls) derived from AHA/ACC and HFSA guidelines and 
focusing on left ventricular function (LVF) evaluation and ACEI use were measured at the 
outset of the project. To assess a practice’s baseline indicators, PROS abstracted data 
from a minimum of 30 patients with 2 or more HF visits between 711998 and 12/1999. 
Additional measures (e.g. beta-blocker and digoxin use, blood pressure control) are 
being tested for abstraction feasibility and acceptability by practictioners. After baseline 
QI assessment, PROS assist practices to develop and implement HF care improvement 
efforts. Remeasurements to help practices monitor their efforts, and for HCFA to evalu- 
ate project success, will occur at intervals through Fall 2001. Results: As of 8/2000 we 
had analyzed 3044 patient records from 84 practices. Median age was 77 years (age 
range 22-100). LVF evaluation was documented in 82.3% of 2333 eligibles, with prac- 
tice-specific rates ranging between 35% and 100%. Of the 756 patients eligible for ACEI, 
568 (75.1%) were prescribed ACEI or had contraindications documented in the office 
records. While the median practice had a rate of 75%, practice-specific rates of appropri- 
ate ACEI use ranged from 0% to 100%. Conclusions: The baseline core QI rates 
reveal significant performance gaps, and appreciable between-practice variation, in LVF 
evaluation and ACEI treatment of heart failure in the office setting. Learning from high- 
performance practices and sharing lessons learned, PROS are facilitating practices’ 
efforts to address performance gaps. Information gained in this project will be applied to 
the next iteration of HCFA’s national efforts to improve HF care. 
1247-6 Pitfalls in Assessing the Quality of Ambulatory Care for 
Congestive Heart Failure in Managed Care Plans 
Thomas G. Di Salvo, Sharon-L& Normand, Paul J. Hauptman, Edward Guadagnoli, R. 
Heather Palmer, Barbara J. McNeil. Harvard Medical School, Boston, MA 
1247-4 Detecting Population-Level Protective Benefits of 
Potassium Replacement In Diuretic Users 
Background: Although sets of quality performance measures for congestive heart failure 
(CHF) have appeared, there have been few large-scale efforts to assess the quality of 
ambulatory care for CHF in managed care health plans. Methods: We developed and 
implemented a set of comprehensive quality performance measures designed to asse?s 
the quality of hospital and ambulatory CHF care in four US health plans at six different 
geographic sites. We used administrative, clinical and patient survey data to construct 23 
measures assessing appropriate therapy, diagnostic evaluation and physician communi- 
cation. We enrolled conwxtive patients discharged from the hospital with a primary 
ICD-9 discharge diagnosis of CHF and assessed care during hospitalization and the 6 
month post-discharge period. Results: Of the initial 694 CHF patients identified and 
enrolled, we excluded 298 (43%). In 140 patients (20%), we could not obtain all neces- 
sary hospital and ambulatory records and in 131 (19%) we could not confirm that CHF 
was the principal reason for admission upon explicit review of the medical record. The 
remainder were excluded for other reasons. We encountered significant delays in data 
retrieval (6-12 months) and problems in identifying the cardiologists within the plans 
accountable for care. There was no documentation of left ventricular ejection fraction 
(LVEF) in the in-patient or ambulatory medical records of 34% of the patients. Failure to 
Peter R. Kowey, Quanwu Zhang, Susan Garavaglia, William Hauer, Christopher Dilascia, 
Charles Alcorn, Raeburn Evans. Lankenau Hospital, Wynnewood, PA, ITG, Schering- 
Plough Corporation, Kenilworth, NJ 
Background: Potassium deficiency is a known risk for serious cardiovascular events. 
Use of diuretics increases the risk of hypokalemia and thus incidence of those events. 
Methods: 4,909 diuretic users were studied using administrative data between 1997-98 
of a commercial HMO. Potassium replacement was linked to a diuretic prescription if 
potassium was claimed within 15 days before or during the diuretic medication period. An 
associated cardiovascular event was coded if a related medical diagnosis appeared 
within 90 days of the index diuretic drug. &variates were measured in 1996. A repeated 
measures, crossover design was used. Results: Older individuals were increasingly 
mole likely to experience one of the cardiovascular events. That risk was doubled in 
males versus females. Diabetics were twice as likely to have one of the cardiovascular 
events. Pre existing coronary artery disease increased the odds by 27 percent. Concur- 
rent digoxin use yielded an odds ratio twice that of those without digoxin. With covariates 
controlled for, patients receiving potassium replacement were on average four times as 
likely to have one of the cardiovascular events. However, when compared within specific 
disease groups such as diabetes and hypertension, potassium replacement reduced the 
odds by 31% and 24%, respectively. In addition, it led to an 18-33% risk reduction for 
patients of 65-75 years and 30, 42 and 51% risk reduction for the end, 3rd and 4th addi- 
tional diuretic prescription, respectively. Conclusions: Two types of potassium effects 
from the study plausibly reflect physician practice and existing clinical findings. One 
shows that physicians prescribe potassium replacement to patients with greater per- 
ceived cardiovascular risk. The other is a clinically established protective benefit that was 
detected only as interaction effects when individuals at the same prior risk level were 
compared. These population-level findings, though exploratory, are informative as the 
data were generated through administrative records of healthcare practice, and in a large 
data set. 
document LVEF was the predominant reason for low ellglbillty rates (range lo-42%) of 
the performance measures of appropriate therapy. Across the plans, levels of perfor- 
mance varied widely across. the different measures ranging from 98% for use of diuretics, 
79% for use of ACEI to 15% for fluid restriction in the hospital. Patient survey response 
rates were disappointingly low (36%). Conclusion: Diagnostic misclassification, missing 
medical records, lack of standardized clinical data captured at the point of clinical care, 
.failure to assess ejection fraction and low measure ellglbillty rates hamper the measure- 
ment of the quality of hospital and ambulatory care for congestive heart failure in man- 
aged care plans. 
1247-7 Predictors of Heart Failure After Incident Myocardial 
Infarction: Have They Changed in the Reperfusion Era? A 
Population-Based Study in Omsted County, MN 
Jens P. Hellermann, Steven J. Jacobsen, Barbara F! Yawn, Susan Weston, Margaret M. 
Redfield, Richard J. Rodeheffer, Guy S. Reeder, Veronique L. Roger. Mayo Clinic, 
Rochester, MN, Olmsted Medical Center, Rochester, MN 
Background: Congestive heart failure (CHF) is a major complication of myocardial inf- 
arction (Ml). Data are limited regarding the predictors of CHF post-MI. Whether they have 
changed in the reperfusion era is unknown. This population-based study characterizes 
the predictors of post-Ml CHF over a lbyear period. 
Methods: Hospitalized MIS were screened from ICD9 codes 410-414 and classified 
using standard epidemiological criteria based on enzyme values, chest pain, and Minne- 
sota (MN) coding of the ECG. The entire community medical record, available via the 
Rochester Epidemiology Project was reviewed to determine incident status. Framingham 
criteria were used for the ascertainment of CHF including both in- and outpatient epi- 
sodes of CHF. Proportional hazard regression was used to identify predictors of CHF and 
thetr change over time. 
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gesting that RRmax and RRmin were reproduciable. RAF-lw and RAF-lm patients had 
significantly longer RRmax and mean IOLRR compared with SR-lm patients. RR-dis dis- 
tinguished all the 3 outcomes clearly ( In table the data presented as mean + SE. the RR 
unit is ms. *= piO.045, t = all 3 p value are <0.04;$= all 3 p value <O.OOZ). In multivariate 
analysis using AF duration, LA ,age, the RRmax ,mean lOL-RR and RR-dis, only 
RRmax, mean lOL-RR and RR-dis were independent predictors.There were significantly 
more patients with RR-dis > 1930ms in RAF-lw (p=O.O5) and RAF-lm groups (p=O.O15) 
than in SR-lm group. RR-dis 1930ms was a predictor for both of RAF-lw (Sens 
60%,Spec 63%) and RAF-lm (Sens 58%, Spec 71%). Conclusion: RRmax, mean lOL- 
RR and RR-dis are reproducable indices of AV conduction in AF and predict the outcome 
of DCC. 
Post DCC 5 Seconds 1 week 1 month 
Results: in the study period, 1657 patients (pts.) (mean age 67.2 ? 13.9 years, 43% 
women) had an incident Ml. History of diabetes, hypertension and prior CHF was found 
in 19%. 54% and 11% of ots. resoectivelv. After 5 “ears. 51% of ots. had exoerienced 
CHF. The clinical factors !nbependently as&iated ijth post-Ml CH; are shown below: 
Clinical Variables Risk Ratio’ (95% Cl) p value 
Age 
His?ory of prior CHF 
History of Diabetes 
History of Hypertension 
History of Tobacco use 
Kiilip Class 2 or greater 
Peak CK 
1.05 (1.04, 1.05) 
1.48 (1.19, 1.84) 
1.59 (1.33, 1.90) 
1.20 (1.02, 1.42) 
1.34 (1.12, 1.60) 
2.90 (2.46, 3.43) 
1.03 (1.02,1.04) 
p=o.o001 
p=o.o004 
p=o.o001 
p=o.o260 
p=o.o011 
p=o.o001 
p=0.0001 
*Proportional Hazard regression was adjusted for all variables 
No interaction between time and these predictors was detected. 
After adjustment for these variables, reperfusion therapy was associated with a 36% risk 
reduc:ion of post-MI CHF (RR 0.64. 95% Cl 0.52, 0.79, p=O.OOOi). 
Conclusion: In this geographically defined MI incidence cohort, there are strong positive 
independent associations between risk factors, clinical characteristics and CHF post-Ml. 
These associaiions did not change over time. After accounting for these predictors, rep- 
erfusion therapy was associated with a nearly 40% reduction in the risk of CHF, docu- 
menting its effectiveness in the community. 
POSTER SESSION 
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1280-l impact on Health Care of Curative Treatment by 
Radiofrequency Catheter Ablation of Accessory Pathway: 
Long-Term Results. 
Dominique Boulmier, Sr., Philippe Mabo, Sr., Dominique Pavin, Sr., Christophe Leclercq, 
Sr., Christina Alonso, Sr., Claude Daubert. Sr.. Departemenf de Cardiologie CHU, 
Rennes, France 
Radiofrequency catheter ablation (RFCA) is widely used as curative treatment in patients 
(pts) with symptomatic or asymptomatic, but potentially high-risk accessory pathway 
(AP). Few data are available on long-term impact in health care expenses. 433 consecu- 
tive pts (472 AP’s), mean age 36 + 17 years (6.85), were treated by RFCA in the same 
institution from 1991 to 1997. Before RFCA 61.5 % pts received antiarrhythmic drugs 
(AAD), mean number = 1.8 I 0.9/pt, during a mean time of 7.5 i 8.5 years. RFCA suc- 
cess rate was 92.2 % after i(86 %), 2 (12 %) or 3 (2 %) procedures. 4 procedure-related 
AV blocks (0.9 %) needed pacemaker implantation. No other serious complications were 
observed. After a mean follow-up (FU) time of 4.3 f 1.8 years, pts were requested to 
complete a standardised questionnaire on AAD use, number of medical visits (cardiolo- 
gist and family doctor), per year and number of unworked days related to arrhythmia. At 
the end of FU, only 30 pts (7 %) were still receiving AAD (p < .OOl). Reasons for contin- 
ued drug treatment ““are mainly paroxysmal AF (n = 13), and palpitations without any 
documented arrhythmia (n = 9). Rate of visits to cardiologist decreased significantly (p < 
.Ol) principally in pts without structural heart disease. There was also a significant trend 
to a decrease in the rate of visits to family doctor (mean decrease of 38 %/year in the 
whole population but only 21 % in pts with associated pathologies). Work absenteeism 
was significantly reduced : only 4 % stopped work once or more per year after RFCA as 
compared to 41 % before (p c .Ol). In conclusion: AP-RFCA results in a significant and 
sustained reduction in health-care expenses. This argues for extended indications of 
RFCA in invalidated or potentially-high risk patients. 
1280-2 Novel and Reproducible Ambulatory ECG Indexes Predic 
Recurrence of Atrial Fibrillation following Direct Current 
Cardioversion: A Prospective Study 
Xiaohua Guo, Mark M. Gallagher, Jan Poloniecki, Monica Harries, A.John Camm, Marek 
Malik. Sr George’s Hospital Medical School. London, Unifed Kingdom 
Background: We hypothesized that abnormal intra-atriai and AV nodal conduction 
reflects chronicity of atrial fibrillation (AF) and the severity of the underlying cardiac dis- 
ease and predicts the outcome of DC Cardioversion (DCC). Methods: Ambulatory EGG 
was recorded before and during DCC in Slpatients with persistent AF (89M, 66+iO yrs) 
All patients had EGG 1 week (1~) and imonth (lm) after DCC to assess the outcome. 
patients were classified as failed DCC, defined as sinus rhythm (SR) for c5 seconds or 
uninterrupted AF; recurrent AF (RAF) within either lw or lm or SR for over 1 m (SR-lm). 
AV conduction in each patient was assessed by measuring the maximum (RRmax) and 
minimum (RRmin), RR dispersion (RR-d@ calculated as RRmax-RRmin, the mean of 
the 10 longest RR intervals (IOL-RR) and 10 shortest RR intervals (IOS-RR) over 24 
hours. Results: There was no significant difference between groups in age, left atrial size 
(LA), AF duration or anti-arrhythmic drug used. There was a strong correlation between 
RRmax and lOL-RR, RRmin and 10s.RR (r:0.96: r:O.S respectively, p all <O.OOOi) sug- 
patients (no) 
RR max 
lOL-RR 
RR-dis 
SR (71) AF (20) SR (41) RAF(30)t SR (28) RAF(43)$ 
2363i652604t135 2193i86 2465+91 2059+832470*84 
2101+56 2271+102 1995?742223+77 1873+742234+69 
1977164 ‘2259?134 1871*852134+89 17422 802138&82 
1280-3 Atrial Flutter is an Independent Predictor of Stroke or Death 
in Both Men and Women 
Humberto Vidaillet, Juan Granada, Po-Huang Chyou, Karen Maassen, Param Sharma. 
Peter N. Smith, John Hayes. Marshfield Clinic and Marshfield Medical Research and 
Educafkm Foundation, Marshfield, WI 
Background: Gender-specific aspects of cardiovascular diseases are significant and 
largely misunderstood health problems. Important gender differences have been noted in 
trials of cardiac arrhythmias. Methods: To determine whether the increased risk of stroke 
or death reported with atrial flutter occurs in persons of both sexes, we analyzed data 
from the Marshfield Epidemiologic Study Area (MESA); a database that captures virtually 
all health events among its -60,000 residents. All new cases of atrial flutter diagnosed in 
persons ~75 years of age from 6/30/91 to 711195 were included in the analysis. For each 
incident case, one control of comparable age and gender was randomly chosen. Overall 
and gender-specific determinations were done using a Cox proportional hazards model 
that adjusted for the following preselected risks; age, congestive heart failure, diabetes 
mellitus, chronic obstructive pulmonary disease (COPD), hypertension, previous stroke, 
myocardial infarction (Ml), rheumatic heart disease, smoking, and thyroid abnormality. 
Results: A total of 224 subjects (112 atrial flutter cases and 112 controls were identified). 
Of these, 150 (67%)were males. In the group as a whole, atrial flutter (<.OOOl), age 
(.0332), COPD (.0381) and Ml (.0244) emerged as independent predictors of stroke or 
death. Of the 10 variables tested, only atrial flutter proved to be a significant marker in 
both sexes, (males,.0013; females, .0023) Conclusions: 1) Our data show that atrial flut- 
ter is an independent predictor of stroke or death in both men and women. 2) These find- 
ings provide additional support of the need to conduct randomized control trials to 
establish the efficacy of catheter-based ablation as a curative procedure for patients with 
this disabling and lethal disease. 
1280-4 Educational Training Program as Treatment of Patients With 
Vasovagal Syncope 
Danilo Cervellati, Carmine Pizzi, Giorgio Visani, Grazia M. Costa, Luca Gabrieli, Alberico 
Borghi. Fiaffaele Bugiardini. Dept. Cardiology, lmola Hospifal University of Bologna, 
Bo@m, /ra/y 
Background. Althought pts with neurocardiogenic syncope are often treated by medical 
therapy and pacing, the medical management is still not satisfactory. Aim of our study 
was to evalute changes in lifestyle in the attempt to reduce the number of syncope racur- 
rences in pts found to have a positive tilt test. Methods. Among 111 consecutive tilt test 
(Westminster protocol) during 36 months, we observed 72 positive test (40 males, 32 
females, mean age 45.5+/-18.6, time to symptoms onset 58.5+/-72.4 months) and we 
grouped these pts in two randomised single blind treatment subsets: group A (36 pts); 
immediately after discharge they were followed by a mixed nurse and cardiologist team 
for a week. During this time the team was devoted to reassure pts about the benignity of 
the syndrome, to inform pts about the way to prevent syncope by recognizing the pro- 
drome symptoms and avoiding any triggering condition (pts were teached to refrain from 
attending hot or crowded places, and staying in upright posture for more than 1 hour). Pts 
were admitted routinely (every 6 months) to the outpatient ambulatory to control their 
clinical conditions and their compliance to the prevention measures they learnt. Group B 
(36 pts): they were given placebo. Both groups had the same number of syncope before 
tilt test (5.45+/-6.5). Pts were followed-up for 1 year. Results. We analysed the number of 
syncope recurrences during the follow-up time. Pts followed-up by the nurse/cardiologist 
educational team had a significantly lower incidence of recurrences(O.23+/-0.76 vs 2.1 +i- 
5; p<O.OOl, respectively)as compared to pts in placebo. Pts in placebo showed a partially 
spontaneous reducuction of symptoms (2.1+/-5 vs 5.45+/-6.5 pre tilt test; p=O.Ol). Con- 
clusions. These data indicate that an appropriate educational trial about changes in pts 
lifestyle may have a therapeutic impact on pts with neurocardiogenic syncope. The clini- 
cal value and the cost/benefit ratio of this educational program has to be compared with 
medical treatment. 
1280-5 The Cost and Utility of Diagnostic Tests in the Evaluation of 
the Child With Syncope 
Leonard A. Steinberg, Timothy K. Knilans. The Heat? Cenferaf Childrens Hospifal 
Medical Center, Cincinnati, OH 
Background: This study was performed to determine the current use, cost, and utility of 
diagnostic tests in the evaluation of syncope in children. Methods: Records of 169 chil- 
dren initially presenting between January 1998 and December 1999 for clinical evalua- 
tion of syncope were reviewed. Diagnoses were recorded as documented in the medlcal 
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record, and the number, type, result, and cost of tests were compiled, including tests per- 
formed at other institutions. The costs of tests were calculated using a relative value unit- 
based costing methodology and were based on hospital outpatient costs for 1999. The 
costs of hospitalizations, clinic visits, and emergency room visits were not included. A 
test was consrdered diagnostic when an abnormal result was consistent with the diagno- 
sis or when, in the absence of abnormalibes, a typical syncopal event was recorded. 
Results: Patients ranged I” age from 4.5 to 18.7 years (mean 13.2 * 3.6). A diagnosis 
was established in 128 patients (76%). Neurocardiogenic syncope was the leading 
cause. A total of 663 tests were performed. The cost par patient ranged from $0 to 
$10,686 and averaged $1,068 per patient (median $503). Diagnostic test results were 
obtained in 24 subjects (14%) and included 26 studies (4%). These studies supported 
the diagnosis of neurocardiogenic syncope (16) long QT syndrome (2) seizure (2) 
pseudoseizure (2) and exercise induced ventricular tachycardia (1). Three studies dem- 
onstrated absence of arrhythmia during a syncopal event. The cost per diagnostic test 
was $6,928. In 104 patients, a dlaQnOSis was established without a diagnostic test. 
Echocardiograms, cardiac catheterizations, ek?CtrOphySiOlOQy studies, chest x-rays, 
serum studies and urinalyses were not diagnostic in any case. Conclusion: The currant 
use of diaQnOStiC tests in the evaluation of the child with syncope is costly and is unlikely 
to produce diagnostic results. Thus, an approach that focuses on the use of tests prima- 
rily too screen for and confirm the presence of life threatening disorders may reduce 
costs with little change in diagnostic efficacy. 
earlier) was associated with lower mortality. Multivariate model revealed only SBP cl00 
mrIIHQ to be associated with mortality (p < 0.001) with periaortic hematoma being mar- 
ginally associated (p =O.lO). 
Univariate Associates Of Mortality Among Survivors AmOnQ Deaths p-Value 
1280-6 Percutaneous Therapeutic Procedures in Acute Aortic 
Dissection: Evidence for Benefit is Mounting 
syncope-% 1.6 10.3 0.028 
Neurologic deficit-% 7.5 21.9 0.028 
SBP c 100 mmHg-% 1.6 18.8 <O.OOi 
Periaortic hematoma-% 17.5 36.7 0.013 
Marginally Associate of Mortality 
Lower mean SBP on presentation mmHg 170 154 0.07 
Aortic atherosclerosis-% 36.1 53.1 0.06 
Surgical (as oppose to medical) treatment-% 13.5 34.4 0.07 
Associated With Decrease Death 
Abrupt onset of pain-% 88.2 72.4 0.018 
Chest pain-% 71.4 43.3 <0.001 
Marginally Associated Decrease Death 
Migrating pain-% 26.9 10.7 0.06 
Conclusions: In- hospital mortality due to ABAD remains higher than generally appreci- 
ated. Current sample size lacks discriminatory power to generate a strong predictive mul- 
tivariate model for death and reflects the variability in presentation. treatment and 
outcomes of this disorder. 
Rossella Fattori, Kim A. Eagle, David Williams, Jeanna Cooper, Eric Isselbacher, 
Christoph Nienaber. Unwersity of Michigan Medical Center, Ann Arbor, MI 
Background: In order to assess the diffusion of percutaneous therapeutic procedures in 
management of acute aortic dissection over the past 4 years, and their effect on short- 
term outcome, we analyzed 760 consecutive patients enrolled in the International Regis- 
try of Aortic Dissection (IRAD) from 1996 to 1999. 
Methods: We assessed the frequency of stem-graft and/or fenestration procedure year 
by year, the type of patients receiving them, and compared hospital mortality of patients 
with Type B dissection treated with stent-graft to patients treated with medical therapy. 
Results: 50 patients received stent-graft and/or fenestration, 38 were in Type B 
dissection. The % of patients annually receiving such therapy from 1996 to 1999 was 
2.6%, 5.3%, 8.4% and 13.2% respectively. Among 31 patients with stent graft only for 
Type B dissection, compared to 207 receiving medical therapy, there were similar fre- 
quencies of comorbid factors known to be predictors of mortality (Table): however, there 
was a trend for lower mortality in those treated with stent-graft. 
Conclusion: Percutaneous therapies, particularly St&-graft, are being increasingly 
used to treat acute Type B aortic dissection. As was shown in small randomized trials of 
subacute Type B dissection, early results from IRAD suggest stent-graft therapy may 
result in superior outcomes compared to medical therapy alone. 
Acute Type B Aortic Dissection 
Predictive Factor Percutaneous TX: Stent Medical Only P Value 
n=31(%) n=205(%) 
Female 8131 (25.8) 72/207 (34.8) 0.32 
Age265 years 19/31 (61.3) 121/207(58.5) 0.76 
Abrupt pain 26/31 (83.9) 173/207(86.1) 0.74 
Hypotension 0131 (0) 7/207 ( 3.5) 0.29 
Pulse deficits 4123 (17.4) 33/187 (17.6) 0.98 
Periaortic hematoma 6/31 (19.4) 361207 (17.4) 0.79 
Hospital death 1135 (2.9) 191207 (9.3) 0.18 
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1505-l Diagnosis of Moderate Coronary Stenosis by Stenosis 
Sounds 
Osamu Tat&hi, Keiichi Chin, Yutaka Gotou, Takeshi Nogimura, Seibu Mochizuki, 
Katsuhiko Machida. Jikei University School of Medicine, Kashiwa, Japan 
1280-7 Mortality in Type B Acute Aortic Dissections in the Current 
Era: Results From the International Registry of Aortic 
Dissection (IRAD) 
Background: Coronary stenosis produces a diastolic sound due to turbulent flow in par- 
tially occluded arteries. This sound is useful for early diagnosis of coronary artery dis- 
ease. We analyzed the diastolic heart sounds in coronary artery patients using power 
spectrum analysis and observed the differences in spectral patterns based on the degree 
of coronary stenosis. Methods: We recorded heart sounds from the second, third and 
fourth left intercostal spaces (2L, 3L, 4L) and the second and third right intercostal 
spaces (2R, 3L) in 137 cases (97 coronary artery patients, 9 aortic or pulmonary regurgi- 
tation patients, 31 normal healthy volunteer). Coronary stenosis was classified into mod- 
erate (50-90%) severe (99-lOO%), and free (O-25%). In each patient, diastolic heart 
sounds were analyzed by the maximum entropy method, and the spectral power between 
400-1500 Hz was measured. Results: The spectral power of the 400-700Hz band was 
highest in the moderate stenosis group. Statistically significant differences between the 
moderate stenosis group and the severe and free groups were observed in 2L and 4L 
when the stenosis was at the left main trunk or the left anterior descending artery, in 4L 
when at the circumflex artery, and in 4L and 3R when at the right coronary artery. Though 
valvular disease patients with diastolic regurgitant murmurs also had high spectral power 
in the 400-700 Hz band, their spectral patterns differed from those moderate stenosis. 
Conclusion: The difference of spectral patterns between the severe and free stenosis 
and the moderate stenosis made possible their diferential diagnosis. 
Toru Suzuki, Christoph A. Nienaber, Peter G. Hagan, Eduardo Bossone, Dan Gilon, 
Jeanna V. Cooper, David Bruckman, William F. Armstrong, Kim A. Eagle, Rajendra H. 
Mehta. University of Tokyo, Tokyo, Japan, University of Michigan for /RAD Invesfigators, 
Ann Arbor, MI 
1505-2 Can Physicians Identify Severe Angiographic Disease 
Better than Scores? 
Background: Acute type B aortic dissection (ABAD) is a medical emergency with high 
mortality. Data are limited regarding the clinical factors predicting death and most reports 
are small, single center experiences that have accumulated patients over 5 years or 
more. Methods: We evaluated 284 patients with ABAD (between 12/95-12/99) from 
International Registry of Aortic Dissection (IRAD) (mean age 66+13 years, males 69%). 
Univariate associations with in-hospital mortality were assessed; and multivariate logistic 
regression was performed to identify predictors of death. Results: In-hospital mortality 
occurred in 11.3% ABAD patients. Univariate associations of mortality are as shown 
(Table). Chest pain on presentation (most likely as it brought patients to medical attention 
Michael J. Lipinski, Dat Do, Eddie Atwood, Lars Osterberg, Jeffrey West, Barry Franklin, 
Victor F. Froelicher. Stanford/PAVAHCS, Palo Alto, CA, William Beaumont fiospital, 
Royal Oak, MI 
The recent ACC/AHA exercise testing guidelines provided the equations to calculate 
treadmill scores and recommended their use to improve diagnostic accuracy. However, if 
physicians can estimate the probability of severe coronary disease as well as the scores, 
there would be no need to add this complexity to test interpretation. To compare the 
scores to physicians, we used a database of 686 patients with exercise test and coronary 
angiographic data to generate clinical/treadmill reports as well as severe disease esti- 
mates based on the recommended scores. Methods: Six hundred and eighty-six con- 
secutive male patients with a mean age of 59+10 years were considered for this study. 
Twenty-five percent of these patients had severe angiographic disease, which was 
defined as coronary lumen occlusion 350% in the proximal LAD and another vessel, triple 
vessel disease, or left main disease. The reports were sent to expert CardioioQists, ran- 
domly selected cardiologists, and internists who classified them as high, low, or interme- 
diate probability of having severe angiographic disease in addition to a probability from O- 
100%. Results: Forty-five expert CardiOfOQiSts returned estimates on 473 patients, 37 
randomly selected practicing cardiologists returned 202, 29 randomly selected internists 
returned 162, 13 academic cardiologists returned 145, and 27 academic internists 
returned 272. When probability estimates ware compared using ROC analysis, the con- 
sensus of scores. performed better than all the physician groups (.67 AUC for experts to 
.72 for Con, .60 AUC for random cards to .78 for Con, .69 AUC for random internists to 
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.76 for Con, and better than both academic groups). Physlclan groups were also much 0.8; trend P=O.2), there was no association with CABG occurring 1 month after discharge 
more likely lo classify a patient wth severe disease as low probability and therefore miss (OR 1 .O; 95% Cl: 0.6, 1.7; trend P=O.7). Laboratory volume also was not significantly 
these patients. Consensus only classified less than 2% of patients with severe disease associated with post-discharge revascularization (PCI or CABG) at 1 month (OR 1.1; 
as low probability while experts missed 28%, random cards missed 22%, and internists 95% Cl: 0.8, 1.4; trend i&0.07) or l-6 months (OR 1.05; 95% Cl: 0.91, 1.20; trend 
missed 15%. Conclusion: The scores based on clinical and exercise test results outper- P=O.47). For any PCI, CABG, MI, or death, the results were: 1 month (OR 0.9; 95% Cl: 
formed physician estimates of the presence of severe angiographic coronary artery dis- 0.6, 1.2: trend P=O.90), l-6 months (OR: 1.08; 95% Cl: 0.95, 1.23: trend PzO.14). Con- 
ease. elusion: This study did not reveal an association between laboratory volume and ravas- 
cularization, myocardial infarction, or mortality following hospital discharge. If confirmed, 
these results suaaest that in-hospital comolications will remain the standard for assess- 
ORAL CONTRIBUTIONS 
I- 
ing laboratory volume and that selective use of higher volume laboratories may not 
improve longer-term outcomes. 
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896-l Management Approach is Changed Most Frequently After 
Electron Beam Computed Tomography (EBCT) Coronary 
Calcium Scanning in Patients With Intermediate 
Conventional Risk Profiles 
Thomas Knickelbine, Timothy A. Dirks, Lise Lunde. Thomas E. Gohman, Geoffrey I?. 
Bodeau, Scott W. Sharkey, Fredarick L. Gobel. Minneapolis Heart Instifute, Minneapolis, 
MN 
Background: Electron Beam Computed Tomography (EBCT) age and sex adjusted cal- 
cium scoring has been proposed as a tool for early cardiac risk stratification. The identifi- 
cation of appropriate patients to refer for screening remains unclear. The value of EBCT 
scanning can be defined as an EBCT risk outcome that is noi concordant with the pre- 
existing NCEP conventional risk profile and would therefore change management 
approach. This study was designed to determine which patients may be most appropri- 
ate for EBCT scanning by examining the relationship between conventional NCEP risk 
profile and EBCT risk. Methods: We assessed the value of EBCT scanning compared io 
existing conventional NCEP risk profiles in 2022 consecutive patients scanned at our 
institution from 9199 io 6100. EBCT calcium scores were calculated by Ihe Agatston 
method and converted to age and sax matched percentiles by comparison to a database 
of 19,000 individuals. ConventIonal risk factors (RF) were gathered by detailed question- 
naire including hypertension, diabetes, smoking, hyperlipidemia, and family history of 
heart disease. Groups were separated into low conventional risk (0 RF), intermediate risk 
(l-2 RF), and high risk (53 RF). EBCT risk was defined as low (<25th age/sex %), inter- 
mediate (25-75th %), and high risk ((875th %). EBCT value was defined as an EBCT 
result which was not concordant with conventional risk and would result in a change in 
management approach. Results: EBCT value was highest in the intermediate conven- 
tional risk group (p<.OOl vs low risk, p=.O4 vs high risk), followed by high conventional 
risk (p c.001 vs low risk) and had the least value in low conventional risk individuals (64% 
concordant result). 
Comparison of Conventional Risk YS EBCT Risk 
Conveniional # RF 
Risk 
LOW hit 
EBCT Risk 
High EBCT Value 
Low (271) 0 173(64%) 67(25%) 31(11%) 98(36%) 
h-d (1320) 
Hiah 14311 
1-2 681(52%) 365(26%) 274(21%) 955(72%) p<.oo1 “S low, 
p=.O4 vs high 
>=3 165f38%1 123(29%1 143(33%1 288(67%\ w.001 “slow 
- /  I /  I I  I I  ~ I .  
Conclusion: Cardiac EBCT calcium age and sex adjusted percentile scoring has most 
value and will most likely change management approach in patients with intermediate 
conventional NCEP risk profiles. 
896-2 
IO:45 a.m. 
Lack of Association Between Coronary Angioplasty 
Laboratory Volume and Outcomes Following Hospital 
Discharge 
Stephen E. Kimmel, William H. Sauer, Colleen Brensinger, John Hirshfeld, Howard L. 
Haber, A. Russell Localio. University of Pennsylvania School of Medicine, Philadelphia, 
PA, Center for Clinical Epidemiology and Biostatistics, Philadelphia, PA 
Background: Although an inverse association has been established between short-term 
complications of percutaneous coronary interventions (PCls) and angioplasty laboratory 
volume, no data are avaIlable on the association between laboratory volume and out- 
comes following hospital discharge. Because in-hospital complications from PCI are 
diminishing, the effect of laboratory volume on post-discharge events may become a 
more important marker of quality. Methods: A cohort study of 25,222 patients undergo- 
ing PCI ovar a 15-month period in 1994 through 1995 in all 43 laboratories in Pennsylva- 
ma was performed using the Pennsylvania Health Care Cost Containment Council 
database. The association between laboratory volume and in-hospital, 1 month, and 6 
month events was determined using multivariable analyses adjusting for age, gender, 
race, insurance. length of stay, multivessel PCI, clustering, prior PCI, and an admission 
severity score. Multivariable odds ratios (OR) are presented for comparisons using cur- 
rent recommendations (<400/year vs. x400) and tests for trend P-values using volumes 
~400, 400.599, 600.899, or 900+. Results: Although higher volume was associated with 
reduced In-hospital coronary bypass (CABG; OR for >=400 PCls/year 0.6; 95% Cl: 0.4, 
896-3 
11:OOa.m. 
Trained and Supervised Physician Assistants Can Safely 
Perform Diagnostic Cardiac Catheterization and Coronary 
Angiography 
Richard A. Krasuski. John J. Warner, Andrew Wang, J. Kevin Harrison, John F. Belles. 
Erica L. Maloney, &role Ross, Thomas M. Bashore, Michael H. Sketch, Jr.. Duke 
University Medical Center, Durham, NC 
Background: The rising costs of medical care and the shortage of qualified physicians 
has led to the routine use of physician extenders in the provision of medical services. 
Some academic and proprietary medical centers use physician extenders to assist in 
diagnostic cardiac catheterization. Despite this fact the safety of this practice has not 
been formally examined. 
Methods: Trained physician’s assistants (PA) were granted privileges to perform diag- 
nostic coronary angiography under close supervision of an attending physician at our 
institution in July 1998. The demographic information and results of cardiac catheteriza- 
tions were prospectively collected in a database. We compared the results of 929 diag- 
nostic cardiac catheterizations performed by PA between July 1998 and April 2000 with 
4521 catheterizations performed by cardiology fellows with similar supervision during the 
same period. 
Results: The demographics of patients undergoing cardiac catheterization by PA did not 
differ from patients undergoing diagnostic cardiac catheterization by fellows in terms of 
gender, race, angina class, prevalence of diabetes, obesity, number of diseased coronary 
arteries or LV ejection fraction. Class Ill and IV congestwe heart failure was more com- 
mon in fellow cases (19.5% of fellow cases and 13.2% of PA cases, p=O.OOi). PA cases 
tended 1o be slightly faster (70.2 + 32.6 minutes vs. 72.6 i 35.2, p=O.O5) and used less 
fluoroscopic time (10.2 ? 6.5 minutes vs. 12.2 i 9.9, p=O.OOOl). No difference in the vol- 
“me of contrast media used was seen. The incidence of major complications including 
myocardial infarction, stroke, arrhythmia requiring defibrillation or pacemaker placement, 
pulmonary edema requiring intubation and vascular complications requiring surgical 
intervention were similar between the two groups (0.22% in PA cases and 0.24% in fellow 
Cases). 
Conclusions: Under the careful supervision of experienced attending cardiologists, 
trained physician assistants can perform diagnostic cardiac catheierization, including 
coronary angiography, with procedural times and complication rates similar to those of 
cardiology fellows in training. 
896-4 
11:15 a.m. 
Should Patients With Acute Coronary Syndromes be 
Managed by Cardiologist or General Physicians? Results 
From the Prospective Registry of Acute lschaemic 
Syndromes in the United Kingdom (PRAIS-UK) 
Diego Perez de Arenaza, Ameet Bakhai, Julian R. Collinson, Marcus D. Flather, Marcelo 
C. Shibata, William Hubbard, John Davies. CTEU, RoyalBrompton and Harefield Trust, 
London, United Kingdom 
Background: Acute coronary syndromes (ACS) without ST elevation are important 
causes of hospital admission. Studies have suggested that care provided to patients var- 
ies according to the treating specialist. We aim to compare practice patterns between 
cardiologists and general physicians. Methods: 1046 patients with ACS were recruited 
from 56 hospitals in the UK and followed up for 6 months. Patients had a history of car- 
diac pain and one or both of the following: ischaemic changes on the EGG; prior evi- 
dence of coronary artery disease. Patients admitted under the care of a cardiologist 
(group A, n=350) ware compared to those admitted under the care of a general physician 
(group B, “~348). Results: Patients in both groups were similar: mean age 65*12yrs, 
men 60.6%, diabetes 17.5% prior Ml 47.4%, ST depression on the admission ECG 
29.5%. During hospital admission 13.2% of patients in group A received angiography 
compared to 9.8% in group B (p=O.Ol) and 10.3% and 4.6% respectively received ravas- 
cularisation (p=O.O04). Less low molecular weight heparin was given to group A 38.5% 
vs. 49.0% (p=O.OOi), but more intravenous heparin was used 36.2% vs. 21 .O% (p=O.OOl) 
with total heparin usage of 72.3% and 64.8% (p=O.Oi). In hospital rates of death/Ml were 
3.9 vs. 4.9% respectively (p=O.7). Use of aspirin, beta blockers and statins ware similar in 
both groups. At 6 months rates of angiography and revascularisation remained higher in 
group A: 31.2% vs. 22.1% (relative risk 1.4, p=O.O4), and 21.7% vs.14.6% (relative risk 
1.5, p=O.O2) respectively while death or new Ml occurred in 11.5% in both groups. Con- 
clusion: Baseline characteristic and outcomes did not appear to differ between patients 
under the care of cardiologists or general physicians. Specialist care increases the rates 
of angiography and revascularization but the impact on outcomes is unclear. Further 
studies in this area are needed to optimize treatments for ACS in UK. 
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896-5 The Outcome of Patients With Acute Myocardial Infarction 
is not Dependent on the Admission Volume of Coronary 
Care Units 
The Israeli Working Group for Intensive Cardiac Care. lsrael Heart Society, Tel 
Hashomer, lsrael 
Background: A recent study suggested that hospitals with low admission volume (AV) 
of patients (pts) with acute myocardial infarction (AMI) had higher mortality rates. Meth- 
ods: We compared the characteristics, management and outcome of a large group 
(n=5398) of AMI pts admitted to all operating coronary care units (CCUs) (1x26) in Israel 
in 4 prospective P-month national surveys in the ‘90’s, in relation to AV defined as low (c/ 
-12 ptsimonth; 6 CCUs), m’edium (13-27 ptsimonth; 13 CCUs) and high >/-28 pts/month; 
7 CC&) AV. All CCU s are staffed by cardiologists. Results: There were no differences 
in patients characteristics and acute repeiiusion therapy in relation to AV. Crude and 
adjusted mortality rates were similar in CC& with low, medium and high AV. 
Low AV Medium AV High AV p Value 
(n=471) (“=2645) (n=2262) 
Men(%) 75 73 75 NS 
Age (mean) 61.5 years 63.7 years 62.6 years 0.01 
Diabetes(%) 29 26 25 NS 
ACE-Inhibitors(%) 34 50 37 <O.OOi 
Beta-blockers(%) 43 60 39 <O.OOl 
Primary PTCA(%) 2 3 5 <O.OOl 
Thrombolysis(%) 46 45 46 NS 
PTCA/CABG(%) 24 23 23 NS 
Odds Ratios*(95% Cl) 
30.day mortality 1.13(0.79-l 61) 1 .o 1.16(0.94-1.42) 
B-month mortality 1.04(0.74-l .44) 11.15(0.96-l .39) 
* Adjusted for age, gender, prior MI, diabetes, congestive heart failure and reperfusion 
therapy 
Conclusion: Our results suggest that in CCUs staffed by cardiologists, management and 
prognosis of AMI pts is unrelated to AV. 
896-6 
11:45 a.m. 
The Frequency and Nature of Warfarin Drug Interactions 
That Increase Bleeding Risk in Atrial Fibrillation Patients 
Patricia A. Howard, Edward F. Ellerbeck, Kimberly K. Engelman, Kelly Patterson. 
University of Kansas Medical Center, Kansas City, KS, Kansas Foundation for Medical 
Care, Topeka, KS 
Background: Practice guidelines for stroke prophylaxis in atrial fibrillation have led to 
increased utilization of wai-farin. However, little is known about the frequency with which 
these patients are prescribed interacting drugs that could increase the risk of bleeding. 
Methods: We retrospectively examined the medical records of 704 Medicare beneficia- 
ries over 65 years of age discharged from Kansas acute care hospitals between 4/i/98 
and g/30/98 with a principal or secondary diagnosis of atrial fibrillation. We identified all 
patients discharged on war&in. We examined all other drugs prescribed at the time of 
discharge and identified any drugs that potentially could increase the international nor- 
malized ratio (INR) through pharmacokinetic or pharmacodynamic interactions with war- 
farin or increase the risk of bleeding through other pharmacological mechanisms. 
Results: We identified 256 patients discharged on warfarin of which 117 (46%) were pre- 
scribed another medication that could prolong the INR and/or increase the risk of bleed- 
ing. Among the 256 patients, 106 (41%) were discharged with a total of 150 prescription?. 
for drugs that could increase the INR. Antibiotics accounted for 67% of these prescrip- 
tions. Among the 256 patients receiving warfarin, 53 (21%) received a total of 56 pre- 
scriptions for agents that could increase the risk of bleeding through pharmacological 
mechanisms. Of these prescriptions, 73% were for antiplatelet agents (including aspirin) 
and 16% were for nonsteroidal antiinflammatory drugs other than aspirin. Utilization of 
medications that could increase the INR or bleeding risk was not related to patient age or 
gender. Patients with a history of coronary artery disease were more likely than others to 
receive antiplatelet agents in combination with warfarin (OR = 2.90, 95% Cl = 1.2 _ 8.7 ) 
Conclusions: Atrial fibrillation patients discharged on warfarin are frequently prescribed 
concomitant medications that may increase the risk of bleeding. The most comrnc~n 
potential interactions are with antibiotics or antiplatelet agents. These patients should be 
counseled to watch for signs of bleeding and have frequent INR monitoring after dis- 
charge. 
